WO2016076240A1 - Female silkworm lethal strain of bombyx mori - Google Patents

Female silkworm lethal strain of bombyx mori Download PDF

Info

Publication number
WO2016076240A1
WO2016076240A1 PCT/JP2015/081397 JP2015081397W WO2016076240A1 WO 2016076240 A1 WO2016076240 A1 WO 2016076240A1 JP 2015081397 W JP2015081397 W JP 2015081397W WO 2016076240 A1 WO2016076240 A1 WO 2016076240A1
Authority
WO
WIPO (PCT)
Prior art keywords
gene
silkworm
masc
female
promoter
Prior art date
Application number
PCT/JP2015/081397
Other languages
French (fr)
Japanese (ja)
Inventor
めぐみ 笠嶋
秀樹 瀬筒
進 勝間
隆史 木内
雅京 鈴木
Original Assignee
国立研究開発法人農業生物資源研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 国立研究開発法人農業生物資源研究所 filed Critical 国立研究開発法人農業生物資源研究所
Publication of WO2016076240A1 publication Critical patent/WO2016076240A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/033Rearing or breeding invertebrates; New breeds of invertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology

Definitions

  • the present invention relates to a female pupal dead silkworm strain having a mutant Masc gene expression vector, and a method of eliminating female pupae using the same.
  • the silk thread spun by male silkworms (Bombyx ⁇ mori) is superior in terms of thread quality because it is slender and has less variation in fineness than silk thread spun by females. Moreover, even when the same amount of feed is ingested, it is known that the production amount of male raw silk is about 20% higher than that of females (Non-patent Document 1). Furthermore, since silkworms have lost their flying ability, they are approved for use in the first type based on the Cartagena Act, that is, use without preventing diffusion into the environment. Can not rule out the possibility of crossing with the male of the quay (Bombyx mandarina) to get. For this reason, there is a need for bred breeding for breeding only male individuals in order to maintain useful strains and prevent the spread of genetically modified organisms into the environment. Therefore, the technology for freely maleizing silkworm breeding individuals is extremely useful in industry.
  • the doublesex (dsx) gene encoding a transcription factor functions at the most downstream of the sex determination cascade, and it has been found that sex determination is made by the splicing pattern of the mRNA.
  • Attempts to overexpress silkworm dsx (Bmdsx), which shows a male splicing pattern, to make males, etc. have been made so far, but none of them have succeeded in order to establish a male breeding method. References 2 and 3).
  • Non-patent Document 4 Non-patent Document 4
  • Non-patent Document 5 since the W chromosome of silkworm has a complex structure with multiple transposons inserted (Non-patent Document 5), it is difficult to determine the base sequence over the entire region, and recombination does not occur in females. No forward genetic analysis was possible, and the identity of the female determinant remained unclear. Therefore, the technique to breed only males using the sex-determining mechanism and sex differentiation genes of silkworms has not been established so far.
  • Platinum Boy registered trademark
  • This breed is designed so that only the male individual can survive by using the two types of equilibrium lethal genes and letting the lethal gene work in the female individual, resulting in embryonic lethality (Non-patent Document 6).
  • Platinum Boy is on the market and has a reputation for the high quality of silk thread produced (Non-patent Document 7).
  • this variety has a big problem that it takes a lot of labor and time to produce. Usually, to get a Platinum Boy, you have to go back two generations before mating, and it takes a year to produce it.
  • the problem of the present invention is that it is possible to easily maintain and manage the strain without disturbing the genetic background using a sex determination mechanism or a sex differentiation gene, and it can be applied to a gene recombination technique.
  • Another object of the present invention is to establish and provide Lepidoptera insect strains, particularly silkworm strains, which can be bred male in a short and simple manner.
  • the present inventors found that when the mutant Masc gene was overexpressed in the silkworm, no abnormality was found in the male individual, but the female individual did not become male, It became clear that he died by the time of larvae. Based on this finding, the present inventors introduced a mutant Masc gene into a host cell of a lepidopteran insect, and controlled its expression to control the female lethality of the host, thereby arbitrarily controlling the domestic individual. Successfully made an individual.
  • the present invention is based on the research results and provides the following.
  • a mutant Masc gene having cleavage resistance against the Fem piRNA-Siwi complex and the activity of the wild-type Masc gene, and the Fem at positions 1391 to 1419 in the silkworm Masc gene comprising the base sequence represented by SEQ ID NO: 1.
  • the mutation is present in a region consisting of 15 consecutive bases including positions 1409 and 1410 in the Fem piRNA recognition sequence in the silkworm Masc gene, or in a corresponding region in the ortholog of the Lepidoptera insect of the silkworm Masc gene.
  • the mutant Masc gene according to (1) (3) The mutant Masc gene according to (1) or (2), wherein the base substitution is a silent mutation.
  • a mutant Masc gene expression vector comprising the mutant Masc gene according to any one of (1) to (3) operably linked downstream of a ubiquitous expression-inducible promoter.
  • the mutant Masc gene expression vector according to (4), wherein the ubiquitous expression-inducible promoter is a heat shock protein 70 promoter.
  • a first expression unit comprising a ubiquitous promoter and a gene encoding a transcriptional regulatory factor operably linked downstream of the promoter, and a functional promoter linked downstream of the target promoter of the transcriptional regulatory factor and the target promoter
  • a mutant Masc gene expression vector comprising a second expression unit comprising the mutant Masc gene according to any one of (1) to (3).
  • a female pupal dead silkworm strain comprising the mutant Masc gene expression vector according to (4) or (5).
  • a method for producing a female pupal dead silkworm comprising the step of subjecting an embryo at an early stage of development to an expression induction treatment in the female pupal dead silkworm strain according to (9).
  • mutant Masc gene and the expression vector of the present invention makes it possible to easily produce a female dead lethal silkworm strain.
  • the female dead lethal silkworm strain of the present invention a strain that can easily obtain a female dead lethal silkworm from the strain can be easily maintained or managed without disturbing the genetic background.
  • Application to genetic recombination technology is possible, and male breeding can be carried out conveniently and arbitrarily in a short period of time. Thereby, high-quality silk thread can be produced efficiently.
  • the female pupal dead male infertile silkworm strain of the present invention since it is possible to suppress crossing with natural mulberry individuals, it is possible to prevent the propagation of offspring of transgenic silkworms into the environment, Contamination can be prevented.
  • an infertile female pup lethal silkworm can be produced according to the sterilized bred breeding method of the present invention.
  • the top row shows the amino acid sequence encoded by the base in the Fem piRNA recognition sequence.
  • Masc WT and MascR represent Fem piRNA recognition sequences of the wild-type Masc gene and the mutant Masc gene, respectively.
  • the underlined base in the MascR base sequence indicates a silent mutation site and its mutant base that are preferred as a cleavage resistant mutation.
  • b represents c, g, or t.
  • d indicates a, g, or t.
  • h represents a, c, or t.
  • the arrowhead indicates the position of the Fem piRNA recognition sequence in the Masc gene. It is a figure which shows the sex ratio of each genotype in a female pupal dead silkworm.
  • a and B are genotypes of individuals living in the 5th instar larva stage among the F1 individuals obtained by crossing the sumi13 line (female lethal silkworm of the present invention) and the 193-2 line (BmA3-GAL4 line).
  • the sex ratios of C and D are the F1 individuals obtained by crossing between the sumi12 line (control silkworm line) and the 193-2 line (BmA3-GAL4 line) in the individual living in the 5th instar larva stage.
  • the genotype sex ratio, and E and F are individuals living in the 5th instar larvae stage of 193-2 line having the first expression unit BmA3-GAL4 of MascR gene expression vector used for mating with the female pupal dead silkworm line
  • the sex ratio of each genotype in is shown.
  • G + R indicates a sex ratio in a population having the second expression unit pUAS-MascR of the MascR gene expression vector of the present invention and the first expression unit BmA3-GAL4.
  • G indicates a sex ratio in a population having only the first expression unit BmA3-GAL4.
  • R represents a sex ratio in a population having only the second expression unit pUAS-MascR of the MascR gene expression vector of the present invention.
  • Negative indicates a sex ratio in a population having neither the first expression unit BmA3-GAL4 nor the MascR gene expression vector second expression unit pUAS-MascR of the present invention.
  • the black squares on each panel indicate the percentage of male individuals, and the white squares indicate the percentage of female individuals.
  • FIG. 1 shows the result of having detected the karyotype of the sex chromosome in F1 individual which has both the 2nd expression unit pUAS-MascR of the MascR gene expression vector of this invention, and 1st expression unit BmA3-GAL4 by PCR.
  • A shows the karyotype of the larva individual who died among the F1 individuals
  • B shows the karyotype of the larva individual who survived to the surviving 5th instar larva stage among the F1 individuals.
  • the form of a cocoon (A) when the silkworm of each strain including a female pupal dead silkworm is formed is shown, and the form and sex (B) of the cocoon in the cocoon.
  • Mutant Masc gene 1-1 Overview
  • a first aspect of the present invention is a mutant Masc gene.
  • the mutant Masc gene of the present invention is characterized by having cleavage resistance to the Fem piRNA-Siwi complex.
  • 1-2 Definitions The following key terms used in this specification are defined.
  • PIWI-interacting RNA is a non-coding small RNA with a length of 23-30 bases involved in germ cell formation and sex determination.
  • the piRNA is expressed in a precursor state, and after processing such as cleavage and modification, becomes a mature piRNA having a recognition region consisting of a base sequence complementary to the target RNA. After that, piRNA forms a complex with PIWI (P-element Induced Wimpy ⁇ Testis) protein, and binds to the target RNA via the recognition region, thereby converting the PIWI protein with single-stranded RNA cleavage activity into the target RNA. Induce.
  • PIWI P-element Induced Wimpy ⁇ Testis
  • the piRNA-PIWI complex is known to cleave the target RNA between the 10th and 11th bases from the 5 'end of piRNA (Brennecke, J., et al., Cell, 2007, 128, 1089). -1103; Gunawardane, L. S., et al., 2007, Science, 315, 1587-1590).
  • Fem piRNA is a small molecule RNA produced from a transcription product of the feminizer (Fem) gene, which is a female determining gene of silkworm.
  • Fem piRNA is composed of piRNA (PIWI-interacting RNA) consisting of 29 bases shown in SEQ ID NO: 3.
  • Fem piRNA forms a complex with silkworm's PIWI ortholog Siwi and cleaves the Masc gene transcript (Masc mRNA), a silkworm's male determinant gene described later, at a specific position. Suppress.
  • dsx double sex gene transcript
  • “Masc (Masculinizer) gene” is a male sex-determining gene of silkworm encoded on the Z chromosome.
  • the Masc gene encodes a zinc finger protein Masc that has two CCCH domains in tandem, and orthologs exist only in Lepidoptera insects.
  • the Masc gene is a target gene of the Fem piRNA-Siwi complex.
  • Masc mRNA is cleaved by the Fem piRNA-Siwi complex.
  • Lepidoptera refers to insects belonging to the taxonomic Lepidoptera, butterfly or moth.
  • the butterfly includes insects belonging to Nymphalidae, Papilionidae, Pieridae, Lycaenidae, and Hesperiidae.
  • the moths include Saturniidae, Bombycidae, Brahmaeidae, Eupterotidae, Lasiocampidae, Psychidae, Geometridae, and idae , Insects belonging to Noctuidae, Pyralidae, Sphingidae and the like.
  • the mutant Masc gene of the present invention is a mutant Masc gene having cleavage resistance to the Fem piRNA-Siwi complex and the activity of the wild-type Masc gene.
  • the “mutant Masc gene” (often referred to herein as “MascR (Fem-piRNA-resistant Masc) gene”) is a Masc gene in which a part of the base sequence of the wild-type Masc gene has been mutated.
  • the mutant Masc protein encoded by the MascR gene (often referred to as “MascR protein” in this specification) does not necessarily have an amino acid mutation.
  • the expressed MascR protein has the same amino acid sequence as the wild-type Masc protein.
  • a “mutation having cleavage resistance to Fem piRNA-Siwi complex” is a mutation that occurs on the Masc gene and is a Fem piRNA-Siwi complex.
  • a mutation that confers cutting resistance to the Masc gene is suppressed, and as a result, cleavage of Masc mRNA by Fem piRNA-Siwi complex is inhibited. Therefore, even in the presence of Fem piRNA, a functional Masc protein can be expressed without cleavage of Masc mRNA.
  • the activity of the wild-type Masc gene means that it encodes a functional Masc protein.
  • “Functional Masc protein” refers to a Masc protein having an activity found in a wild-type Masc protein, that is, an activity that induces intracellular dsx mRNA into a male-specific splicing pattern. Whether or not the mutant Masc gene retains the activity of the wild-type Masc gene is determined, for example, by introducing an expression vector of the mutant Masc gene into a cultured cell derived from a female silkworm and expressing it in the cultured cell. It can be determined by examining whether the splicing pattern of dsxdsmRNA possessed by a cell is converted to a male-specific splicing pattern by Masc protein (Kiuchi T., et al., 2014; supra).
  • a mutant Masc gene expression vector having a drug resistance marker gene is introduced into a cultured cell derived from a female silkworm (for example, BmN4 cell derived from a silkworm ovary) by a transformation method, and then the cell is treated with a drug. Select with. Subsequently, mRNA is purified from cells that hold the above expression vector and express the mutant Masc gene according to a conventional method, and cDNA is prepared using this mRNA as a template.
  • DNA primer pair that can distinguish whether the splicing pattern of dsx mRNA is male-specific or female-specific using cDNA as a template (for example, Bmdsx-F pair shown in SEQ ID NO: 4 and Bmdsx-R pair shown in SEQ ID NO: 5) )
  • cDNA for example, Bmdsx-F pair shown in SEQ ID NO: 4 and Bmdsx-R pair shown in SEQ ID NO: 5
  • the mutant Masc gene retains the wild-type Masc gene activity. It is shown to be a gene.
  • the cleavage-resistant mutation is present in the Fem piRNA recognition sequence on the Masc gene.
  • the Fem piRNA recognition sequence corresponds to the nucleotide sequence of positions 1391 to 1419 when the a (adenine) of the start codon atg is 1 in the Masc gene consisting of the nucleotide sequence represented by SEQ ID NO: 1.
  • the base sequence corresponding to the Fem piRNA recognition sequence of the silkworm Masc gene corresponds to the silkworm Masc gene ortholog.
  • a preferred region where a cleavage resistant mutation is present is a region that forms direct base pairing by complementary binding with Fem ⁇ ⁇ ⁇ ⁇ piRNA.
  • the base sequence corresponding to the region corresponds to the silkworm Masc gene ortholog.
  • Types of cleavage resistant mutations include base substitutions other than nonsense mutations, deletions that do not cause frame shifts, or additions that do not cause frame shifts.
  • Base substitution other than nonsense mutation The “base substitution (mutation)” is a mutation in which a part of the base of the wild-type gene is replaced with another base. In the present specification, a mutation in which a part of the base of the wild type Masc gene is replaced with another base corresponds.
  • the base substitution includes a single base substitution such as a point mutation and a substitution of two or more consecutive bases. However, in the MascR gene of the present invention, any base substitution is included.
  • Base substitution includes transition mutation and transversion mutation based on the nature between bases before and after substitution.
  • Transition mutations are substitutions between purines or pyrimidines. For example, a (adenine) to g (guanine) substitution and g to a substitution.
  • Transversion mutations are substitutions between purines and pyrimidines. For example, substitution from c (cytosine) to t (thymine) and substitution from t to c can be mentioned. Any mutation may be used in the MascR gene of the present invention.
  • silent mutation is a substitution to a degenerate codon that does not result in an amino acid substitution.
  • a missense mutation is a base substitution that results in an amino acid substitution in the amino acid sequence of the Masc protein.
  • Nonsense mutations are base substitutions that result in stop codons.
  • the base substitution there is no frame shift because the number of bases does not increase or decrease before and after the base substitution occurs (for example, between the wild type Masc gene and the MascR gene).
  • a nonsense mutation it becomes a truncated protein from which a downstream amino acid has been deleted by insertion of a stop codon. Therefore, it is not preferable as the base substitution of the present invention. Therefore, the base substitution in the MascR gene of the invention may be either a silent mutation or a missense mutation as long as it is other than a nonsense mutation.
  • the MascR protein having the amino acid substitution is a functional Masc protein. Silent mutation that does not change the amino acid sequence of the Masc protein is preferable.
  • FIG. 2 shows a preferred silent mutation as a cleavage resistant mutation in the Fem piRNA recognition sequence of the silkworm Masc gene.
  • the silkworm Masc gene ortholog may be a silent mutation that does not cause an amino acid substitution in the base sequence corresponding to the Fem piRNA recognition sequence, similarly to the silkworm.
  • the amino acid substitution caused by the missense mutation may be a conservative amino acid substitution.
  • “Conservative amino acid substitution” refers to substitution between amino acids in the same amino acid group when amino acids are classified based on their properties. In the case of conservative amino acid substitution, since the properties of the amino acid before and after substitution are similar, the structure and properties substantially equivalent to the wild-type protein can be brought to the mutant protein.
  • the amino acid groups include non-polar amino acid groups (alanine (A), phenylalanine (F), leucine (L), isoleucine (I), valine (V), methionine (M), proline (P), tryptophan (W).
  • Polar amino acid groups (glycine (G), serine (S), threonine (T), cysteine (C), asparagine (N), glutamine (Q), tyrosine (Y), lysine (K), histidine (H) , Arginine (R), glutamic acid (E), aspartic acid (D)), acidic amino acid group (D, E), basic amino acid group (R, H, K), aromatic amino acid group (F, W, Y) And aliphatic amino acid groups (G, A, L, I, V) and the like.
  • Table 1 shows suitable missense mutations as cleavage-resistant mutations of the present invention within the Fem piRNA recognition sequence of the silkworm Masc gene (substantially within the range of positions 1393 to 1419 which can cause missense mutations).
  • Deletion that does not cause a frame shift is a mutation that loses the base of the wild-type gene.
  • Deletion mutations include deletions that cause frameshifts and deletions that do not. In the MascR gene of the present invention, deletion mutations that do not cause frame shift are targeted.
  • “Deletions that do not cause frameshift” are the deletion of 3n consecutive bases (n is an integer) in the wild-type gene, resulting in the deletion of one or several amino acids in the amino acid sequence encoded by the wild-type gene. It is a mutation that causes loss. This mutation does not cause a reading frame shift, that is, a frame shift downstream of the mutation site.
  • Deletion mutations suitable as cleavage-resistant mutations of the present invention result in a deletion at positions 425 to 476 (Masc-md1) when the initiation methionine is position 1 in the silkworm Masc protein shown in SEQ ID NO: 2.
  • Deletions from 1273 to 1428 in the Masc gene, deletions from 450 to 476 (Masc-md2), deletions from 1348 to 1428 in the Masc gene, and deletions from 463 to 476 (Masc-md3) Deletion of positions 1387 to 1428 in the Masc gene, and deletion of positions 1408 to 1428 in the Masc gene that results in a deletion of positions 469 to 476 (Masc-md4).
  • Addition that does not cause frame shift is a mutation in which a base is inserted into the base sequence of a wild-type gene. Addition mutations, like deletion mutations, include additions that cause frameshifts and additions that do not. In the MascR gene of the present invention, additional mutations that do not cause frame shift are targeted.
  • “Addition that does not cause frame shift” means that the insertion of one or several amino acids in the amino acid sequence encoded by the wild type gene results from the addition of 3n consecutive bases (n is an integer) in the wild type gene. It is a mutation that brings about. This mutation does not cause a frameshift downstream of the mutation site.
  • the number of cleavage resistant mutations is not particularly limited as long as it can inhibit the binding of Fem piRNA and Masc mRNA via base pairing.
  • 1 or 2 or more within the Fem piRNA recognition sequence specifically, for example, 1 to 10, 1 to 9, 1 to 8, 1 to 7, 1 to 6, 1 to 3
  • the number of cleavage resistant mutations also depends on the type of mutation. In the case of single base substitution, it is preferable to have a plurality of mutations in the Fem piRNA recognition sequence in order to effectively inhibit the binding of Fem piRNA and Masc mRNA via base pairing. For example, 2, 3, 4, 5, 6, 7, 8, 9, or 10.
  • the number of mutations may be small if the number of bases lost by one mutation or the number of inserted bases is large.
  • each mutation when there are a plurality of cleavage resistance mutations, each mutation may be the same type of mutation or a different mutation.
  • one MascR gene may have two or more substitution mutations and one deletion mutation.
  • the MascR gene of the present invention may be inserted into a suitable cloning vector for conservation and / or cloning.
  • a method for constructing a cloning vector and a method for producing a transformant such as Escherichia coli or yeast into which the vector has been introduced may be performed using molecular biology techniques known in the art. These methods are described in Green & Sambrook, 2012, Molecular Cloning: A Laboratory Manual Fourth Ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, etc. 2.
  • a second aspect of the present invention is a mutant Masc gene expression vector (often referred to herein as “MascR gene expression vector”).
  • the MascR gene expression vector of the present invention comprises the MascR gene of the first aspect in a state capable of being expressed. According to the MascR gene expression vector of the present invention, the MascR gene can be overexpressed by introduction into the host. 2-2. Configuration
  • an “expression vector” refers to one expression system unit that contains a target gene in a state capable of being expressed and can control the expression of the gene.
  • the target gene of interest in the present invention is the MascR gene described in the first embodiment.
  • the “expressible state” means that a target gene is placed under the control of a promoter in an expression vector.
  • an autonomously replicable expression vector such as a plasmid or Bacmid, a viral vector, an expression vector capable of homologous or non-homologous recombination in a chromosome, or a part of a chromosome in which it is inserted into a host chromosome.
  • a shuttle vector that can replicate in E. coli, Bacillus subtilis, or yeast can also be used.
  • 2-2-1. Components of MascR gene expression vector The MascR gene expression vector is configured to express the MascR gene in a host cell.
  • the components of the MascR gene expression vector include the MascR gene of the first embodiment and a ubiquitous promoter as essential components.
  • a multicloning site, 5′UTR, 3′UTR, terminator, enhancer, marker gene, insulator, transposon inverted terminal repeat and the like are included as selection components.
  • the MascR gene expression vector is composed of two units, a first expression unit and a second expression unit, which will be described later, a transcription regulatory factor gene and a target promoter of the transcription regulatory factor are essential components. Include.
  • each component of the MascR gene expression vector of the present invention will be specifically described.
  • (1) MascR gene The configuration of the MascR gene is described in detail in the first embodiment, and a description thereof is omitted here.
  • Promoter The promoter included in the MascR gene expression vector of the present invention is a ubiquitous promoter.
  • the “ubiquitous promoter” is a promoter capable of expressing the target gene arranged downstream (3 ′ end side) of the promoter, that is, the MascR gene in the entire host individual into which the expression vector has been introduced. In this specification, it uses as a term corresponding to the site-specific promoter which controls the expression in a specific cell or tissue.
  • Ubiquitous promoters can be classified into constitutively active promoters, expression-inducible promoters, or time-specific active promoters based on their expression control timing.
  • a constitutively active promoter can constitutively express a target gene in a host cell.
  • constitutively active promoters in silkworms include actin 3 gene-derived actin 3 promoter (A3 promoter), silkworm heat shock protein 90 (hsp90) gene-derived heat shock protein 90 promoter (hsp90 promoter), silkworm elongation factor 1 ⁇ (Elongation Factor-1 ⁇ ) gene-derived elongation factor 1 promoter (EF-1 promoter), BmNPV (Bombyx mori nuclear polyhedrosis virus) early gene 1 (immediate-early gene 1; ie-1) promoter, etc. Can be mentioned.
  • the base sequence of A3 promoter is shown in SEQ ID NO: 6, and the base sequence of hsp90 promoter is shown in SEQ ID NO: 7.
  • An expression-inducible promoter can induce the expression of a target gene in a host cell at any time. Therefore, this type of promoter is used to maintain a host strain having a MascR gene expression vector when the MascR gene expression vector is composed of one gene expression unit in “Unit structure of MascR gene expression vector” described later. And is particularly useful.
  • a specific example of the expression-inducible promoter in the silkworm is a heat shock protein 70 promoter (hsp70 promoter) derived from the heat shock protein 70 (hsp70) gene. The base sequence of the hsp70 promoter is shown in SEQ ID NO: 8.
  • a time-specific active promoter can induce the expression of a target gene in a host cell only at a specific stage of development.
  • the MascR protein needs to function at an early stage of embryonic development. Therefore, it is desirable that a time-specific active promoter that can be included in the MascR gene expression vector of the present invention induces expression at an early stage of embryonic development.
  • any of the above ubiquitous promoters can cause overexpression of the MascR gene in the host cell. Therefore, the ubiquitous promoter in this specification may be interpreted as an overexpression promoter.
  • the donor species of the promoter is not particularly limited as long as it is operable in the host cell into which the MascR gene expression vector is introduced.
  • Preferred donor species are those that belong taxonomically with the host of the MascR gene expression vector.
  • the donor species is a species belonging to the same Lepidoptera as the silkworm, preferably a species belonging to the same family Bombycidae as the silkworm, more preferably a mulberry (Bombyx mandarina). Species belonging to the same genus Bombyx are suitable.
  • the most preferred donor species is the same silkworm.
  • Multicloning site is a cluster sequence comprising a plurality of cloning restriction enzyme sites.
  • the type and number of restriction enzyme sites to be included in the base sequence constituting the multicloning site there are no particular restrictions on the type and number of restriction enzyme sites to be included in the base sequence constituting the multicloning site.
  • the number of multi-cloning sites in the MascR gene expression vector and the position at which the multi-cloning site is arranged are not limited, but are preferably arranged within the control region of the ubiquitous promoter. This is because the MascR gene can be easily inserted into the MascR gene expression vector of the present invention by arranging at such a position.
  • 5′UTR (5'untranslated region) and 3'UTR (3'untranslated region) “5′UTR and 3′UTR” are both polynucleotides consisting of untranslated regions that do not themselves encode proteins, fragments thereof, or functional nucleic acids.
  • each UTR is preferably, but not limited to, 5′UTR and 3′UTR derived from the Masc gene. Particularly preferred are 5'UTR and 3'UTR derived nucleotide sequences of the Masc gene itself.
  • 5′UTR is located upstream (5 ′ end side) of the start codon of the MascR gene
  • 3′UTR is located downstream (3 ′ end side) of the stop codon of the MascR gene.
  • the 3 ′ UTR can contain a poly A signal.
  • Terminator is a base sequence that is located at the 3 ′ end of the MascR gene, preferably downstream of the stop codon in the MascR gene expression vector of the present invention, and is a base sequence that can terminate the transcription of the MascR gene. It is configured.
  • the hsp70 terminator consisting of the base sequence shown in SEQ ID NO: 9
  • the SV40 terminator consisting of the base sequence shown in SEQ ID NO: 10 can be mentioned.
  • Enhancer An “enhancer” consists of a base sequence that can further enhance the expression of a MascR gene by controlling a ubiquitous promoter in the MascR gene expression vector of the present invention.
  • Marker gene A “marker gene” is a gene encoding a labeled protein, also called a selection marker.
  • Labeled protein refers to a polypeptide that can determine the presence or absence of expression of a labeled gene based on its activity. Therefore, when the MascR gene expression vector contains a marker gene, the host carrying the MascR gene expression vector, that is, a transformant can be easily identified based on the activity of the marker protein.
  • “based on activity” means based on the detection result of activity. The activity may be detected directly by the activity of the labeled protein itself or indirectly by a metabolite generated by the activity of the labeled protein such as a dye. Good. Detection can be chemical detection (including enzymatic reaction detection), physical detection (including behavioral analysis detection), or sensory detection of the detector (including visual, tactile, olfactory, auditory, taste detection) Either may be sufficient.
  • the type of labeled protein encoded by the labeled gene is not particularly limited as long as its activity can be detected by a method known in the art.
  • it is a labeled protein with low invasiveness to the transformant upon detection.
  • fluorescent proteins, chromogenic proteins, photoproteins, external secreted proteins, proteins that control external morphology, and the like can be mentioned.
  • Fluorescent proteins, chromogenic proteins, photoproteins, and exocrine proteins can be visually detected under certain conditions without changing the external form of the transformant, and therefore are less invasive to the transformant.
  • it is particularly suitable because it is easy to identify and select transformants.
  • Fluorescent protein refers to a protein that emits fluorescence of a specific wavelength when irradiated with excitation light of a specific wavelength. Either a natural type or a non-natural type may be used. Further, the excitation wavelength and the fluorescence wavelength are not particularly limited. Specifically, for example, CFP, RFP, DsRed (including derivatives such as 3xP3-DsRed), YFP, PE, PerCP, APC, GFP (including derivatives such as EGFP and 3xP3-EGFP), etc. It is done.
  • Chrosome synthesis protein is a protein involved in pigment biosynthesis and is usually an enzyme.
  • the “dye” here is a low molecular compound or peptide capable of imparting a dye to a transformant, and the kind thereof is not limited.
  • a pigment that appears as an external color of an individual is preferable. Examples include melanin pigments (including dopamine melanin), omochrome pigments, and pteridine pigments.
  • photoprotein refers to a substrate protein that can emit light without the need for excitation light or an enzyme that catalyzes the light emission of the substrate protein.
  • luciferin or aequorin as a substrate protein and luciferase as an enzyme can be mentioned.
  • exocrine protein refers to a protein that is secreted extracellularly or externally, and includes exocrine enzymes, fiber proteins such as fibroin, and sericin. Exocrine enzymes include digestive enzymes in addition to enzymes that contribute to the degradation or inactivation of drugs such as blasticidin and impart drug resistance to the host.
  • the marker gene is placed in a state capable of being expressed downstream of the promoter in the MascR gene expression vector.
  • Insulator An “insulator” is a base sequence that can stably control the transcription of a gene sandwiched between sequences without being affected by chromatin of surrounding chromosomes. Examples include the cHS4 sequence of chicken and the gypsy sequence of Drosophila.
  • ITRs Inverted terminal repeat sequences of transposon “Inverted terminal repeat sequences (ITRs)” are included when the MascR gene expression vector of the present invention is used as an expression vector capable of homologous recombination. Is a selection component to obtain.
  • the inverted terminal repeats are usually used in pairs, and piggyBac, mariner, minos, etc.
  • Transcriptional regulatory factor gene is an essential component of the first expression unit described below.
  • transcriptional regulatory factor refers to a protein factor that can bind to a target promoter described later and activate the target promoter. Examples thereof include GAL4 protein, which is a galactose metabolic activation protein of yeast, tTA, which is a tetracycline-regulated transactivator, and mutants thereof.
  • Target promoter of transcription regulator is an essential element of the second expression unit described later, and the transcription regulator encoded by the first expression unit binds to it.
  • the transcriptional regulatory factor and its target promoter are in a corresponding relationship with the transcriptional regulatory factor. Normally, when a transcriptional regulatory factor is determined, the target promoter is inevitably determined. For example, when the transcriptional regulatory factor is GAL4 protein, UAS (Upstream Activating Sequence) is used.
  • GAL4 protein Upstream Activating Sequence
  • UAS Upstream Activating Sequence
  • the MascR gene expression vector When configured with a single gene expression unit, the MascR gene expression vector contains all the necessary elements for expressing the MascR gene in a host cell.
  • the components are contained within one gene expression vector. Specifically, it includes a ubiquitous promoter that is an essential component and a MascR gene operably linked downstream of the promoter.
  • the promoter is preferably an expression-inducible promoter for the maintenance and management of female lethal lines.
  • the MascR gene expression vector may contain two or more MascR genes under the control of one promoter.
  • the MascR gene expression vector is composed of one gene expression unit, the MascR gene can be overexpressed in the host cell simply by introducing the MascR gene expression vector into the host.
  • the first and second expression units function as one MascR gene expression vector only when they coexist in the host cell. That is, in the same cell, a transcriptional regulatory factor is expressed from the first expression unit by activating the promoter contained in the first expression unit, which activates the target promoter of the second expression unit, thereby obtaining the target MascR gene. Can be expressed.
  • the first and second expression units have the following configuration.
  • the “first expression unit” comprises a promoter and a gene of the above-mentioned transcription regulatory factor operably linked downstream of the promoter.
  • the aforementioned ubiquitous promoter is used as the promoter used in the first expression unit.
  • the same or different two or more transcriptional regulatory factors may be included under the control of one promoter.
  • the first expression unit may have two or more sets of promoters and transcription regulatory factor genes under the control of the promoter.
  • each set may be the same set or different sets.
  • an existing gene expression vector can also be used.
  • the “second expression unit” comprises a target promoter of a transcriptional regulatory factor encoded by the first expression unit and a MascR gene operably linked downstream of the target promoter.
  • the target promoter contained in the second expression unit selects a promoter that is activated by the transcriptional regulatory factor encoded by the first expression unit.
  • the gene of the transcriptional regulatory factor contained in the target promoter first expression unit is a GAL4 gene
  • UAS is used for the GAL4 target promoter of the second expression unit.
  • the second expression unit may include two or more identical or different MascR genes under the control of one target promoter.
  • the second expression unit may have two or more pairs of a target promoter and a MascR gene under its control.
  • each set may be the same set or different sets.
  • the second expression unit may be composed of two or more identical or different units containing the MascR gene.
  • the transcriptional regulatory factor expressed from one first expression unit can express the MascR gene contained in each second expression unit by activating the target promoters of the plurality of second expression units.
  • the MascR gene expression vector of this configuration is useful for the maintenance and management of female lethal lines. Normally, when the MascR gene is overexpressed in a host cell, it becomes female lethal and the strain cannot be maintained. However, maintenance of the first and second expression units can be facilitated by preparing a line that holds each of the first and second expression units and managing each of them individually.
  • the MascR gene expression vector of this configuration can amplify the expression of the MascR gene of the second expression unit via the transcriptional regulatory factor encoded by the first expression unit. Therefore, it is suitable for overexpression of the MascR gene in a host cell. 2-3.
  • MascR gene expression vector host introduction method A MascR gene expression vector host introduction method will be described.
  • the host into which the MascR gene expression vector is introduced is a lepidopteran insect individual, a cell derived from a lepidopteran insect (including a cell line), or a tissue derived from a lepidopterous insect. Particularly preferred are lepidopteran insects.
  • a lepidopteran insect individual a cell derived from a lepidopteran insect (including a cell line), or a tissue derived from a lepidopterous insect.
  • lepidopteran insects When introduced into a cell or tissue, the stage of development of the collected individual is not particularly limited. When introduced into an individual, there are no particular limitations on the developmental stage or sex, and any stage of an embryo, larva, pupa, or adult can be used. Preferably, it is an embryonic time when a higher effect can be expected.
  • the MascR gene expression vector can be introduced by a method known in the art depending on the MascR gene expression vector to be introduced.
  • the MascR gene expression vector is a plasmid having transposon inverted terminal repeats (ITRs) (Handler AM. Et al., 1998, Proc. Natl. Acad. Sci. USA 95: 7520-5) and introduced. If the host is a silkworm, the method of Tamura et al. (Tamura T. et al., 2000, Nature Biotechnology, 18, 81-84) can be applied.
  • the MascR gene expression vector of the present invention diluted to an appropriate concentration may be injected into an early embryo of a silkworm egg together with a helper vector having a transposon transferase gene.
  • a helper vector having a transposon transferase gene For example, pHA3PIG can be used as the helper vector.
  • the MascR gene expression vector of the present invention contains a marker gene, as described above, the target transformant can be easily selected based on the expression of the gene or the like.
  • the transgenic silkworm obtained by this method the MascR gene expression vector is integrated into the chromosome via the transposon inverted terminal repeat sequence. If necessary, this transgenic silkworm may be sibling or inbred to obtain a homozygous expression vector inserted into the chromosome. 2-4.
  • the host can be made female lethal.
  • a MascR gene expression vector composed of two gene expression units it is possible to easily maintain and manage the produced female lethal line. Therefore, a MascR gene expression vector composed of two gene expression units can reduce costs and labor in producing a female lethal line.
  • summary The 3rd aspect of this invention is a puerperal lethal silkworm strain
  • the fetus lethal silkworm strain of this embodiment is a transgenic silkworm strain having the MascR gene expression vector described in the second embodiment.
  • female pupal dead silkworms can be easily obtained.
  • female-killed silkworm refers to a silkworm in which a female individual dies by the 5th instar larva stage after the start of development.
  • the “feminine lethal silkworm strain” refers to a passable genetically modified silkworm or its progeny that has the potential to kill a female individual.
  • the female mortal silkworm strain of the present invention has the MascR gene expression vector described in the second embodiment.
  • the MascR gene expression vector possessed by the female pupal dead silkworm strain may be either composed of one gene expression unit described in the second embodiment or composed of two gene expression units. In the latter case, a transgenic silkworm strain in which the transgenic silkworm has only the second expression unit is included in the female pupal dead silkworm strain of the present invention.
  • the transgenic silkworm strain having only the second expression unit is mated with the silkworm strain containing the first expression unit, and the MascR gene from the second expression unit contained in the transgenic silkworm strain having only the second expression unit. This is because a transgenic silkworm strain having only the second expression unit has the potential to kill a female individual in that it can easily produce a female dead lethal silkworm by inducing expression. .
  • the transgenic silkworm lines having only the second expression unit are exemplified by the sumi-13 lines (sumi13-1, sumi13-2) described in Example 2, but are not limited thereto.
  • a transgenic silkworm strain having only the first expression unit does not correspond to the female dead lethal silkworm strain of the present invention because it has no direct potential to kill a female individual.
  • the MascR gene expression vector may be present transiently in the silkworm cell, or may be stably and continuously present in a state of being introduced into the chromosome. Usually, it is preferable to exist stably and continuously.
  • the ubiquitous promoter that controls the expression of the MascR gene in the MascR gene expression vector is an expression-inducible promoter. It is desirable that
  • the MascR gene expression vector is composed of two gene expression units, a first expression unit and a second expression unit, and each is integrated on a silkworm chromosome
  • the first and second expression units are the same chromosome of the same silkworm individual. It may exist on the top, or may exist on different chromosomes of the same silkworm individual. Furthermore, it is desirable that the first expression unit and the second expression unit are incorporated into chromosomes of silkworm individuals or silkworm strains different from each other.
  • the first and second in F1 A female pupal dead silkworm having 2 expression units can be easily obtained.
  • any promoter can be used as long as the ubiquitous promoter contained in the first expression unit is the ubiquitous promoter described in the second embodiment.
  • the ubiquitous promoter contained in the first expression unit is preferably an expression-inducible promoter.
  • Method for producing a female pupal dead silkworm strain The method for producing a female pupal dead silkworm strain of the present invention is not particularly limited because any method capable of producing a recombinant silkworm can be used. Examples of a method for producing a recombinant silkworm include a method of introducing a MascR gene expression vector into a silkworm. The specific method is the same as the method described in the section “2-3. Method for introducing host of MascR gene expression vector” in the second embodiment.
  • the MascR gene expression vector is composed of one gene expression unit
  • the MascR gene expression vector is composed
  • the MascR gene expression vector is composed of two gene expression units, the first and second expression units.
  • Method for producing female pupal dead silkworm In order to produce female pupal dead silkworm composed only of male population using the female pupal dead silkworm strain of the present invention, for example, (1) expression induction in female pupal dead dead silkworm strain And (2) mating two transgenic silkworm strains each having the first expression unit and the second expression unit of the MascR gene expression vector, and combining both the first expression unit and the second expression unit.
  • the expression of the MascR gene is suppressed in an untreated state of expression induction, and since it does not become a female pupal dead silkworm, it can be maintained and managed in the same manner as a wild type silkworm.
  • an expression inducing treatment may be performed at the early embryo stage for this female pupal dead silkworm strain.
  • the expression induction treatment method may be appropriately selected according to the properties of the expression inducible promoter. For example, if the expression-inducible promoter is an hsp70 promoter, a female pupal dead silkworm can be produced by treating the early embryo at 42 ° C. for 30 minutes to 1 hour.
  • This method is a gene set in which the MascR gene expression vector is composed of two gene expression units, the first and second expression units, and has the first expression unit. This is carried out when there is a female silkworm dead silkworm strain having a replacement silkworm strain and a second expression unit. By mating two transgenic silkworm strains, it is possible to produce female pupal dead silkworms having first and second expression units in F1 individuals.
  • a genetically modified silkworm strain having the first expression unit and a female pupal dead silkworm strain having the second expression unit may be crossed based on a conventional method.
  • a transgenic silkworm having two expression units is preferably preliminarily sibling or inbred and made homozygous for each expression unit.
  • F1 individuals having the first and second expression units may be selected based on the activity of the labeled protein encoded by the labeled gene contained in each expression vector. 4).
  • Summary The 4th aspect of this invention is a female pupal dead dead male silkworm infertile silkworm strain
  • the female pupal dead male silkworm infertile silkworm strain of the present invention can also be understood as one form of the female pupal dead silkworm strain of the third aspect.
  • this strain it is possible to obtain a silkworm population in which not only the female individual is lethal but also the surviving male individual is infertile. 4-2. Configuration Since the basic configuration of this aspect is the same as the configuration of the third aspect, a characteristic configuration of this aspect will be described below.
  • female dead dead male sterilized silkworm refers to a silkworm in which a female individual becomes lethal at the developmental stage and a living male individual becomes infertile.
  • Male sterility or “male (individual) infertility” means that the male fertility is lost.
  • Infertile silkworms that are deadly male and female are composed only of infertile male individuals.
  • the female mortal male sterilized silkworm has first and second expression units of the MascR gene expression vector described later in the cell.
  • a female individual can be killed by the MascR protein expressed from the second expression unit by activating the promoter, and a male individual can be sterilized by the action of the transcriptional regulatory factor GAL4 protein encoded by the first expression unit.
  • female-lethal dead male sterilized silkworm strain refers to a genetically-transmissible silkworm or its progeny that can be passaged and has the potential to let female individuals become dead and males become infertile.
  • the female mortal male sterilized silkworm strain of the present invention has the MascR gene expression vector described in the second embodiment.
  • This MascR gene expression vector is composed of two gene expression units composed of first and second expression units.
  • the basic configuration of the first expression unit may be the same as the configuration of the first expression unit described in the second aspect.
  • the gene of the transcriptional regulatory factor included in the vector is limited to the GAL4 gene encoded by the GAL4 protein, which is a galactose metabolic activation protein of yeast.
  • the basic structure of the second expression unit may be the same as that of the second expression unit described in the second aspect.
  • the gene of the transcriptional regulatory factor included in the first expression unit is the GAL4 gene
  • the target promoter of the transcriptional regulatory factor included in the second expression unit must be the target promoter of GAL4.
  • An example of a target promoter for GAL4 is UAS.
  • the female pupal lethal male sterilized silkworm strain has either one of the first and second expression units. Unlike the third embodiment, in this embodiment, not only the transgenic silkworm strain having only the second expression unit but also the transgenic silkworm strain having only the first expression unit is the female pupal lethal male pupal infertile silkworm strain of the present invention. included.
  • the MascR gene expression vector may be transiently present in the silkworm cell, or may be stably and continuously present in the state introduced into the chromosome. Also good. Usually, it is preferable to exist stably and continuously. When two expression vectors of the MascR gene expression vector are present on the chromosome, each expression vector is preferably present on a different chromosome. 4-3.
  • Method for producing female slaughtered male sterilized silkworm strain The method for producing a female slaughtered male sterilized silkworm strain of the present invention is in accordance with the method for producing the female slaughtered male silkworm strain of the third aspect.
  • Example 1 Construction of MascR gene expression vector> (the purpose)
  • the MascR gene expression vector of the present invention is constructed.
  • a MascR gene expression vector composed of two gene expression units, a first expression unit and a second expression unit was constructed.
  • the first expression unit a known gene expression vector for transformation pBac [A3-GAL4: 3xP3-DsRed] having an actin 3 promoter which is a ubiquitous promoter and a GAL4 gene which is a gene of a transcriptional regulator (Uchino et al ., 2006, J. Insect Biotechnol.
  • a pUAS-MascR vector was constructed here as the second expression unit.
  • the pUAS-Masc vector containing the wild-type silkworm Musc gene was constructed as a control for the second expression unit.
  • RNA-PCR-Kit TaKaRa Bio-Inc.
  • PCR was performed using Prime STAR® GXL (TaKaRa Bio Inc.), and the composition of the reaction solution was in accordance with the standard method of the protocol attached to Prime STAR® GXL.
  • the PCR cycle conditions were 40 cycles with 98 ° C. for 10 seconds, 60 ° C. for 15 seconds and 68 ° C. for 2 minutes as one cycle.
  • the amplification product thus obtained was subjected to A addition using 10 ⁇ A-attachment Mix (TOYOBO) and then cloned into pGemTeasy (Promega) to construct a silkworm Masc gene cloning vector “Masc-pGemTeasy”.
  • PCR was performed using Masc-pGemTeasy as a template and a primer pair of Masc_hind_FlagF (SEQ ID NO: 13) and Masc_bamR (SEQ ID NO: 14). PCR conditions were in accordance with the above conditions.
  • the obtained amplification product encodes a silkworm Masc protein in which a FLAG tag is fused on the N-terminal side. This amplified fragment was inserted into the HindIII / BamHI site of pIZ / V5-His (life technologies) to construct “Masc-pIZ”.
  • the MascR gene has 5 base substitutions introduced into the FemFpiRNA recognition sequence as shown in FIG. PCR using PrimeSTAR Mutagenesis Basal Kit (TaKaRa) and Masc_ resistant1 (SEQ ID NO: 19) and Masc_ resistant2 (SEQ ID NO: 20) primer pairs using Masc-pIZ as a template, and a silkworm fused with a FLAG tag on the N-terminal side
  • a plasmid containing MascR protein was constructed and designated as “MascR-pIZ”.
  • PBacMCS [UAS-SV40, 3xP3-GFP TtoH] is a pBacMCS [UAS-SV40, 3XP3-EGFP] (Sakudoh et al., 2007, Proc Natl Acad Sci USA 104: 8941-8946.)
  • Vector 3xP3-EGFP After the fragment containing the DNA was excised from the vector by digestion with EcoRI, the direction of the 3xP3-EGFP fragment was changed and ligated again to the vector.
  • PBacMCS [UAS-MascR-SV40,3xP3-EGFP] (often referred to herein as “pUAS-MascR”) as the second expression unit of the MascR gene expression vector of the present invention and pBacMCS as the second expression unit for the control [UAS-Masc-SV40, 3xP3-EGFP] (often referred to herein as “pUAS-Masc”) was obtained.
  • the structures of pUAS-MascR and pUAS-Masc are shown in FIG.
  • the target promoter of the transcription factor in these second expression units is UAS and the terminator is SV40 terminator.
  • the marker gene is 3xP3 EGFP that expresses EGFP in embryonic, larval and adult eyes.
  • piggyBacL and piggyBacR are included as transposon inverted terminal repeats (ITRs) upstream of UAS and downstream of the marker gene, respectively.
  • Example 2 Production of a silkworm strain killed by female pupae> (the purpose) Using the MascR gene expression vector constructed in Example 1, the female pupal dead silkworm strain of the present invention is produced.
  • the MascR gene expression vector second expression unit pUAS-MascR constructed in Example 1 and its control second expression unit pUAS-Masc were purified using Qiagen Plasmid Midi Kit (Qiagen). The specific production method followed the protocol attached to the kit.
  • the purified pUAS-MascR and pUAS-Masc were microinjected together with piggyBac helper plasmids, each encoding transposon transferase, into eggs 2-8 hours after laying in silkworm w1, pnd, which is a non-dormant strain (Tamura et al.) al. 2000; supra). Eggs after injection were incubated at 25 ° C.
  • “sumi13 strain” two strains of sumi13-1 and sumi13-3) as a female dead lethal silkworm strain with pUAS-MascR integrated into the chromosome
  • “sumi12 strain” as a control strain with UAS-Masc integrated into the chromosome (2 systems of sumi12-1 and sumi12-2) were obtained.
  • the insertion of pUAS-MascR into the chromosome was confirmed by Southern blotting (not shown) for two strains of the female dead lethal silkworm strain.
  • Example 3 Verification of sex ratio in female dead lethal silkworm> (the purpose) It is verified that a female pupal dead silkworm produced using the female pupal dead silkworm strain of the present invention is only a male individual.
  • the male individuals of the sumi13 line (UAS-MascR line; female pupal dead silkworm line) and the sumi12 line (UAS-Masc; control line) established in Example 2 were respectively 193-2 lines (BmA3-GAL4 line) ( F1 individuals were obtained by mating with female individuals of Uchino et al., 2006;
  • Line 193-2 is a transgenic silkworm line in which a known gene expression vector having the structure of the first expression unit in which the silkworm actin 3 promoter and the GAL4 gene are linked is incorporated into the chromosome.
  • the eye has green fluorescence (G), in individuals with only the BmA3-GAL4 line, the eye has red fluorescence (R), and BmA3-GAL4 and UAS-MascR, Or in individuals with BmA3-GAL4 and UAS-Masc, the eyes exhibit green and red fluorescence (G + R).
  • G green fluorescence
  • R red fluorescence
  • G + R green and red fluorescence
  • no fluorescent color is seen in the eye (Negative).
  • the classified genotypes were the above four types.
  • Table 2 shows the number of embryos of each genotype, the hatching rate, and the number of male and female individuals of 5th instar (final) larvae, and FIG. 4 shows the genotype sex ratio in each line.
  • Genomic DNA from larvae dead individuals (17 individuals) in sumi13-1 ⁇ 193-2 (G + R) group and larvae dead individuals (9 individuals) in sumi13-3 ⁇ 193-2 (G + R) group Extracted.
  • the genomic DNA was extracted according to the method described in Green & Sambrook (2012; mentioned above). Gender was determined using a method of detecting the RAPD marker on the W chromosome by PCR.
  • genomic DNA was used as a template, and Musashi-A1 (SEQ ID NO: 17) and Musashi-B1 (SEQ ID NO: 18) were used as primer pairs.
  • PCR was performed using ExTaq (TaKaRa Bio Inc.), and the composition of the reaction solution was in accordance with the standard method of the protocol attached to ExTaq.
  • the PCR cycle conditions were 40 cycles, with 98 ° C for 10 seconds, 55 ° C for 30 seconds and 72 ° C for 1 minute as one cycle.
  • the amplified product was electrophoresed on a 1.5% agarose gel, and the sex was confirmed from the number of bands. (result)
  • the results are shown in FIG. 5A.
  • the majority of the dead individuals were female.
  • the growth after 2 years of age was significantly delayed compared to male individuals that grew normally (not shown). Therefore, it was suggested that MascR protein causes growth delay in the larva stage in female individuals and induces female lethality.
  • Example 5 Verification of cocoons formed by dead pupae silkworm> (the purpose) It verifies about the form etc. of the cocoon which the female pupal dead silkworm produced from the female pupal dead silkworm line of this invention forms. (Method) The surviving individuals of female pupal dead silkworms obtained in the sumi13-1 ⁇ 193-2 (G + R) group and the sumi13-3 ⁇ 193-2 (G + R) group of Example 3 were all male. . In order to confirm that these individuals were male at the sex chromosome level, the karyotype of each individual was examined.
  • the surviving individuals obtained in the sumi13-1 ⁇ 193-2 (G + R) and sumi13-3 ⁇ 193-2 (G + R) groups have wings formed, and abnormalities are observed in their morphology. I checked it. Furthermore, the cocoon was taken out of the cocoon and the morphological abnormalities and sex were confirmed. The gender of the moth was identified from the morphological difference at the tail end. (result) The results are shown in FIG. 5B and FIG.
  • FIG. 5B shows the karyotype of the sex chromosome in the 5th instar larva of the female dead lethal silkworm. It was confirmed that the surviving individuals of the female pupae dead silkworm were males with sex chromosome type ZZ.
  • FIG. 6 shows the form of a cocoon (A) and the form and sex (B) of the cocoon in the cocoon when the silkworm of each strain including a female pupal dead silkworm is formed.
  • A no morphological abnormality was observed in the pupae formed by female pupal dead silkworms (indicated by sumi13-1 (G + R) and sumi13-1 (G + R) in the figure) It was found that normal silkworms can be obtained from dead female silkworms. B also confirmed that the wings were normal and all male.
  • Example 6 Verification of male infertility in line 193-2> (the purpose)
  • the 193-2 line contains the GAL4 gene as a transcriptional regulator gene
  • the sumi13 line contains the UAS and MascR genes that are the target promoters of GAL4. It is not only a lethal silkworm strain, but also a female dead lethal male infertile silkworm strain in which a surviving male becomes infertile.
  • the 193-2 line used for the production of the female mortal male sterilized silkworm line of the present invention becomes male infertile.
  • Method It is described in Uchino et al. (Uchino et al., 2008, JIBS, Insect biochem. Mol. Biol., 38: 1165-1173) that the 193-2 line is a male infertile line. Therefore, when mating 193-2 females and white / C males, and when mating white / C females and 193-2 males, the number of eggs laid by each female was confirmed. .
  • FIG. 7 shows the egg-laying state of the female when the 193-2 line and the white / C line are crossed with each other.
  • A shows the case where 193-2 females and white / C males were crossed
  • B shows the case where white / C females and 193-2 males were crossed.
  • 193-2 females laid eggs normally and the next generation was obtained, but white / C females mated with 193-2 males could lay eggs less than 1/4 of the normal number of eggs laid. And none of them hatched.
  • FIG. 8 is a diagram showing the difference in the number of eggs laid in white / C females when white / C females and various males are crossed. 1 is unmating female, 2 is white / C female x193-2 male, 3 is white / C female xw1-pnd male, and 4 is white / C female x white / C male It is. Even when females of the same strain were used, when 193-2 males were used, the number of eggs laid by unmated females was lower, and none of the eggs hatched.

Abstract

Established and provided is a strain of an insect belonging to the order Lepidoptera, said strain being able to be easily maintained and managed without interrupting the genetic background thereof, being applicable to genetic modification technology and easily and arbitrarily allowing male-specific breeding within a short period of time. A female lethal strain can be obtained by transferring a gene expression vector, said gene expression vector encoding a mutated Masc gene that has cleavage resistance against Fem piRNA-Siwi complex and maintains the activity of the wild type Masc gene, into an insect belonging to the order Lepidoptera.

Description

雌蚕致死カイコ系統Female pupal dead silkworm strain
 本発明は、変異型Masc遺伝子発現ベクターを有する雌蚕致死カイコ系統、及びそれを用いた雌蚕排除方法に関する。 The present invention relates to a female pupal dead silkworm strain having a mutant Masc gene expression vector, and a method of eliminating female pupae using the same.
 カイコ(Bombyx mori)のオスが吐糸する絹糸は、メスが吐糸する絹糸よりも細長く、繊度偏差も少ないことから糸質的に優れている。また、同量の餌量を摂取させた場合でも、オスの生糸の産生量は、メスよりも約20%も多いことが知られている(非特許文献1)。さらに、カイコは飛翔能力を失っているため、カルタヘナ法に基づく第一種使用、すなわち環境中への拡散を防止せずに行う使用が承認されているが、カイコのメスは、外部から侵入し得るクワコ(Bombyx mandarina)のオスと交雑する可能性を排除できない。そのため、有用系統の維持や遺伝子組換え体の環境中への拡散を防止する上でもオス個体のみを飼育する雄蚕飼育が求められている。それ故にカイコの飼育個体を自在にオス化する技術は、産業上極めて有用である。 The silk thread spun by male silkworms (Bombyx 細 mori) is superior in terms of thread quality because it is slender and has less variation in fineness than silk thread spun by females. Moreover, even when the same amount of feed is ingested, it is known that the production amount of male raw silk is about 20% higher than that of females (Non-patent Document 1). Furthermore, since silkworms have lost their flying ability, they are approved for use in the first type based on the Cartagena Act, that is, use without preventing diffusion into the environment. Can not rule out the possibility of crossing with the male of the quay (Bombyx mandarina) to get. For this reason, there is a need for bred breeding for breeding only male individuals in order to maintain useful strains and prevent the spread of genetically modified organisms into the environment. Therefore, the technology for freely maleizing silkworm breeding individuals is extremely useful in industry.
 カイコを含むチョウ目の昆虫では、性決定カスケードの最下流で転写因子をコードするdoublesex(dsx)遺伝子が機能し、そのmRNAのスプライシングパターンによって性決定がなされることが判明している。雄蚕飼育法を確立するため、これまでにオス型スプライシングパターンを示すカイコdsx(Bmdsx)を過剰発現させて、個体をオス化する試み等がなされたが、いずれも成功していない(非特許文献2及び3)。 In the Lepidoptera insects including silkworms, the doublesex (dsx) gene encoding a transcription factor functions at the most downstream of the sex determination cascade, and it has been found that sex determination is made by the splicing pattern of the mRNA. Attempts to overexpress silkworm dsx (Bmdsx), which shows a male splicing pattern, to make males, etc. have been made so far, but none of them have succeeded in order to establish a male breeding method. References 2 and 3).
 カイコを含むチョウ目の昆虫では、dsx遺伝子の上流において性決定カスケードに機能する因子がほとんど明らかにされていない。カイコの性染色体は、ZW型であり、Z/Wがメスになり、Z/Zがオスになることが知られている。すなわち、メスへテロ型の染色体で、W染色体の存在が雌性を決定する(非特許文献4)。それ故、W染色体上にメス決定遺伝子が存在することが予想され、長年にわたりその実体について研究がなされてきた。ところが、カイコのW染色体はトランスポゾンが多重に挿入された複雑な構造をしている(非特許文献5)ことから全領域にわたる塩基配列の決定が困難であり、またメスでは組換えが起こらないため順遺伝学的な解析ができず、メス決定遺伝子の正体は明らかにされないままであった。したがって、カイコの性決定機構や性分化遺伝子を利用して、オスのみを飼育する技術は現在まで確立していない。 In insects of the order Lepidoptera including silkworms, few factors that function in the sex-determining cascade are revealed upstream of the dsx gene. The silkworm's sex chromosome is ZW type, and it is known that Z / W becomes female and Z / Z becomes male. That is, the presence of the W chromosome in the female heterotype chromosome determines femaleity (Non-patent Document 4). Therefore, it is expected that a female determinant gene exists on the W chromosome, and the substance has been studied for many years. However, since the W chromosome of silkworm has a complex structure with multiple transposons inserted (Non-patent Document 5), it is difficult to determine the base sequence over the entire region, and recombination does not occur in females. No forward genetic analysis was possible, and the identity of the female determinant remained unclear. Therefore, the technique to breed only males using the sex-determining mechanism and sex differentiation genes of silkworms has not been established so far.
 ただし、雄蚕飼育が可能な品種としては、日本で育種開発された「プラチナボーイ(登録商標)」(大日本蚕糸会)が知られている。この品種は、2種類の平衡致死遺伝子を利用して、メス個体では致死遺伝子が働いて胚致死となり、オス個体のみが生存できるように設計されている(非特許文献6)。プラチナボーイは、上市されており、生産される絹糸の品質の高さには定評がある(非特許文献7)。しかし、この品種は、作出までに多大な労力と時間を要するという大きな問題がある。通常、プラチナボーイを得るには、2世代前にまで遡って交配作業を行なわなければならず、作出までに1年という時間を要する。さらに、系統を維持するためには、オス個体に前記平衡致死遺伝子を保持させておく必要があり、そのためには、別途、特殊な染色体を持つメスと交配させ続けておく必要がある。また、この品種をトランスジェニック系統に応用した場合、平衡致死遺伝子と外来遺伝子を保持させるために数代の交配が必要となり、系統の維持及び管理が極めて煩雑になるという問題もある。 However, “Platinum Boy (registered trademark)” (Dainippon Silk Association), which has been bred and developed in Japan, is known as a variety that can be bred and raised. This breed is designed so that only the male individual can survive by using the two types of equilibrium lethal genes and letting the lethal gene work in the female individual, resulting in embryonic lethality (Non-patent Document 6). Platinum Boy is on the market and has a reputation for the high quality of silk thread produced (Non-patent Document 7). However, this variety has a big problem that it takes a lot of labor and time to produce. Usually, to get a Platinum Boy, you have to go back two generations before mating, and it takes a year to produce it. Furthermore, in order to maintain the strain, it is necessary for the male individual to retain the balanced lethal gene, and for that purpose, it is necessary to keep mating with a female having a special chromosome separately. In addition, when this variety is applied to a transgenic line, crossing of several generations is required to retain the balanced lethal gene and the foreign gene, resulting in a problem that the maintenance and management of the line becomes extremely complicated.
 本発明の課題は、性決定機構又は性分化遺伝子を利用して、遺伝的バックグラウンドを乱すこと無く系統の維持及び管理を容易に行うことができ、遺伝子組換え技術への応用が可能で、また短期間で簡便に、かつ任意に、雄性飼育できるチョウ目昆虫系統、特にカイコ系統を確立し、提供することである。 The problem of the present invention is that it is possible to easily maintain and manage the strain without disturbing the genetic background using a sex determination mechanism or a sex differentiation gene, and it can be applied to a gene recombination technique. Another object of the present invention is to establish and provide Lepidoptera insect strains, particularly silkworm strains, which can be bred male in a short and simple manner.
 本発明者らは、近年、カイコの初期胚において雌雄のトランスクリプトームを比較することによってW染色体から産生されるメスに特異的な転写産物を同定し、それがpiRNAの前駆体であることを突き止めた(Kiuchi T., et al., 2014, Nature, 509: 633-636)。また、この転写産物から産生されるFem piRNAの標的遺伝子がZ染色体に存在する雄化遺伝子Masculinizer(Masc)遺伝子であることを見出した(Kiuchi T., et al., 2014;前述)。オスではMasc遺伝子の働きによってオス化が誘導されるのに対して、メスではMasc遺伝子がFem piRNAとカイコのPIWIタンパク質であるSiwiとの複合体の働きによって切断されるためメス化が誘導されることが明らかになった(Kiuchi T., et al., 2014;前述)。一方、Fem piRNA-Siwi複合体は、Masc遺伝子のFem認識領域内に置換変異を導入した変異型Masc遺伝子を切断できないことも判明した(Kiuchi T., et al., 2014;前述)。 We have recently identified a female-specific transcript produced from the W chromosome by comparing the male and female transcriptomes in the silkworm early embryo, and found that it is a precursor of piRNA. (Kiuchi T., et al., 2014, Nature, 509: 633-636). In addition, the present inventors have found that the target gene of Fem piRNA produced from this transcript is the maleizing gene Masculinizer (Masc) gene present in the Z chromosome (Kiuchi T., et al., 2014; mentioned above). In males, maleization is induced by the action of the Masc gene, whereas in females, the Masc gene is cleaved by the action of a complex between Fem piRNA and Siwi, the silkworm's PIWI protein. (Kiuchi T., et al., 2014; mentioned above). On the other hand, the Fem 判明 piRNA-Siwi complex was also found to be unable to cleave a mutant Masc gene introduced with a substitution mutation in the Fem recognition region of the Masc gene (Kiuchi T., et al., 2014; see above).
 本発明者らは、さらに研究を進めた結果、変異型Masc遺伝子をカイコ内で過剰発現させた場合、オス個体には異常は見られなかったが、メス個体はオス化することなく、若齢幼虫時までに死亡することが明らかとなった。本発明者らは、この知見に基づいて、変異型Masc遺伝子をチョウ目昆虫の宿主細胞内に導入し、その発現を制御することによって宿主のメス致死性を制御し、飼育個体を任意にオス個体にすることに成功した。本発明は、当該研究成果に基づくものであって以下を提供する。
(1)Fem piRNA-Siwi複合体に対する切断耐性と野生型Masc遺伝子の活性を有する変異型Masc遺伝子であって、配列番号1で示される塩基配列からなるカイコMasc遺伝子において1391位~1419位のFem piRNA認識配列内、又はカイコMasc遺伝子のチョウ目昆虫のオルソログにおいて前記Fem piRNA認識配列に対応する塩基配列内に1又は2以上の、ナンセンス変異以外の塩基置換、フレームシフトを生じない欠失、及び/又はフレームシフトを生じない付加を有する前記変異型Masc遺伝子。
(2)前記変異がカイコMasc遺伝子におけるFem piRNA認識配列内の1409位及び1410位を含む連続する15塩基からなる領域内、又はカイコMasc遺伝子のチョウ目昆虫のオルソログにおける対応する領域内に存在する、(1)に記載の変異型Masc遺伝子。
(3)前記塩基置換がサイレント変異である、(1)又は(2)に記載の変異型Masc遺伝子。
(4)ユビキタスな発現誘導型プロモーターの下流に機能的に連結した(1)~(3)のいずれかに記載の変異型Masc遺伝子を発現可能な状態で含む変異型Masc遺伝子発現ベクター。
(5)前記ユビキタスな発現誘導型プロモーターが熱ショックタンパク質70プロモーターである、(4)に記載の変異型Masc遺伝子発現ベクター。
(6)ユビキタスなプロモーター及び該プロモーターの下流に機能的に連結した転写調節因子をコードする遺伝子を含む第1発現ユニット、及び該転写調節因子の標的プロモーター及び該標的プロモーターの下流に機能的に連結した(1)~(3)のいずれかに記載の変異型Masc遺伝子を含む第2発現ユニットから構成される変異型Masc遺伝子発現ベクター。
(7)前記ユビキタスなプロモーターがアクチン3プロモーター、熱ショックタンパク質70プロモーター、又は伸長因子プロモーターである、(6)に記載の変異型Masc遺伝子発現ベクター。
(8)前記転写調節因子をコードする遺伝子がGAL4遺伝子であり、かつ該転写調節因子の標的プロモーターがUASプロモーターである、(6)又は(7)に記載の変異型Masc遺伝子発現ベクター。
(9)前記(4)又は(5)に記載の変異型Masc遺伝子発現ベクターを含む雌蚕致死カイコ系統。
(10)前記(6)に記載の第2発現ユニットのみを含む雌蚕致死カイコ系統。
(11)前記(8)に記載の第2発現ユニットのみを含む雌蚕致死雄蚕不妊カイコ系統。
(12)前記(9)に記載の雌蚕致死カイコ系統において、発生初期の胚に発現誘導処理を施す工程を含む雌蚕致死カイコの作出方法。
(13)前記(6)又は(7)に記載の第1発現ユニットを有する遺伝子組換えカイコ系統と(10)に記載の雌蚕致死カイコ系統とを交配させる工程、及び前記第1及び第2発現ユニットを有する雌蚕致死カイコを選択する工程を含む雌蚕致死カイコの作出方法。
(14)前記(8)に記載の第1発現ユニットを有する雌蚕致死雄蚕不妊カイコ系統と(11)に記載の雌蚕致死雄蚕不妊系統とを交配させる工程、及び前記第1及び第2発現ユニットを有する雌蚕致死雄蚕不妊カイコを選択する工程を含む雌蚕致死雄蚕不妊カイコの作出方法。
As a result of further research, the present inventors found that when the mutant Masc gene was overexpressed in the silkworm, no abnormality was found in the male individual, but the female individual did not become male, It became clear that he died by the time of larvae. Based on this finding, the present inventors introduced a mutant Masc gene into a host cell of a lepidopteran insect, and controlled its expression to control the female lethality of the host, thereby arbitrarily controlling the domestic individual. Successfully made an individual. The present invention is based on the research results and provides the following.
(1) A mutant Masc gene having cleavage resistance against the Fem piRNA-Siwi complex and the activity of the wild-type Masc gene, and the Fem at positions 1391 to 1419 in the silkworm Masc gene comprising the base sequence represented by SEQ ID NO: 1. One or more base substitutions other than nonsense mutations, deletions that do not cause a frame shift in the piRNA recognition sequence or in the base sequence corresponding to the Fem piRNA recognition sequence in the ortholog of the Lepidoptera insect of the silkworm Masc gene, and The mutant Masc gene having an addition that does not cause a frame shift.
(2) The mutation is present in a region consisting of 15 consecutive bases including positions 1409 and 1410 in the Fem piRNA recognition sequence in the silkworm Masc gene, or in a corresponding region in the ortholog of the Lepidoptera insect of the silkworm Masc gene. The mutant Masc gene according to (1).
(3) The mutant Masc gene according to (1) or (2), wherein the base substitution is a silent mutation.
(4) A mutant Masc gene expression vector comprising the mutant Masc gene according to any one of (1) to (3) operably linked downstream of a ubiquitous expression-inducible promoter.
(5) The mutant Masc gene expression vector according to (4), wherein the ubiquitous expression-inducible promoter is a heat shock protein 70 promoter.
(6) a first expression unit comprising a ubiquitous promoter and a gene encoding a transcriptional regulatory factor operably linked downstream of the promoter, and a functional promoter linked downstream of the target promoter of the transcriptional regulatory factor and the target promoter A mutant Masc gene expression vector comprising a second expression unit comprising the mutant Masc gene according to any one of (1) to (3).
(7) The mutant Masc gene expression vector according to (6), wherein the ubiquitous promoter is an actin 3 promoter, a heat shock protein 70 promoter, or an elongation factor promoter.
(8) The mutant Masc gene expression vector according to (6) or (7), wherein the gene encoding the transcriptional regulatory factor is a GAL4 gene and the target promoter of the transcriptional regulatory factor is a UAS promoter.
(9) A female pupal dead silkworm strain comprising the mutant Masc gene expression vector according to (4) or (5).
(10) A female pupal dead silkworm strain containing only the second expression unit according to (6).
(11) A female pupal dead male sterilized silkworm strain containing only the second expression unit according to (8).
(12) A method for producing a female pupal dead silkworm, comprising the step of subjecting an embryo at an early stage of development to an expression induction treatment in the female pupal dead silkworm strain according to (9).
(13) a step of mating the transgenic silkworm strain having the first expression unit according to (6) or (7) above with the female pupal dead silkworm strain according to (10), and the first and second A method for producing a female pupal dead silkworm, comprising a step of selecting a female pupal dead dead silkworm having an expression unit.
(14) a step of mating the female mortal male sterilized silkworm strain having the first expression unit according to (8) and the female mortal male sterilized female strain described in (11); and A method for producing a female genus dead male sterilized silkworm, comprising a step of selecting a female genital dead male sterilized silkworm having an expression unit.
 本明細書は本願の優先権の基礎となる日本国特許出願番号2014-232218号の開示内容を包含する。 This specification includes the disclosure of Japanese Patent Application No. 2014-232218, which is the basis of the priority of this application.
 本発明の変異型Masc遺伝子及び発現ベクターを使用すれば、雌蚕致死カイコ系統を容易に作出することができる。 The use of the mutant Masc gene and the expression vector of the present invention makes it possible to easily produce a female dead lethal silkworm strain.
 本発明の雌蚕致死カイコ系統によれば、当該系統から雌蚕致死カイコを容易に得ることが可能な系統を、遺伝的バックグラウンドを乱すこと無く、容易に維持又は管理することができる。遺伝子組換え技術への応用が可能で、短期間で簡便に、かつ任意に、雄性飼育をすることができる。それによって、高品質の絹糸を効率的に生産することができる。 According to the female dead lethal silkworm strain of the present invention, a strain that can easily obtain a female dead lethal silkworm from the strain can be easily maintained or managed without disturbing the genetic background. Application to genetic recombination technology is possible, and male breeding can be carried out conveniently and arbitrarily in a short period of time. Thereby, high-quality silk thread can be produced efficiently.
 本発明の雌蚕致死雄不妊カイコ系統によれば、自然界のクワコ個体との交雑を抑止できることから遺伝子組換えカイコの子孫の環境中への拡散を防止し、また有用な系統への遺伝的なコンタミを防ぐことができる。 According to the female pupal dead male infertile silkworm strain of the present invention, since it is possible to suppress crossing with natural mulberry individuals, it is possible to prevent the propagation of offspring of transgenic silkworms into the environment, Contamination can be prevented.
 本発明の雄蚕飼育方法によれば、蚕品種や遺伝的バックグラウンドに依ることなく雌蚕致死カイコを作出することができる。 According to the male bred breeding method of the present invention, it is possible to produce dead silkworm silkworms without depending on the cultivar variety or genetic background.
 本発明の不妊雄蚕飼育方法によれば、前記雄蚕飼育方法の効果に加えて、不妊の雌蚕致死カイコを作出することができる。 In addition to the effects of the stamen breeding method, an infertile female pup lethal silkworm can be produced according to the sterilized bred breeding method of the present invention.
野生型Masc遺伝子(Masc WT)と本実施例で使用した変異型Masc遺伝子(MascR)におけるFem piRNA認識配列周辺の塩基配列を示した図である。図中、黒枠で囲んだ領域がFem piRNA認識配列である。星印は、Masc WTとMascRで対応する塩基が一致していることを示す。また、黒丸は、変異型Masc遺伝子において置換変異を導入した箇所である。矢印は、Fem piRNA-Siwi複合体によって切断される位置を示す。It is the figure which showed the base sequence of the Fem (pi) piRNA recognition sequence periphery in a wild-type Masc gene (Masc | WT) and the mutant-type Masc gene (MascR) used in the present Example. In the figure, the region surrounded by a black frame is the Fem piRNA recognition sequence. An asterisk indicates that the corresponding bases match in Masc WT and MascR. A black circle is a place where a substitution mutation was introduced in the mutant Masc gene. The arrow indicates the position cleaved by the Fem piRNA-Siwi complex. カイコMasc遺伝子のFem piRNA認識配列において、切断耐性変異として好ましいサイレント変異を示す。最上段はFem piRNA認識配列内の塩基がコードするアミノ酸配列を示す。Masc WT及びMascRは、それぞれ野生型Masc遺伝子と変異型Masc遺伝子のFem piRNA認識配列を示す。MascRの塩基配列で下線を引いた塩基は、切断耐性変異として好ましいサイレント変異の部位とその変異塩基を示している。bは、c、g又はtであることを示す。dは、a、g又はtであることを示す。hは、a、c又はtであることを示す。In the Fem と し て piRNA recognition sequence of the silkworm Masc gene, a silent mutation preferable as a cleavage resistant mutation is shown. The top row shows the amino acid sequence encoded by the base in the Fem piRNA recognition sequence. Masc WT and MascR represent Fem piRNA recognition sequences of the wild-type Masc gene and the mutant Masc gene, respectively. The underlined base in the MascR base sequence indicates a silent mutation site and its mutant base that are preferred as a cleavage resistant mutation. b represents c, g, or t. d indicates a, g, or t. h represents a, c, or t. 本発明のMascR遺伝子発現ベクター第2発現ユニットpUAS-MascRと、その対照用第2発現ユニットpUAS-Mascの構成を示す概念図である。矢頭は、Masc遺伝子におけるFem piRNA認識配列の位置を示している。It is a conceptual diagram which shows the structure of the 2nd expression unit pUAS-MascR of the MascR gene expression vector of this invention, and the 2nd expression unit for control pUAS-Masc. The arrowhead indicates the position of the Fem piRNA recognition sequence in the Masc gene. 雌蚕致死カイコにおける各遺伝子型の性比を示す図である。A及びBは、sumi13系統(本発明の雌蚕致死カイコ)と193-2系統(BmA3-GAL4系統)との交配で得られたF1個体のうち5齢幼虫ステージで生存する個体における各遺伝子型の性比を、C及びDは、sumi12系統(対照用カイコ系統)と193-2系統(BmA3-GAL4系統)との交配で得られたF1個体のうち5齢幼虫ステージで生存する個体における各遺伝子型の性比を、そしてE及びFは、雌蚕致死カイコ系統との交配に用いたMascR遺伝子発現ベクター第1発現ユニットBmA3-GAL4を有する193-2系統の5齢幼虫ステージで生存する個体における各遺伝子型の性比を示す。各パネルにおいて、G+Rは、本発明のMascR遺伝子発現ベクター第2発現ユニットpUAS-MascR及び第1発現ユニットBmA3-GAL4を有する個体群における性比であることを示す。Gは、第1発現ユニットBmA3-GAL4のみを有する個体群における性比であることを示す。Rは、本発明のMascR遺伝子発現ベクター第2発現ユニットpUAS-MascRのみを有する個体群における性比であることを示す。Negativeは、第1発現ユニットBmA3-GAL4及び本発明のMascR遺伝子発現ベクター第2発現ユニットpUAS-MascRのいずれをも有さない個体群における性比であることを示す。各パネルの黒四角はオス個体の割合を示し、白四角はメス個体の割合を示す。It is a figure which shows the sex ratio of each genotype in a female pupal dead silkworm. A and B are genotypes of individuals living in the 5th instar larva stage among the F1 individuals obtained by crossing the sumi13 line (female lethal silkworm of the present invention) and the 193-2 line (BmA3-GAL4 line). The sex ratios of C and D are the F1 individuals obtained by crossing between the sumi12 line (control silkworm line) and the 193-2 line (BmA3-GAL4 line) in the individual living in the 5th instar larva stage. The genotype sex ratio, and E and F are individuals living in the 5th instar larvae stage of 193-2 line having the first expression unit BmA3-GAL4 of MascR gene expression vector used for mating with the female pupal dead silkworm line The sex ratio of each genotype in is shown. In each panel, G + R indicates a sex ratio in a population having the second expression unit pUAS-MascR of the MascR gene expression vector of the present invention and the first expression unit BmA3-GAL4. G indicates a sex ratio in a population having only the first expression unit BmA3-GAL4. R represents a sex ratio in a population having only the second expression unit pUAS-MascR of the MascR gene expression vector of the present invention. Negative indicates a sex ratio in a population having neither the first expression unit BmA3-GAL4 nor the MascR gene expression vector second expression unit pUAS-MascR of the present invention. The black squares on each panel indicate the percentage of male individuals, and the white squares indicate the percentage of female individuals. 本発明のMascR遺伝子発現ベクター第2発現ユニットpUAS-MascR及び第1発現ユニットBmA3-GAL4をともに有するF1個体における性染色体の核型をPCRによって検出した結果を示す図である。AはF1個体のうち死亡した幼虫個体の核型を、BはF1個体のうち生存する5齢幼虫ステージまで生存した幼虫個体の核型を示している。It is a figure which shows the result of having detected the karyotype of the sex chromosome in F1 individual which has both the 2nd expression unit pUAS-MascR of the MascR gene expression vector of this invention, and 1st expression unit BmA3-GAL4 by PCR. A shows the karyotype of the larva individual who died among the F1 individuals, and B shows the karyotype of the larva individual who survived to the surviving 5th instar larva stage among the F1 individuals. 雌蚕致死カイコを含む各系統のカイコに繭を形成させたときの繭の形態(A)とその繭内の蛹の形態及び性別(B)を示す。The form of a cocoon (A) when the silkworm of each strain including a female pupal dead silkworm is formed is shown, and the form and sex (B) of the cocoon in the cocoon. 193-2系統と白/C系統を相互交配させた時のメスの産卵状態を示した図である。Aは193-2系統のメスと白/C系統のオスを交配させた場合、Bは白/C系統のメスと193-2系統のオスを交配させた場合の同面積内における産卵数を示す。It is the figure which showed the egg-laying state of the female when a 193-2 system | strain and a white / C system | strain were mutually crossed. A shows the number of eggs laid in the same area when 193-2 female and white / C male are mated, and B shows white / C female and 193-2 male mated. . 白/C系統のメスと様々な系統のオスを交配させたときの白/C系統メスにおける産卵数の違いを示す図である。1は未交尾メス、2は白/C系統メス×193-2系統オス、3は白/C系統メス×w1-pnd系統オス、及び4は白/C系統メス×白/C系統オスを示す。It is a figure which shows the difference in the number of eggs laying in a white / C system female when a white / C system female and a male of various systems are crossed. 1 is unmating female, 2 is white / C female x193-2 male, 3 is white / C female xw1-pnd male, and 4 is white / C female x white / C male .
1.変異型Masc遺伝子
1-1.概要
 本発明の第1の態様は変異型Masc遺伝子である。本発明の変異型Masc遺伝子は、Fem piRNA-Siwi複合体に対して切断耐性を有することを特徴とする。
1-2.定義
 本明細書で使用する以下の主要な用語について定義する。
1. Mutant Masc gene 1-1. Overview A first aspect of the present invention is a mutant Masc gene. The mutant Masc gene of the present invention is characterized by having cleavage resistance to the Fem piRNA-Siwi complex.
1-2. Definitions The following key terms used in this specification are defined.
 「piRNA(PIWI-interacting RNA)」とは、生殖細胞形成や性決定に関与する23~30塩基長の非コーディング小分子RNAである。piRNAは、前駆体の状態で発現し、切断及び修飾等のプロセシングを経た後、標的RNAに相補的な塩基配列からなる認識領域を有する成熟piRNAとなる。その後、piRNAは、PIWI(P-element Induced Wimpy Testis)タンパク質と複合体を形成し、認識領域を介して標的RNAと結合することによって、一本鎖RNAの切断活性を有するPIWIタンパク質を標的RNAに誘導する。piRNA-PIWI複合体は、標的RNAをpiRNAの5’末端から10位と11位の塩基間を切断することが知られている(Brennecke, J., et al., Cell, 2007, 128, 1089-1103;Gunawardane, L. S., et al., 2007, Science, 315, 1587-1590)。 “PiRNA (PIWI-interacting RNA)” is a non-coding small RNA with a length of 23-30 bases involved in germ cell formation and sex determination. The piRNA is expressed in a precursor state, and after processing such as cleavage and modification, becomes a mature piRNA having a recognition region consisting of a base sequence complementary to the target RNA. After that, piRNA forms a complex with PIWI (P-element Induced Wimpy 、 Testis) protein, and binds to the target RNA via the recognition region, thereby converting the PIWI protein with single-stranded RNA cleavage activity into the target RNA. Induce. The piRNA-PIWI complex is known to cleave the target RNA between the 10th and 11th bases from the 5 'end of piRNA (Brennecke, J., et al., Cell, 2007, 128, 1089). -1103; Gunawardane, L. S., et al., 2007, Science, 315, 1587-1590).
 「Fem piRNA」とは、カイコの雌性決定遺伝子であるFeminizer(Fem)遺伝子の転写産物から産生される小分子RNAである。Fem piRNAは、配列番号3で示す29塩基からなるpiRNA(PIWI-interacting RNA)で構成されている。Fem piRNAは、カイコのPIWIオルソログであるSiwiと複合体を形成し、後述するカイコの雄性決定遺伝子であるMasc遺伝子の転写産物(Masc mRNA)を特定の位置で切断することによって、Mascタンパク質の発現を抑制する。Masc mRNAが切断されたメス個体では、性決定カスケードの最下流で機能するdouble sex(dsx)遺伝子の転写産物(dsx mRNA)がメス特異的なスプライシングパターンを示し、雌化が誘導される。 “Fem piRNA” is a small molecule RNA produced from a transcription product of the feminizer (Fem) gene, which is a female determining gene of silkworm. Fem piRNA is composed of piRNA (PIWI-interacting RNA) consisting of 29 bases shown in SEQ ID NO: 3. Fem piRNA forms a complex with silkworm's PIWI ortholog Siwi and cleaves the Masc gene transcript (Masc mRNA), a silkworm's male determinant gene described later, at a specific position. Suppress. In females whose Masc mRNA has been cleaved, the double sex (dsx) gene transcript (dsx mRNA), which functions at the most downstream of the sex determination cascade, shows a female-specific splicing pattern and induces feminization.
 「Masc(Masculinizer)遺伝子」とは、Z染色体上にコードされるカイコの雄性決定遺伝子である。Masc遺伝子は、2つのCCCHドメインをタンデムに有するジンクフィンガータンパク質Mascをコードしており、チョウ目昆虫においてのみオルソログが存在する。前述のようにMasc遺伝子は、Fem piRNA-Siwi複合体の標的遺伝子であり、W染色体を有する雌個体中ではFem piRNA-Siwi複合体によりMasc mRNAが切断される。一方、W染色体のない雄個体中では、Fem遺伝子が存在しないため、Masc mRNAは切断されることがなく、発現したMascタンパク質は、dsx mRNAをオス特異的なスプライシングパターンに誘導する結果、個体の雄化が誘導される。 “Masc (Masculinizer) gene” is a male sex-determining gene of silkworm encoded on the Z chromosome. The Masc gene encodes a zinc finger protein Masc that has two CCCH domains in tandem, and orthologs exist only in Lepidoptera insects. As described above, the Masc gene is a target gene of the Fem piRNA-Siwi complex. In a female individual having a W chromosome, Masc mRNA is cleaved by the Fem piRNA-Siwi complex. On the other hand, in male individuals without the W chromosome, since the Fem gene does not exist, Masc mRNA is not cleaved, and the expressed Masc protein induces dsx mRNA into a male-specific splicing pattern. Masinization is induced.
 「チョウ目昆虫」とは、分類学上のチョウ目(Lepidoptera)に属する昆虫であって、チョウ又はガをいう。チョウには、タテハチョウ科(Nymphalidae)、アゲハチョウ科(Papilionidae)、シロチョウ科(Pieridae)、シジミチョウ科(Lycaenidae)、及びセセリチョウ科(Hesperiidae)に属する昆虫が含まれる。ガには、ヤママユガ科(Saturniidae)、カイコガ科(Bombycidae)、イボタガ科(Brahmaeidae)、オビガ科(Eupterotidae)、カレハガ科(Lasiocampidae)、ミノガ科(Psychidae)、シャクガ(Geometridae)、ヒトリガ科(Archtiidae)、ヤガ科(Noctuidae)、メイガ科(Pyralidae)、スズメガ科(Sphingidae)等に属する昆虫が含まれる。例えば、ガであれば、Bombyx属、Samia属、Antheraea属、Saturnia属、Attacus属、Rhodinia属に属する種、具体的には、カイコ、クワコ(Bombyx mandarina)、シンジュサン(Samia cynthia;エリサンSamia cynthia ricini及びシンジュサンとエリサンの交配種を含む)、ヤママユガ(Antheraea yamamai)、サクサン(Antheraea pernyi)、ヒメヤママユ(Saturnia japonica)、オオミズアオ(Actias gnoma)等が挙げられるが、本発明のチョウ目昆虫は、これらに限定はされない。
1-3.構成
 本発明の変異型Masc遺伝子は、Fem piRNA-Siwi複合体に対する切断耐性と野生型Masc遺伝子の活性を有する変異型Masc遺伝子である。
“Lepidoptera” refers to insects belonging to the taxonomic Lepidoptera, butterfly or moth. The butterfly includes insects belonging to Nymphalidae, Papilionidae, Pieridae, Lycaenidae, and Hesperiidae. The moths include Saturniidae, Bombycidae, Brahmaeidae, Eupterotidae, Lasiocampidae, Psychidae, Geometridae, and idae , Insects belonging to Noctuidae, Pyralidae, Sphingidae and the like. For example, in the case of moths, species belonging to the genus Bombyx, Samia, Antheraea, Saturnia, Attacus, Rhodinia, specifically, silkworms, Bombyx mandarina, Shina cynthia; ricini and Shinjusan-Erysan hybrids), Antheraea yamamai, Saksan (Antheraea pernyi), Saturnia japonica, Actias gnoma, etc., but the Lepidoptera insects of the present invention are These are not limited.
1-3. Configuration The mutant Masc gene of the present invention is a mutant Masc gene having cleavage resistance to the Fem piRNA-Siwi complex and the activity of the wild-type Masc gene.
 「変異型Masc遺伝子」(本明細書では、しばしばMascR(Fem piRNA-resistant Masc)遺伝子と表記する)とは、野生型Masc遺伝子の塩基配列の一部に変異を生じたMasc遺伝子である。ただし、MascR遺伝子がコードする変異型Mascタンパク質(本明細書では、しばしばMascRタンパク質と表記する)は、必ずしもアミノ酸変異を有するとは限らない。例えば、後述する塩基置換がサイレント変異の場合、発現するMascRタンパク質は、野生型Mascタンパク質と同一のアミノ酸配列である。 The “mutant Masc gene” (often referred to herein as “MascR (Fem-piRNA-resistant Masc) gene”) is a Masc gene in which a part of the base sequence of the wild-type Masc gene has been mutated. However, the mutant Masc protein encoded by the MascR gene (often referred to as “MascR protein” in this specification) does not necessarily have an amino acid mutation. For example, when the base substitution described later is a silent mutation, the expressed MascR protein has the same amino acid sequence as the wild-type Masc protein.
 「Fem piRNA-Siwi複合体に対する切断耐性を有する変異」(本明細書では、しばしば「切断耐性変異」と略称する)とは、Masc遺伝子上に生じた変異であって、Fem piRNA-Siwi複合体に対する切断耐性能をMasc遺伝子に付与する変異をいう。当該変異により、Fem piRNAによる塩基対合を介したMasc mRNAとの結合及び認識が抑制され、その結果、Fem piRNA-Siwi複合体によるMasc mRNAの切断が阻害される。それ故、Fem piRNA存在下であっても、Masc mRNAが切断されることなく機能的なMascタンパク質を発現することができる。 A “mutation having cleavage resistance to Fem piRNA-Siwi complex” (often abbreviated as “cleavage resistance mutation” in the present specification) is a mutation that occurs on the Masc gene and is a Fem piRNA-Siwi complex. A mutation that confers cutting resistance to the Masc gene. By this mutation, binding and recognition with Masc mRNA via base pairing by Fem piRNA is suppressed, and as a result, cleavage of Masc mRNA by Fem piRNA-Siwi complex is inhibited. Therefore, even in the presence of Fem piRNA, a functional Masc protein can be expressed without cleavage of Masc mRNA.
 「野生型Masc遺伝子の活性」とは、機能的なMascタンパク質をコードしていることをいう。 “The activity of the wild-type Masc gene” means that it encodes a functional Masc protein.
 「機能的なMascタンパク質」とは、野生型Mascタンパク質に見られる活性、すなわち細胞内のdsx mRNAをオス特異的スプライシングパターンに誘導する活性を有するMascタンパク質をいう。変異型Masc遺伝子が野生型Masc遺伝子の活性を保持しているか否かは、例えば、メスのカイコ由来の培養細胞に、変異型Masc遺伝子の発現ベクターを導入し、培養細胞内で発現する変異型Mascタンパク質によって細胞が有するdsx mRNAのスプライシングパターンがオス特異的スプライシングパターンに変換するか否かを調べることによって決定できる(Kiuchi T., et al., 2014;前述)。具体的には、まず、薬剤耐性マーカー遺伝子を有する変異型Masc遺伝子の発現ベクターをメスのカイコ由来の培養細胞(例えば、カイコ卵巣由来のBmN4細胞)に形質転換法で導入した後、細胞を薬剤で選抜する。続いて、上記発現ベクターを保持し、変異型Masc遺伝子を発現する細胞から常法に従いmRNAを精製し、これを鋳型としてcDNAを作製する。cDNAを鋳型とし、dsx mRNAのスプライシングパターンがオス特異的かメス特異的かを区別することができるDNAプライマーペア(例えば、配列番号4で示すBmdsx-Fと配列番号5で示すBmdsx-Rのペア)を用いたPCRにより、細胞内のdsx mRNAのスプライシングパターンがオス特異的スプライシングパターンに変換されているか否かを調べる。その結果、変異型Masc遺伝子が導入された細胞におけるdsx mRNAのスプライシングパターンがオス特異的スプライシングパターンに変換されている場合は、当該変異型Masc遺伝子は、野生型Masc遺伝子活性を保持する変異型Masc遺伝子であることが示される。 “Functional Masc protein” refers to a Masc protein having an activity found in a wild-type Masc protein, that is, an activity that induces intracellular dsx mRNA into a male-specific splicing pattern. Whether or not the mutant Masc gene retains the activity of the wild-type Masc gene is determined, for example, by introducing an expression vector of the mutant Masc gene into a cultured cell derived from a female silkworm and expressing it in the cultured cell. It can be determined by examining whether the splicing pattern of dsxdsmRNA possessed by a cell is converted to a male-specific splicing pattern by Masc protein (Kiuchi T., et al., 2014; supra). Specifically, first, a mutant Masc gene expression vector having a drug resistance marker gene is introduced into a cultured cell derived from a female silkworm (for example, BmN4 cell derived from a silkworm ovary) by a transformation method, and then the cell is treated with a drug. Select with. Subsequently, mRNA is purified from cells that hold the above expression vector and express the mutant Masc gene according to a conventional method, and cDNA is prepared using this mRNA as a template. DNA primer pair that can distinguish whether the splicing pattern of dsx mRNA is male-specific or female-specific using cDNA as a template (for example, Bmdsx-F pair shown in SEQ ID NO: 4 and Bmdsx-R pair shown in SEQ ID NO: 5) ) To determine whether the intracellular splicing pattern of dsx mRNA has been converted to a male-specific splicing pattern. As a result, when the splicing pattern of dsx mRNA in a cell into which the mutant Masc gene has been introduced has been converted to a male-specific splicing pattern, the mutant Masc gene retains the wild-type Masc gene activity. It is shown to be a gene.
 前記切断耐性変異は、Masc遺伝子上のFem piRNA認識配列内に存在する。Fem piRNA認識配列は、カイコの場合、配列番号1で示される塩基配列からなるMasc遺伝子において開始コドンatgのa(アデニン)を1位としたときに1391位~1419位の塩基配列が該当する。また、カイコ以外のチョウ目昆虫の場合であれば、カイコMasc遺伝子オルソログにおいて、カイコMasc遺伝子のFem piRNA認識配列に対応する塩基配列が該当する。 The cleavage-resistant mutation is present in the Fem piRNA recognition sequence on the Masc gene. In the case of silkworms, the Fem piRNA recognition sequence corresponds to the nucleotide sequence of positions 1391 to 1419 when the a (adenine) of the start codon atg is 1 in the Masc gene consisting of the nucleotide sequence represented by SEQ ID NO: 1. In the case of Lepidoptera insects other than silkworms, the base sequence corresponding to the Fem piRNA recognition sequence of the silkworm Masc gene corresponds to the silkworm Masc gene ortholog.
 前記Fem piRNA認識配列内で、切断耐性変異が存在する位置として好ましい領域は、Fem piRNAと相補結合によって直接塩基対合を形成する領域である。例えば、カイコの場合には、Masc遺伝子の1409位及び1410位を含む15塩基からなる領域、特にMasc mRNAの切断に重要な1407位~1418位の12塩基からなる領域が該当する。またカイコ以外のチョウ目昆虫の場合も、カイコMasc遺伝子オルソログにおいて前記領域に対応する塩基配列が該当する。 In the Fem piRNA recognition sequence, a preferred region where a cleavage resistant mutation is present is a region that forms direct base pairing by complementary binding with Fem に よ っ て piRNA. For example, in the case of silkworms, a region consisting of 15 bases including positions 1409 and 1410 of the Masc gene, particularly a region consisting of 12 bases from positions 1407 to 1418 that are important for the cleavage of Masc mRNA. In the case of Lepidoptera insects other than silkworms, the base sequence corresponding to the region corresponds to the silkworm Masc gene ortholog.
 切断耐性変異の種類には、ナンセンス変異以外の塩基置換、フレームシフトを生じない欠失、又はフレームシフトを生じない付加が挙げられる。
(1)ナンセンス変異以外の塩基置換
 「塩基置換(変異)」は、野生型遺伝子の塩基の一部が他の塩基と置き換わる変異である。本明細書では、野生型Masc遺伝子の塩基の一部が他の塩基と置き換わった変異が該当する。
Types of cleavage resistant mutations include base substitutions other than nonsense mutations, deletions that do not cause frame shifts, or additions that do not cause frame shifts.
(1) Base substitution other than nonsense mutation The “base substitution (mutation)” is a mutation in which a part of the base of the wild-type gene is replaced with another base. In the present specification, a mutation in which a part of the base of the wild type Masc gene is replaced with another base corresponds.
 塩基置換には、点突然変異のような1塩基置換の他、連続する2塩基以上の置換があるが、本発明のMascR遺伝子においては、いずれの塩基置換も包含する。 The base substitution includes a single base substitution such as a point mutation and a substitution of two or more consecutive bases. However, in the MascR gene of the present invention, any base substitution is included.
 塩基置換には、置換前後の塩基間の性質に基づいて、トランジション変異及びトランスバージョン変異がある。トランジション変異は、プリン間又はピリミジン間の置換である。例えば、a(アデニン)からg(グアニン)への置換、及びgからへaの置換が挙げられる。トランスバージョン変異は、プリンとピリミジン間の置換である。例えば、c(シトシン)からt(チミン)への置換、及びtからcへの置換が挙げられる。本発明のMascR遺伝子においては、いずれの変異であってもよい。 Base substitution includes transition mutation and transversion mutation based on the nature between bases before and after substitution. Transition mutations are substitutions between purines or pyrimidines. For example, a (adenine) to g (guanine) substitution and g to a substitution. Transversion mutations are substitutions between purines and pyrimidines. For example, substitution from c (cytosine) to t (thymine) and substitution from t to c can be mentioned. Any mutation may be used in the MascR gene of the present invention.
 塩基置換には、コードするアミノ酸への影響に基づいた変異として、サイレント変異、ミスセンス変異、及びナンセンス変異がある。サイレント変異は、縮重コドンへの置換であって、アミノ酸置換を生じない塩基置換である。ミスセンス変異は、Mascタンパク質のアミノ酸配列にアミノ酸置換をもたらす塩基置換である。また、ナンセンス変異は、終止コドンをもたらす塩基置換である。 In the base substitution, there are a silent mutation, a missense mutation, and a nonsense mutation as mutations based on the influence on the encoded amino acid. Silent mutation is a substitution to a degenerate codon that does not result in an amino acid substitution. A missense mutation is a base substitution that results in an amino acid substitution in the amino acid sequence of the Masc protein. Nonsense mutations are base substitutions that result in stop codons.
 塩基置換では、塩基置換を生じる前と生じた後(例えば、野生型Masc遺伝子とMascR遺伝子との間)で塩基数が増減しないことからフレームシフトは生じない。ただし、ナンセンス変異の場合、終止コドンの挿入により下流のアミノ酸が欠失した切断型(truncated)タンパク質となる。それ故、本発明の塩基置換としては好ましくない。したがって、発明のMascR遺伝子における塩基置換は、ナンセンス変異以外であれば、サイレント変異又はミスセンス変異のいずれであってもよい。ただし、ミスセンス変異の場合、そのアミノ酸置換を有するMascRタンパク質が機能的なMascタンパク質であることが望ましい。好ましくはMascタンパク質のアミノ酸配列を変化させないサイレント変異である。 In the base substitution, there is no frame shift because the number of bases does not increase or decrease before and after the base substitution occurs (for example, between the wild type Masc gene and the MascR gene). However, in the case of a nonsense mutation, it becomes a truncated protein from which a downstream amino acid has been deleted by insertion of a stop codon. Therefore, it is not preferable as the base substitution of the present invention. Therefore, the base substitution in the MascR gene of the invention may be either a silent mutation or a missense mutation as long as it is other than a nonsense mutation. However, in the case of a missense mutation, it is desirable that the MascR protein having the amino acid substitution is a functional Masc protein. Silent mutation that does not change the amino acid sequence of the Masc protein is preferable.
 図2にカイコMasc遺伝子のFem piRNA認識配列において切断耐性変異として好ましいサイレント変異を示す。カイコMasc遺伝子では、1395位のcからa、g又はtへの変異(本明細書では「c1395d」と表記する。以下同様;d=a, g, t)、t1398c、g1401h(h=a, c, t)、t1404c、c1405a/a1407g(c1405a及びa1407gの二重変異を示す)、a1407b(b=c, g, t)、a1410g、a1413g、g1416a、及びa1419bが切断耐性変異として挙げられる。カイコMasc遺伝子オルソログにおいても、カイコと同様に、Fem piRNA認識配列に対応する塩基配列において、アミノ酸置換を生じないサイレント変異であればよい。 FIG. 2 shows a preferred silent mutation as a cleavage resistant mutation in the Fem piRNA recognition sequence of the silkworm Masc gene. In the silkworm Masc gene, a mutation at position 1395 from c to a, g, or t (referred to as “c1395d” in this specification; the same applies hereinafter; d = a, g, t), t1398c, g1401h (h = a, c, t), t1404c, c1405a / a1407g (representing double mutations of c1405a and a1407g), a1407b (b = c, g, t), a1410g, a1413g, g1416a, and a1419b. The silkworm Masc gene ortholog may be a silent mutation that does not cause an amino acid substitution in the base sequence corresponding to the Fem piRNA recognition sequence, similarly to the silkworm.
 一方、ミスセンス変異によって生じるMascRタンパク質が機能的なMascタンパク質であるためには、ミスセンス変異によって生じるアミノ酸置換が保存的アミノ酸置換であればよい。 On the other hand, in order for the MascR protein caused by the missense mutation to be a functional Masc protein, the amino acid substitution caused by the missense mutation may be a conservative amino acid substitution.
 「保存的アミノ酸置換」とは、アミノ酸をその性質に基づいて分類したときに、同じアミノ酸群内のアミノ酸間での置換をいう。保存的アミノ酸置換であれば、置換前と置換後のアミノ酸の性質が類似することから野生型タンパク質と実質的に同等な構造や性質を変異型タンパク質にもたらし得る。前記アミノ酸群には、非極性アミノ酸群(アラニン(A)、フェニルアラニン(F)、ロイシン(L)、イソロイシン(I)、バリン(V)、メチオニン(M)、プロリン(P)、トリプトファン(W))、極性アミノ酸群(グリシン(G)、セリン(S)、トレオニン(T)、システイン(C)、アスパラギン(N)、グルタミン(Q)、チロシン(Y)、リシン(K)、ヒスチジン(H)、アルギニン(R)、グルタミン酸(E)、アスパラギン酸(D))、酸性アミノ酸群(D、E)、塩基性アミノ酸群(R、H、K)、芳香族アミノ酸群(F、W、Y)、及び脂肪族アミノ酸群(G、A、L、I、V)等が挙げられる。 “Conservative amino acid substitution” refers to substitution between amino acids in the same amino acid group when amino acids are classified based on their properties. In the case of conservative amino acid substitution, since the properties of the amino acid before and after substitution are similar, the structure and properties substantially equivalent to the wild-type protein can be brought to the mutant protein. The amino acid groups include non-polar amino acid groups (alanine (A), phenylalanine (F), leucine (L), isoleucine (I), valine (V), methionine (M), proline (P), tryptophan (W). ), Polar amino acid groups (glycine (G), serine (S), threonine (T), cysteine (C), asparagine (N), glutamine (Q), tyrosine (Y), lysine (K), histidine (H) , Arginine (R), glutamic acid (E), aspartic acid (D)), acidic amino acid group (D, E), basic amino acid group (R, H, K), aromatic amino acid group (F, W, Y) And aliphatic amino acid groups (G, A, L, I, V) and the like.
 カイコMasc遺伝子のFem piRNA認識配列内(実質的にはミスセンス変異を生じ得る1393位~1419位の範囲内)において、本発明の切断耐性変異として適当なミスセンス変異を表1に示す。 Table 1 shows suitable missense mutations as cleavage-resistant mutations of the present invention within the Fem piRNA recognition sequence of the silkworm Masc gene (substantially within the range of positions 1393 to 1419 which can cause missense mutations).
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
(2)フレームシフトを生じない欠失
 「欠失(変異)」とは、野生型遺伝子の塩基が失われる変異である。欠失変異には、フレームシフトを生じる欠失と生じない欠失がある。本発明のMascR遺伝子においては、フレームシフトを生じない欠失変異が対象となる。
(2) Deletion that does not cause a frame shift “Deletion (mutation)” is a mutation that loses the base of the wild-type gene. Deletion mutations include deletions that cause frameshifts and deletions that do not. In the MascR gene of the present invention, deletion mutations that do not cause frame shift are targeted.
 「フレームシフトを生じない欠失」とは、野生型遺伝子において連続する3n個(nは整数)の塩基が欠失する結果、野生型遺伝子がコードするアミノ酸配列において1又は数個のアミノ酸の欠失をもたらす変異である。この変異は、変異部位の下流で読取枠のずれ、すなわちフレームシフトを生じない。 “Deletions that do not cause frameshift” are the deletion of 3n consecutive bases (n is an integer) in the wild-type gene, resulting in the deletion of one or several amino acids in the amino acid sequence encoded by the wild-type gene. It is a mutation that causes loss. This mutation does not cause a reading frame shift, that is, a frame shift downstream of the mutation site.
 本発明の切断耐性変異として適当な欠失変異には、配列番号2に示すカイコMascタンパク質において、開始メチオニンを1位としたときに、425位~476位の欠損(Masc-md1)をもたらす、Masc遺伝子における1273位~1428位の欠失、450位~476位の欠損(Masc-md2)をもたらす、Masc遺伝子における1348位~1428位の欠失、463位~476位の欠損(Masc-md3)をもたらす、Masc遺伝子における1387位~1428位の欠失、及び469位~476位の欠損(Masc-md4)をもたらす、Masc遺伝子における1408位~1428位の欠失が挙げられる。
(3)フレームシフトを生じない付加
 「付加(変異)」とは、野生型遺伝子の塩基配列中に塩基が挿入される変異である。付加変異には、欠失変異と同様に、フレームシフトを生じる付加と生じない付加がある。本発明のMascR遺伝子においては、フレームシフトを生じない付加変異が対象となる。
Deletion mutations suitable as cleavage-resistant mutations of the present invention result in a deletion at positions 425 to 476 (Masc-md1) when the initiation methionine is position 1 in the silkworm Masc protein shown in SEQ ID NO: 2. Deletions from 1273 to 1428 in the Masc gene, deletions from 450 to 476 (Masc-md2), deletions from 1348 to 1428 in the Masc gene, and deletions from 463 to 476 (Masc-md3) Deletion of positions 1387 to 1428 in the Masc gene, and deletion of positions 1408 to 1428 in the Masc gene that results in a deletion of positions 469 to 476 (Masc-md4).
(3) Addition that does not cause frame shift “Addition (mutation)” is a mutation in which a base is inserted into the base sequence of a wild-type gene. Addition mutations, like deletion mutations, include additions that cause frameshifts and additions that do not. In the MascR gene of the present invention, additional mutations that do not cause frame shift are targeted.
 「フレームシフトを生じない付加」とは、野生型遺伝子において連続する3n個(nは整数)の塩基が付加される結果、野生型遺伝子がコードするアミノ酸配列において1又は数個のアミノ酸の挿入をもたらす変異である。この変異は、変異部位の下流でフレームシフトを生じない。 “Addition that does not cause frame shift” means that the insertion of one or several amino acids in the amino acid sequence encoded by the wild type gene results from the addition of 3n consecutive bases (n is an integer) in the wild type gene. It is a mutation that brings about. This mutation does not cause a frameshift downstream of the mutation site.
 本発明のMascR遺伝子において、切断耐性変異の数は、Fem piRNAとMasc mRNAの塩基対合を介した結合を阻害できればよく、特に限定はしない。通常は、Fem piRNA認識配列内に1又は2以上、具体的には、例えば、1~10個、1~9個、1~8個、1~7個、1~6個、1~3個、1~4個、1~3個、又は1又は2個あればよい。この切断耐性変異の数は、変異の種類にも依存する。1塩基置換の場合であれば、Fem piRNAとMasc mRNAとの塩基対合を介した結合を効果的に阻害するためには、Fem piRNA認識配列内に複数の変異を有することが好ましい。例えば、2個、3個、4個、5個、6個、7個、8個、9個、又は10個である。一方、フレームシフトを生じない欠失変異や付加変異の場合であれば、1つの変異によって失われる塩基数や挿入される塩基数が多ければ、変異の数は少なくてもよい。 In the MascR gene of the present invention, the number of cleavage resistant mutations is not particularly limited as long as it can inhibit the binding of Fem piRNA and Masc mRNA via base pairing. Usually, 1 or 2 or more within the Fem piRNA recognition sequence, specifically, for example, 1 to 10, 1 to 9, 1 to 8, 1 to 7, 1 to 6, 1 to 3 There may be one to four, one to three, or one or two. The number of cleavage resistant mutations also depends on the type of mutation. In the case of single base substitution, it is preferable to have a plurality of mutations in the Fem piRNA recognition sequence in order to effectively inhibit the binding of Fem piRNA and Masc mRNA via base pairing. For example, 2, 3, 4, 5, 6, 7, 8, 9, or 10. On the other hand, in the case of a deletion mutation or an addition mutation that does not cause a frame shift, the number of mutations may be small if the number of bases lost by one mutation or the number of inserted bases is large.
 本発明のMascR遺伝子において、切断耐性変異が複数存在する場合、各変異は、同じ種類の変異であってもよいし、異なる変異であってもよい。例えば、1のMascR遺伝子が2以上の置換変異と1つの欠失変異を有していてもよい。 In the MascR gene of the present invention, when there are a plurality of cleavage resistance mutations, each mutation may be the same type of mutation or a different mutation. For example, one MascR gene may have two or more substitution mutations and one deletion mutation.
 本発明のMascR遺伝子は、保存及び/又はクローニングのため、適当なクローニングベクター内に挿入されていてもよい。クローニングベクターの構築方法やそれを導入した大腸菌や酵母等の形質転換体の作製方法は、当該分野で公知の分子生物学技術を用いて行えばよい。これらの方法については、Green & Sambrook, 2012, Molecular Cloning: A Laboratory Manual Fourth Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York等のプロトコルを参考にすればよい。
2.変異型Masc遺伝子発現ベクター
2-1.概要
 本発明の第2の態様は、変異型Masc遺伝子発現ベクター(本明細書では、しばしば「MascR遺伝子発現ベクター」と表記する)である。本発明のMascR遺伝子発現ベクターは、第1態様のMascR遺伝子を発現可能な状態で含むことを特徴とする。本発明のMascR遺伝子発現ベクターによれば、宿主に導入することで、MascR遺伝子を過剰発現させることができる。
2-2.構成
 本明細書で「発現ベクター」とは、目的の遺伝子を発現可能な状態で含み、その遺伝子の発現を制御することのできる一つの発現系単位をいう。本発明で対象となる目的の遺伝子は、第1態様に記載したMascR遺伝子である。
The MascR gene of the present invention may be inserted into a suitable cloning vector for conservation and / or cloning. A method for constructing a cloning vector and a method for producing a transformant such as Escherichia coli or yeast into which the vector has been introduced may be performed using molecular biology techniques known in the art. These methods are described in Green & Sambrook, 2012, Molecular Cloning: A Laboratory Manual Fourth Ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, etc.
2. Mutant Masc gene expression vector 2-1. Overview A second aspect of the present invention is a mutant Masc gene expression vector (often referred to herein as “MascR gene expression vector”). The MascR gene expression vector of the present invention comprises the MascR gene of the first aspect in a state capable of being expressed. According to the MascR gene expression vector of the present invention, the MascR gene can be overexpressed by introduction into the host.
2-2. Configuration In the present specification, an “expression vector” refers to one expression system unit that contains a target gene in a state capable of being expressed and can control the expression of the gene. The target gene of interest in the present invention is the MascR gene described in the first embodiment.
 本明細書で「発現可能な状態」とは、発現ベクター内で目的の遺伝子をプロモーターの制御下に配置することをいう。 In this specification, the “expressible state” means that a target gene is placed under the control of a promoter in an expression vector.
 本発明のMascR遺伝子発現ベクターの母核には、宿主細胞内で複製可能な様々な遺伝子発現ベクターを利用することができる。例えば、プラスミド若しくはバクミド(Bacmid)のような自律複製可能な発現ベクター、ウイルスベクター、又は染色体中に相同又は非相同組換え可能な発現ベクター若しくはそれを宿主の染色体中に挿入した染色体の一部が挙げられる。また、大腸菌、枯草菌又は酵母内でも複製可能なシャトルベクターを利用することもできる。
2-2-1.MascR遺伝子発現ベクターの構成要素
 MascR遺伝子発現ベクターは、宿主細胞内でMascR遺伝子を発現できるように構成されている。MascR遺伝子発現ベクターの構成要素には、第1態様のMascR遺伝子及びユビキタスなプロモーターを必須構成要素として含む。また、マルチクローニングサイト、5’UTR、3’UTR、ターミネーター、エンハンサー、標識遺伝子、インスレーター、及びトランスポゾンの逆位末端反復配列等を選択構成要素として含む。さらに、MascR遺伝子発現ベクターが、後述する第1発現ユニットと第2発現ユニットの2つのユニットで構成される場合には、転写調節因子の遺伝子及び該転写調節因子の標的プロモーターを必須の構成要素として包含する。以下、本発明のMascR遺伝子発現ベクターの各構成要素について具体的に説明をする。
(1)MascR遺伝子
 MascR遺伝子の構成については、第1態様に詳述しており、ここでの説明は省略する。
(2)プロモーター
 本発明のMascR遺伝子発現ベクターに包含されるプロモーターは、ユビキタスなプロモーターである。
As the mother nucleus of the MascR gene expression vector of the present invention, various gene expression vectors capable of replicating in a host cell can be used. For example, an autonomously replicable expression vector such as a plasmid or Bacmid, a viral vector, an expression vector capable of homologous or non-homologous recombination in a chromosome, or a part of a chromosome in which it is inserted into a host chromosome. Can be mentioned. A shuttle vector that can replicate in E. coli, Bacillus subtilis, or yeast can also be used.
2-2-1. Components of MascR gene expression vector The MascR gene expression vector is configured to express the MascR gene in a host cell. The components of the MascR gene expression vector include the MascR gene of the first embodiment and a ubiquitous promoter as essential components. In addition, a multicloning site, 5′UTR, 3′UTR, terminator, enhancer, marker gene, insulator, transposon inverted terminal repeat and the like are included as selection components. Furthermore, when the MascR gene expression vector is composed of two units, a first expression unit and a second expression unit, which will be described later, a transcription regulatory factor gene and a target promoter of the transcription regulatory factor are essential components. Include. Hereinafter, each component of the MascR gene expression vector of the present invention will be specifically described.
(1) MascR gene The configuration of the MascR gene is described in detail in the first embodiment, and a description thereof is omitted here.
(2) Promoter The promoter included in the MascR gene expression vector of the present invention is a ubiquitous promoter.
 「ユビキタスなプロモーター」とは、当該プロモーターの下流(3’末端側)に配置された目的の遺伝子、すなわちMascR遺伝子を、当該発現ベクターを導入した宿主個体全体で発現することのできるプロモーターである。本明細書では、特定の細胞や組織での発現を制御する部位特異的プロモーターに対応する用語として使用する。 The “ubiquitous promoter” is a promoter capable of expressing the target gene arranged downstream (3 ′ end side) of the promoter, that is, the MascR gene in the entire host individual into which the expression vector has been introduced. In this specification, it uses as a term corresponding to the site-specific promoter which controls the expression in a specific cell or tissue.
 ユビキタスなプロモーターは、その発現制御時期から、構成的活性型プロモーター、発現誘導型プロモーター又は時期特異的活性型プロモーターに分類することができる。 Ubiquitous promoters can be classified into constitutively active promoters, expression-inducible promoters, or time-specific active promoters based on their expression control timing.
 構成的活性型プロモーターは、宿主細胞内で目的の遺伝子を恒常的に発現することができる。カイコにおける構成的活性型プロモーターの具体例としては、アクチン3遺伝子由来のアクチン3プロモーター(A3プロモーター)、カイコ熱ショックタンパク質90(hsp90)遺伝子由来の熱ショックタンパク質90プロモーター(hsp90プロモーター)、カイコ伸長因子1α(Elongation Factor-1α)遺伝子由来の伸長因子1プロモーター(EF-1プロモーター)、及びBmNPV(Bombyx mori nuclear polyhedrosis virus)の最初期遺伝子1(immediate-early gene 1;ie-1)のプロモーター等が挙げられる。A3プロモーターの塩基配列を配列番号6に、またhsp90プロモーターの塩基配列を配列番号7に示す。 A constitutively active promoter can constitutively express a target gene in a host cell. Specific examples of constitutively active promoters in silkworms include actin 3 gene-derived actin 3 promoter (A3 promoter), silkworm heat shock protein 90 (hsp90) gene-derived heat shock protein 90 promoter (hsp90 promoter), silkworm elongation factor 1α (Elongation Factor-1α) gene-derived elongation factor 1 promoter (EF-1 promoter), BmNPV (Bombyx mori nuclear polyhedrosis virus) early gene 1 (immediate-early gene 1; ie-1) promoter, etc. Can be mentioned. The base sequence of A3 promoter is shown in SEQ ID NO: 6, and the base sequence of hsp90 promoter is shown in SEQ ID NO: 7.
 発現誘導型プロモーターは、宿主細胞内で目的の遺伝子の発現を任意の時期に誘導することができる。したがって、このタイプのプロモーターは、後述する「MascR遺伝子発現ベクターのユニット構成」において、MascR遺伝子発現ベクターが1つの遺伝子発現ユニットで構成される場合に、MascR遺伝子発現ベクターを有する宿主系統を維持する上で、特に有用である。カイコにおける発現誘導型プロモーターの具体例としては、熱ショックタンパク質70(hsp70)遺伝子由来の熱ショックタンパク質70プロモーター(hsp70プロモーター)が挙げられる。hsp70プロモーターの塩基配列を配列番号8に示す。 An expression-inducible promoter can induce the expression of a target gene in a host cell at any time. Therefore, this type of promoter is used to maintain a host strain having a MascR gene expression vector when the MascR gene expression vector is composed of one gene expression unit in “Unit structure of MascR gene expression vector” described later. And is particularly useful. A specific example of the expression-inducible promoter in the silkworm is a heat shock protein 70 promoter (hsp70 promoter) derived from the heat shock protein 70 (hsp70) gene. The base sequence of the hsp70 promoter is shown in SEQ ID NO: 8.
 時期特異的活性型プロモーターは、宿主細胞内で目的の遺伝子を発生段階の特定の時期のみに発現誘導することができる。本発明の解決課題の一つである、雌個体の致死化を達成するためには、MascRタンパク質は、胚発生の初期段階で機能する必要がある。したがって、本発明のMascR遺伝子発現ベクターに包含され得る時期特異的活性型プロモーターは、胚発生の初期段階での発現を誘導することが望ましい。 A time-specific active promoter can induce the expression of a target gene in a host cell only at a specific stage of development. In order to achieve the lethality of a female individual, which is one of the problems to be solved by the present invention, the MascR protein needs to function at an early stage of embryonic development. Therefore, it is desirable that a time-specific active promoter that can be included in the MascR gene expression vector of the present invention induces expression at an early stage of embryonic development.
 上記ユビキタスなプロモーターは、いずれも宿主細胞内にMascR遺伝子の過剰な発現をもたらし得る。したがって、本明細書におけるユビキタスなプロモーターは、過剰発現型プロモーターと解してよい。 Any of the above ubiquitous promoters can cause overexpression of the MascR gene in the host cell. Therefore, the ubiquitous promoter in this specification may be interpreted as an overexpression promoter.
 プロモーターのドナー生物種は、MascR遺伝子発現ベクターを導入する宿主細胞内で作動可能である限り、特に限定はしない。好適なドナー生物種は、MascR遺伝子発現ベクターの宿主と分類学上で同目に属する種である。例えば、宿主がカイコの場合、ドナー生物種は、カイコと同じチョウ目(Lepidoptera)に属する種、好ましくはカイコと同じカイコガ科(Bombycidae)に属する種、より好ましくはクワコ(Bombyx mandarina)のように同じBombyx属に属する種が適当である。最も好ましくいドナー生物種は、同種のカイコである。
(3)マルチクローニングサイト
 「マルチクローニングサイト」は、複数のクローニング用制限酵素部位からなるクラスター配列である。マルチクローニングサイトを構成する塩基配列や包含する制限酵素部位の種類及び数については、特に制限はしない。また、MascR遺伝子発現ベクターにおけるマルチクローニングサイトの数や配置される位置についても、制限はしないが、前記ユビキタスなプロモーターの制御領域範囲内に配置することが好ましい。そのような位置に配置することで、MascR遺伝子を本発明のMascR遺伝子発現ベクター内に容易に挿入できるからである。
(4)5’UTR(5’untranslated region)及び3’UTR(3’untranslated region)
 「5’UTR及び3’UTR」は、いずれもそれ自身がタンパク質やその断片、又は機能性核酸をコードしない非翻訳領域からなるポリヌクレオチドである。各UTRを構成する塩基配列は、限定はしないがMasc遺伝子に由来する5’UTR及び3’UTRであることが好ましい。特に好ましいのはMasc遺伝子自身の5’UTR及び3’UTR由来の塩基配列である。MascR遺伝子発現ベクターにおいて5’UTRは、前記MascR遺伝子の開始コドンの上流(5’末端側)に配置され、3’UTRは、MascR遺伝子の終止コドンの下流(3’末端側)に配置される。なお、3’UTRは、ポリAシグナルを含むことができる。
(5)ターミネーター
 「ターミネーター」は、本発明のMascR遺伝子発現ベクターにおいて、MascR遺伝子の3’末端側、好ましくは終止コドンの下流に配置される塩基配列で、MascR遺伝子の転写を終結できる塩基配列で構成されている。例えば、配列番号9で示す塩基配列からなるhsp70ターミネーターや配列番号10で示す塩基配列からなるSV40ターミネーターが挙げられる。
(6)エンハンサー
 「エンハンサー」は、本発明のMascR遺伝子発現ベクターにおいて、ユビキタスなプロモーターの制御によるMascR遺伝子の発現をさらに増強することができる塩基配列からなる。
(7)標識遺伝子
 「標識遺伝子」は、選抜マーカーとも呼ばれる標識タンパク質をコードする遺伝子である。「標識タンパク質」とは、その活性に基づいて標識遺伝子の発現の有無を判別することのできるポリペプチドをいう。したがって、MascR遺伝子発現ベクターが標識遺伝子を含んでいる場合、標識タンパク質の活性に基づいて、MascR遺伝子発現ベクターを保有する宿主、すなわち形質転換体を容易に判別することができる。ここで「活性に基づいて」とは、活性の検出結果に基づいて、という意味である。活性の検出は、標識タンパク質の活性そのものを直接的に検出するものであってもよいし、色素のような標識タンパク質の活性によって発生する代謝物を介して間接的に検出するものであってもよい。検出は、化学的検出(酵素反応的検出を含む)、物理的検出(行動分析的検出を含む)、又は検出者の感覚的検出(視覚、触覚、嗅覚、聴覚、味覚による検出を含む)のいずれであってもよい。
The donor species of the promoter is not particularly limited as long as it is operable in the host cell into which the MascR gene expression vector is introduced. Preferred donor species are those that belong taxonomically with the host of the MascR gene expression vector. For example, when the host is a silkworm, the donor species is a species belonging to the same Lepidoptera as the silkworm, preferably a species belonging to the same family Bombycidae as the silkworm, more preferably a mulberry (Bombyx mandarina). Species belonging to the same genus Bombyx are suitable. The most preferred donor species is the same silkworm.
(3) Multicloning site A “multicloning site” is a cluster sequence comprising a plurality of cloning restriction enzyme sites. There are no particular restrictions on the type and number of restriction enzyme sites to be included in the base sequence constituting the multicloning site. Further, the number of multi-cloning sites in the MascR gene expression vector and the position at which the multi-cloning site is arranged are not limited, but are preferably arranged within the control region of the ubiquitous promoter. This is because the MascR gene can be easily inserted into the MascR gene expression vector of the present invention by arranging at such a position.
(4) 5'UTR (5'untranslated region) and 3'UTR (3'untranslated region)
“5′UTR and 3′UTR” are both polynucleotides consisting of untranslated regions that do not themselves encode proteins, fragments thereof, or functional nucleic acids. The base sequence constituting each UTR is preferably, but not limited to, 5′UTR and 3′UTR derived from the Masc gene. Particularly preferred are 5'UTR and 3'UTR derived nucleotide sequences of the Masc gene itself. In the MascR gene expression vector, 5′UTR is located upstream (5 ′ end side) of the start codon of the MascR gene, and 3′UTR is located downstream (3 ′ end side) of the stop codon of the MascR gene. . The 3 ′ UTR can contain a poly A signal.
(5) Terminator The “terminator” is a base sequence that is located at the 3 ′ end of the MascR gene, preferably downstream of the stop codon in the MascR gene expression vector of the present invention, and is a base sequence that can terminate the transcription of the MascR gene. It is configured. For example, the hsp70 terminator consisting of the base sequence shown in SEQ ID NO: 9 and the SV40 terminator consisting of the base sequence shown in SEQ ID NO: 10 can be mentioned.
(6) Enhancer An “enhancer” consists of a base sequence that can further enhance the expression of a MascR gene by controlling a ubiquitous promoter in the MascR gene expression vector of the present invention.
(7) Marker gene A “marker gene” is a gene encoding a labeled protein, also called a selection marker. “Labeled protein” refers to a polypeptide that can determine the presence or absence of expression of a labeled gene based on its activity. Therefore, when the MascR gene expression vector contains a marker gene, the host carrying the MascR gene expression vector, that is, a transformant can be easily identified based on the activity of the marker protein. Here, “based on activity” means based on the detection result of activity. The activity may be detected directly by the activity of the labeled protein itself or indirectly by a metabolite generated by the activity of the labeled protein such as a dye. Good. Detection can be chemical detection (including enzymatic reaction detection), physical detection (including behavioral analysis detection), or sensory detection of the detector (including visual, tactile, olfactory, auditory, taste detection) Either may be sufficient.
 標識遺伝子がコードする標識タンパク質の種類は、当該分野で公知の方法によりその活性を検出可能な限り、特に限定はしない。好ましくは検出に際して形質転換体に対する侵襲性の低い標識タンパク質である。例えば、蛍光タンパク質、色素合成タンパク質、発光タンパク質、外部分泌タンパク質、外部形態を制御するタンパク質等が挙げられる。蛍光タンパク質、色素合成タンパク質、発光タンパク質、外部分泌タンパク質は、形質転換体の外部形態を変化させることなく特定の条件下で視覚的に検出可能なことから、形質転換体に対する侵襲性が非常に低く、また形質転換体の判別及び選抜が容易なため特に好適である。 The type of labeled protein encoded by the labeled gene is not particularly limited as long as its activity can be detected by a method known in the art. Preferably, it is a labeled protein with low invasiveness to the transformant upon detection. For example, fluorescent proteins, chromogenic proteins, photoproteins, external secreted proteins, proteins that control external morphology, and the like can be mentioned. Fluorescent proteins, chromogenic proteins, photoproteins, and exocrine proteins can be visually detected under certain conditions without changing the external form of the transformant, and therefore are less invasive to the transformant. In addition, it is particularly suitable because it is easy to identify and select transformants.
 「蛍光タンパク質」は、特定波長の励起光を照射したときに特定波長の蛍光を発するタンパク質をいう。天然型及び非天然型のいずれであってもよい。また、励起波長、蛍光波長も特に限定はしない。具体的には、例えば、CFP、RFP、DsRed(3xP3-DsRedのような派生物を含む)、YFP、PE、PerCP、APC、GFP(EGFP、3xP3-EGFP等の派生物を含む)等が挙げられる。 “Fluorescent protein” refers to a protein that emits fluorescence of a specific wavelength when irradiated with excitation light of a specific wavelength. Either a natural type or a non-natural type may be used. Further, the excitation wavelength and the fluorescence wavelength are not particularly limited. Specifically, for example, CFP, RFP, DsRed (including derivatives such as 3xP3-DsRed), YFP, PE, PerCP, APC, GFP (including derivatives such as EGFP and 3xP3-EGFP), etc. It is done.
 「色素合成タンパク質」は、色素の生合成に関与するタンパク質であり、通常は酵素である。ここでいう「色素」とは、形質転換体に色素を付与することができる低分子化合物又はペプチドで、その種類は問わない。好ましくは個体の外部色彩として表れる色素である。例えば、メラニン系色素(ドーパミンメラニンを含む)、オモクローム系色素、又はプテリジン系色素が挙げられる。 “Chromosome synthesis protein” is a protein involved in pigment biosynthesis and is usually an enzyme. The “dye” here is a low molecular compound or peptide capable of imparting a dye to a transformant, and the kind thereof is not limited. A pigment that appears as an external color of an individual is preferable. Examples include melanin pigments (including dopamine melanin), omochrome pigments, and pteridine pigments.
 本明細書で「発光タンパク質」とは、励起光を必要とすることなく発光することのできる基質タンパク質又はその基質タンパク質の発光を触媒する酵素をいう。例えば、基質タンパク質としてのルシフェリン又はイクオリン、酵素としてのルシフェラーゼが挙げられる。 As used herein, “photoprotein” refers to a substrate protein that can emit light without the need for excitation light or an enzyme that catalyzes the light emission of the substrate protein. For example, luciferin or aequorin as a substrate protein and luciferase as an enzyme can be mentioned.
 本明細書で「外部分泌タンパク質」とは、細胞外又は体外に分泌されるタンパク質であり、外分泌性酵素の他、フィブロインのような繊維タンパク質やセリシンが該当する。外分泌性酵素には、ブラストサイジンのような薬剤の分解又は不活化に寄与し、宿主に薬剤耐性を付与する酵素の他、消化酵素が該当する。 As used herein, “externally secreted protein” refers to a protein that is secreted extracellularly or externally, and includes exocrine enzymes, fiber proteins such as fibroin, and sericin. Exocrine enzymes include digestive enzymes in addition to enzymes that contribute to the degradation or inactivation of drugs such as blasticidin and impart drug resistance to the host.
 標識遺伝子は、MascR遺伝子発現ベクターにおいてプロモーターの下流に発現可能な状態で配置される。
(8)インスレーター
 「インスレーター」は、周囲の染色体のクロマチンによる影響を受けることなく、その配列に挟まれた遺伝子の転写を、安定的に制御できる塩基配列である。例えば、ニワトリのcHS4配列やショウジョウバエのgypsy配列などが挙げられる。
(9)トランスポゾンの逆位末端反復配列
 「トランスポゾンの逆位末端反復配列(ITRs:inverted terminal repeat sequence)」は、本発明のMascR遺伝子発現ベクターを相同組換え可能な発現ベクターとする場合に含まれ得る選択構成要素である。逆位末端反復配列は、通常は2個1組で使用され、トランスポゾンとしては、piggyBac、mariner、minos等を用いることができる(Shimizu,K. et al., 2000, Insect Mol. Biol., 9, 277-281;Wang W. et al.,2000, Insect Mol Biol 9(2):145-55)。
(10)転写調節因子の遺伝子
 「転写調節因子の遺伝子」は、後述する第1発現ユニットの必須構成要素である。本明細書でいう「転写調節因子」とは、後述する標的プロモーターに結合して、その標的プロモーターを活性化することのできるタンパク質因子をいう。例えば、酵母のガラクトース代謝活性化タンパク質であるGAL4タンパク質、及びテトラサイクリン制御性トランス活性化因子であるtTA及びその変異体等が挙げられる。
(11)転写調節因子の標的プロモーター
 「転写調節因子の標的プロモーター」とは、後述する第2発現ユニットの必須要素であって、第1発現ユニットにコードされた転写調節因子が結合することよって、その制御下にある遺伝子発現を活性化することのできるプロモーターをいう。前記転写調節因子とその標的プロモーターは、前記転写調節因子とは対応関係にあり、通常、転写調節因子が定まれば、その標的プロモーターも必然的に定まる。例えば、転写調節因子がGAL4タンパク質の場合には、UAS(Upstream Activating Sequence)が使用される。
2-2-2.MascR遺伝子発現ベクターのユニット構成
 MascR遺伝子発現ベクターは、1つの遺伝子発現ユニットで構成される場合と、2つの遺伝子発現ユニットで構成される場合がある。以下、それぞれの場合について説明をする。
(1)1つの遺伝子発現ユニットで構成される場合
 MascR遺伝子発現ベクターが1つの遺伝子発現ユニットで構成される場合、MascR遺伝子発現ベクターは、MascR遺伝子を宿主細胞内で発現させる上で必要な全ての構成要素を1つの遺伝子発現ベクター内に含む。具体的には、必須の構成要素であるユビキタスなプロモーター及びそのプロモーターの下流に機能的に結合したMascR遺伝子を含む。
The marker gene is placed in a state capable of being expressed downstream of the promoter in the MascR gene expression vector.
(8) Insulator An “insulator” is a base sequence that can stably control the transcription of a gene sandwiched between sequences without being affected by chromatin of surrounding chromosomes. Examples include the cHS4 sequence of chicken and the gypsy sequence of Drosophila.
(9) Inverted terminal repeat sequences of transposon “Inverted terminal repeat sequences (ITRs)” are included when the MascR gene expression vector of the present invention is used as an expression vector capable of homologous recombination. Is a selection component to obtain. The inverted terminal repeats are usually used in pairs, and piggyBac, mariner, minos, etc. can be used as transposons (Shimizu, K. et al., 2000, Insect Mol. Biol., 9 , 277-281; Wang W. et al., 2000, Insect Mol Biol 9 (2): 145-55).
(10) Transcriptional Regulatory Factor Gene “Transcriptional regulatory factor gene” is an essential component of the first expression unit described below. As used herein, the term “transcriptional regulatory factor” refers to a protein factor that can bind to a target promoter described later and activate the target promoter. Examples thereof include GAL4 protein, which is a galactose metabolic activation protein of yeast, tTA, which is a tetracycline-regulated transactivator, and mutants thereof.
(11) Target Promoter of Transcription Regulator “Target promoter of transcription regulator” is an essential element of the second expression unit described later, and the transcription regulator encoded by the first expression unit binds to it. A promoter capable of activating gene expression under its control. The transcriptional regulatory factor and its target promoter are in a corresponding relationship with the transcriptional regulatory factor. Normally, when a transcriptional regulatory factor is determined, the target promoter is inevitably determined. For example, when the transcriptional regulatory factor is GAL4 protein, UAS (Upstream Activating Sequence) is used.
2-2-2. Unit Configuration of MascR Gene Expression Vector A MascR gene expression vector may be composed of one gene expression unit or may be composed of two gene expression units. Hereinafter, each case will be described.
(1) When configured with a single gene expression unit When a MascR gene expression vector is configured with a single gene expression unit, the MascR gene expression vector contains all the necessary elements for expressing the MascR gene in a host cell. The components are contained within one gene expression vector. Specifically, it includes a ubiquitous promoter that is an essential component and a MascR gene operably linked downstream of the promoter.
 MascR遺伝子発現ベクターが1つの遺伝子発現ユニットで構成される場合、プロモーターは、雌性致死系統の維持、管理上、発現誘導型プロモーターが望ましい。また、MascR遺伝子発現ベクターは、1つのプロモーター制御下にMascR遺伝子を2以上含んでいてもよい。MascR遺伝子発現ベクターが1つの遺伝子発現ユニットで構成される場合、MascR遺伝子発現ベクターを宿主に導入するだけで、宿主細胞内でMascR遺伝子を過剰発現することができる。
(2)2つの遺伝子発現ユニットで構成される場合
 MascR遺伝子発現ベクターが第1発現ユニット及び第2発現ユニットの2つの遺伝子発現ユニットで構成される場合、MascR遺伝子を発現する上で必須の構成要素は2つのユニットに分割されて存在する。本構成では、第1及び第2発現ユニットが宿主細胞内に併存してはじめて1つのMascR遺伝子発現ベクターとして機能する。すなわち、同一細胞内で第1発現ユニットに含まれるプロモーターの活性化により第1発現ユニットから転写調節因子が発現し、それが第2発現ユニットの標的プロモーターを活性化することによって目的のMascR遺伝子を発現することができる。第1及び第2発現ユニットは、以下の構成を有する。
When the MascR gene expression vector is composed of one gene expression unit, the promoter is preferably an expression-inducible promoter for the maintenance and management of female lethal lines. Further, the MascR gene expression vector may contain two or more MascR genes under the control of one promoter. When the MascR gene expression vector is composed of one gene expression unit, the MascR gene can be overexpressed in the host cell simply by introducing the MascR gene expression vector into the host.
(2) When composed of two gene expression units When a MascR gene expression vector is composed of two gene expression units, a first expression unit and a second expression unit, the essential elements for expressing the MascR gene Is divided into two units. In this configuration, the first and second expression units function as one MascR gene expression vector only when they coexist in the host cell. That is, in the same cell, a transcriptional regulatory factor is expressed from the first expression unit by activating the promoter contained in the first expression unit, which activates the target promoter of the second expression unit, thereby obtaining the target MascR gene. Can be expressed. The first and second expression units have the following configuration.
 「第1発現ユニット」は、プロモーターと該プロモーターの下流に機能的に結合した前述の転写調節因子の遺伝子を含んでなる。第1発現ユニットで使用するプロモーターは、前述のユビキタスなプロモーターを使用する。このとき、1つのプロモーター制御下に同一の又は異なる2以上の転写調節因子を含んでいてもよい。 The “first expression unit” comprises a promoter and a gene of the above-mentioned transcription regulatory factor operably linked downstream of the promoter. The aforementioned ubiquitous promoter is used as the promoter used in the first expression unit. At this time, the same or different two or more transcriptional regulatory factors may be included under the control of one promoter.
 また、第1発現ユニットは、プロモーターとその制御下にある転写調節因子の遺伝子からなる組を2組以上有することもできる。この場合、各組は同一の組であっても、又は異なる組であってもよい。 In addition, the first expression unit may have two or more sets of promoters and transcription regulatory factor genes under the control of the promoter. In this case, each set may be the same set or different sets.
 第1発現ユニットが包含するプロモーターは、既知のユビキタスなプロモーターを利用できることから、既存の遺伝子発現ベクターを利用することもできる。 Since the known ubiquitous promoter can be used as the promoter included in the first expression unit, an existing gene expression vector can also be used.
 「第2発現ユニット」は、前記第1発現ユニットにコードされた転写調節因子の標的プロモーターとその標的プロモーターの下流に機能的に結合したMascR遺伝子を含んでなる。第2発現ユニットに含まれる標的プロモーターは、第1発現ユニットにコードされる転写調節因子によって活性化されるプロモーターを選択する。例えば、標的プロモーター第1発現ユニットに含まれる転写調節因子の遺伝子がGAL4遺伝子であれば、第2発現ユニットのGAL4標的プロモーターにはUASが使用される。第2発現ユニットは、1つの標的プロモーター制御下に同一の又は異なるMascR遺伝子を2以上含んでいてもよい。 The “second expression unit” comprises a target promoter of a transcriptional regulatory factor encoded by the first expression unit and a MascR gene operably linked downstream of the target promoter. The target promoter contained in the second expression unit selects a promoter that is activated by the transcriptional regulatory factor encoded by the first expression unit. For example, if the gene of the transcriptional regulatory factor contained in the target promoter first expression unit is a GAL4 gene, UAS is used for the GAL4 target promoter of the second expression unit. The second expression unit may include two or more identical or different MascR genes under the control of one target promoter.
 また、第2発現ユニットは、標的プロモーターとその制御下にあるMascR遺伝子からなる組を2組以上有していてもよい。この場合、各組は同一の組であっても、又は異なる組であってもよい。 In addition, the second expression unit may have two or more pairs of a target promoter and a MascR gene under its control. In this case, each set may be the same set or different sets.
 さらに、第2発現ユニットは、MascR遺伝子を含む同一の又は異なる2以上のユニットで構成されていてもよい。この場合、1つの第1発現ユニットから発現した転写調節因子は、複数の第2発現ユニットの標的プロモーターを活性化することによって、それぞれの第2発現ユニットに含まれるMascR遺伝子を発現することができる。 Furthermore, the second expression unit may be composed of two or more identical or different units containing the MascR gene. In this case, the transcriptional regulatory factor expressed from one first expression unit can express the MascR gene contained in each second expression unit by activating the target promoters of the plurality of second expression units. .
 本構成のMascR遺伝子発現ベクターは、雌性致死系統の維持管理の上で有用である。通常、宿主細胞内でMascR遺伝子を過剰発現させた場合、雌性致死となり系統を維持できない。しかし、第1及び第2発現ユニットのそれぞれを保有する系統を作製して、それぞれを個別に管理しておくことで、その維持が容易となる。 The MascR gene expression vector of this configuration is useful for the maintenance and management of female lethal lines. Normally, when the MascR gene is overexpressed in a host cell, it becomes female lethal and the strain cannot be maintained. However, maintenance of the first and second expression units can be facilitated by preparing a line that holds each of the first and second expression units and managing each of them individually.
 本構成のMascR遺伝子発現ベクターは、第1発現ユニットにコードされた転写調節因子を介して第2発現ユニットのMascR遺伝子の発現を増幅させることができる。したがって、MascR遺伝子を宿主細胞内で過剰発現させる上で好適である。
2-3.MascR遺伝子発現ベクターの宿主導入方法
 MascR遺伝子発現ベクターの宿主導入方法について、説明をする。
The MascR gene expression vector of this configuration can amplify the expression of the MascR gene of the second expression unit via the transcriptional regulatory factor encoded by the first expression unit. Therefore, it is suitable for overexpression of the MascR gene in a host cell.
2-3. MascR gene expression vector host introduction method A MascR gene expression vector host introduction method will be described.
 MascR遺伝子発現ベクターを導入する宿主は、チョウ目昆虫個体、チョウ目昆虫由来の細胞(株化細胞を含む)、又はチョウ目昆虫由来の組織である。特に好ましいのはチョウ目昆虫個体である。細胞若しくは組織に導入する場合、採取された個体の発生ステージは、特に限定はしない。個体に導入する場合も、発生ステージや雌雄の限定は特になく、胚、幼虫、蛹、又は成虫のいずれのステージであってもよい。好ましくは、より高い効果が期待できる胚時期である。 The host into which the MascR gene expression vector is introduced is a lepidopteran insect individual, a cell derived from a lepidopteran insect (including a cell line), or a tissue derived from a lepidopterous insect. Particularly preferred are lepidopteran insects. When introduced into a cell or tissue, the stage of development of the collected individual is not particularly limited. When introduced into an individual, there are no particular limitations on the developmental stage or sex, and any stage of an embryo, larva, pupa, or adult can be used. Preferably, it is an embryonic time when a higher effect can be expected.
 MascR遺伝子発現ベクター導入方法は、導入するMascR遺伝子発現ベクターに応じて当該分野で公知の方法によって行えばよい。例えば、MascR遺伝子発現ベクターがトランスポゾンの逆位末端反復配列(ITRs)(Handler AM. et al., 1998, Proc. Natl. Acad. Sci. U.S.A. 95:7520-5)を有するプラスミドであり、導入する宿主がカイコであれば、Tamuraらの方法(Tamura T. et al., 2000, Nature Biotechnology, 18, 81-84)を応用することができる。例えば、適当な濃度に希釈した本発明のMascR遺伝子発現ベクターを、トランスポゾン転移酵素の遺伝子を有するヘルパーベクターと共にカイコ卵の初期胚にインジェクションすればよい。ヘルパーベクターには、例えば、pHA3PIGが利用できる。本発明のMascR遺伝子発現ベクターが標識遺伝子を含む場合には、前述のように、その遺伝子等の発現に基づいて目的の形質転換体を容易に選抜することができる。なお、この方法で得られた遺伝子組換えカイコは、MascR遺伝子発現ベクターがトランスポゾンの逆位末端反復配列を介して染色体中に組み込まれている。この遺伝子組換えカイコを必要に応じて兄妹交配又は同系交配を行い、染色体に挿入された発現ベクターのホモ接合体を得てもよい。
2-4.効果
 本発明の変異型Masc(MascR)遺伝子発現ベクターをチョウ目昆虫の宿主に導入することで、その宿主を雌性致死にすることができる。また、2つの遺伝子発現ユニットで構成されるMascR遺伝子発現ベクターを用いることで、作出した雌性致死系統を容易に維持及び管理することが可能となる。それ故、2つの遺伝子発現ユニットで構成されるMascR遺伝子発現ベクターは、雌性致死系統を作出する上で、コストや労力を削減することができる。
3.雌蚕致死カイコ系統
3-1.概要
 本発明の第3の態様は、雌蚕致死カイコ系統である。本態様の雌蚕致死カイコ系統は、第2態様に記載のMascR遺伝子発現ベクターを有する遺伝子組換えカイコ系統である。本系統を用いることで、雌蚕致死カイコを容易に得ることができる。
3-2.構成
 本明細書で「雌蚕致死カイコ」とは、メス個体が発生開始後5齢幼虫ステージまでに死亡するカイコをいう。
The MascR gene expression vector can be introduced by a method known in the art depending on the MascR gene expression vector to be introduced. For example, the MascR gene expression vector is a plasmid having transposon inverted terminal repeats (ITRs) (Handler AM. Et al., 1998, Proc. Natl. Acad. Sci. USA 95: 7520-5) and introduced. If the host is a silkworm, the method of Tamura et al. (Tamura T. et al., 2000, Nature Biotechnology, 18, 81-84) can be applied. For example, the MascR gene expression vector of the present invention diluted to an appropriate concentration may be injected into an early embryo of a silkworm egg together with a helper vector having a transposon transferase gene. For example, pHA3PIG can be used as the helper vector. When the MascR gene expression vector of the present invention contains a marker gene, as described above, the target transformant can be easily selected based on the expression of the gene or the like. In the transgenic silkworm obtained by this method, the MascR gene expression vector is integrated into the chromosome via the transposon inverted terminal repeat sequence. If necessary, this transgenic silkworm may be sibling or inbred to obtain a homozygous expression vector inserted into the chromosome.
2-4. Effect By introducing the mutant Masc (MascR) gene expression vector of the present invention into a lepidopteran insect host, the host can be made female lethal. In addition, by using a MascR gene expression vector composed of two gene expression units, it is possible to easily maintain and manage the produced female lethal line. Therefore, a MascR gene expression vector composed of two gene expression units can reduce costs and labor in producing a female lethal line.
3. Female pupal dead silkworm strain 3-1. Outline | summary The 3rd aspect of this invention is a puerperal lethal silkworm strain | stump | stock. The fetus lethal silkworm strain of this embodiment is a transgenic silkworm strain having the MascR gene expression vector described in the second embodiment. By using this strain, female pupal dead silkworms can be easily obtained.
3-2. Configuration As used herein, “female-killed silkworm” refers to a silkworm in which a female individual dies by the 5th instar larva stage after the start of development.
 「雌蚕致死カイコ系統」とは、メス個体を致死化する潜在性を有する継代可能な遺伝子組換えカイコ又はその後代をいう。 The “feminine lethal silkworm strain” refers to a passable genetically modified silkworm or its progeny that has the potential to kill a female individual.
 本発明の雌蚕致死カイコ系統は、第2態様に記載のMascR遺伝子発現ベクターを有する。雌蚕致死カイコ系統が有するMascR遺伝子発現ベクターは、第2態様で記載した1つの遺伝子発現ユニットで構成される場合と2つの遺伝子発現ユニットで構成される場合のいずれであってもよい。後者の場合、遺伝子組換えカイコが第2発現ユニットのみを有する遺伝子組換えカイコ系統が本発明の雌蚕致死カイコ系統に含まれる。第2発現ユニットのみを有する遺伝子組換えカイコ系統を、第1発現ユニットを含むカイコ系統と交配し、第2発現ユニットのみを有する遺伝子組換えカイコ系統に含まれる第2発現ユニットからのMascR遺伝子の発現を誘導することにより、雌蚕致死カイコを容易に生産することができるという点で、第2発現ユニットのみを有する遺伝子組換えカイコ系統は、メス個体を致死化する潜在性を有するからである。第2発現ユニットのみを有する遺伝子組換えカイコ系統は、実施例2に記載のsumi-13系統(sumi13-1、sumi13-2)によって例示されるがそれらに限定されない。一方、第1発現ユニットのみを有する遺伝子組換えカイコ系統は、メス個体を致死化する直接的な潜在性はないことから、本発明の雌蚕致死カイコ系統には該当しない。 The female mortal silkworm strain of the present invention has the MascR gene expression vector described in the second embodiment. The MascR gene expression vector possessed by the female pupal dead silkworm strain may be either composed of one gene expression unit described in the second embodiment or composed of two gene expression units. In the latter case, a transgenic silkworm strain in which the transgenic silkworm has only the second expression unit is included in the female pupal dead silkworm strain of the present invention. The transgenic silkworm strain having only the second expression unit is mated with the silkworm strain containing the first expression unit, and the MascR gene from the second expression unit contained in the transgenic silkworm strain having only the second expression unit This is because a transgenic silkworm strain having only the second expression unit has the potential to kill a female individual in that it can easily produce a female dead lethal silkworm by inducing expression. . The transgenic silkworm lines having only the second expression unit are exemplified by the sumi-13 lines (sumi13-1, sumi13-2) described in Example 2, but are not limited thereto. On the other hand, a transgenic silkworm strain having only the first expression unit does not correspond to the female dead lethal silkworm strain of the present invention because it has no direct potential to kill a female individual.
 雌蚕致死カイコ系統において、MascR遺伝子発現ベクターは、カイコ細胞内に一過的に存在してもよいし、また染色体中に導入された状態等で安定的かつ継続的に存在してもよい。通常は、安定的かつ継続的に存在することが好ましい。 In the female dead lethal silkworm strain, the MascR gene expression vector may be present transiently in the silkworm cell, or may be stably and continuously present in a state of being introduced into the chromosome. Usually, it is preferable to exist stably and continuously.
 MascR遺伝子発現ベクターが1つの遺伝子発現ユニットで構成され、それが雌蚕致死カイコ系統の染色体上に存在する場合、MascR遺伝子発現ベクターにおいてMascR遺伝子の発現を制御するユビキタスなプロモーターは、発現誘導型プロモーターであることが望ましい。 When a MascR gene expression vector is composed of one gene expression unit and it is present on the chromosome of a female dead lethal silkworm strain, the ubiquitous promoter that controls the expression of the MascR gene in the MascR gene expression vector is an expression-inducible promoter. It is desirable that
 MascR遺伝子発現ベクターが第1及び第2発現ユニットの2つの遺伝子発現ユニットで構成され、それぞれがカイコの染色体上に組み込まれている場合、第1及び第2発現ユニットは同一のカイコ個体の同一染色体上に存在していてもよいし、同一のカイコ個体の異なる染色体上に存在していてもよい。さらに、第1の発現ユニットと第2の発現ユニットがそれぞれ互いに異なるカイコ個体又はカイコ系統が有する染色体に組み込まれていることが望ましい。第1発現ユニットのみを(好ましくはホモ接合体で)有する系統と第2発現ユニットのみを(好ましくはホモ接合体で)有する雌蚕致死カイコ系統とを交配させることによって、F1で第1及び第2発現ユニットを有する雌蚕致死カイコを容易に得ることができる。この場合、第1発現ユニットに含まれるユビキタスなプロモーターは、第2態様に記載したユビキタスなプロモーターであれば、いずれのプロモーターを使用することができる。 When the MascR gene expression vector is composed of two gene expression units, a first expression unit and a second expression unit, and each is integrated on a silkworm chromosome, the first and second expression units are the same chromosome of the same silkworm individual. It may exist on the top, or may exist on different chromosomes of the same silkworm individual. Furthermore, it is desirable that the first expression unit and the second expression unit are incorporated into chromosomes of silkworm individuals or silkworm strains different from each other. By crossing a strain having only the first expression unit (preferably in a homozygote) with a female pupal dead silkworm strain having only a second expression unit (preferably in a homozygote), the first and second in F1 A female pupal dead silkworm having 2 expression units can be easily obtained. In this case, any promoter can be used as long as the ubiquitous promoter contained in the first expression unit is the ubiquitous promoter described in the second embodiment.
 一方、第1発現ユニット及び第2発現ユニットが同一のカイコ個体が有する同一染色体上に存在する場合には、継代過程で組換えによってそれぞれが分離しないように、発現ベクター間の距離が近く、互いに連鎖している方が好ましい。この場合、第1発現ユニットに含まれるユビキタスなプロモーターは、発現誘導型プロモーターであることが好ましい。
3-3.雌蚕致死カイコ系統の作出方法
 本発明の雌蚕致死カイコ系統の作出方法は、組換えカイコを作出できるあらゆる方法を利用することができることから、特に限定はしない。組換えカイコを作出する方法として、例えば、MascR遺伝子発現ベクターをカイコに導入する方法が挙げられる。その具体的な方法は、第2態様の「2-3.MascR遺伝子発現ベクターの宿主導入方法」の項に記載した方法に準ずる。
On the other hand, when the first expression unit and the second expression unit are present on the same chromosome of the same silkworm individual, the distance between the expression vectors is close so that they are not separated by recombination in the passage process, It is preferable that they are linked to each other. In this case, the ubiquitous promoter contained in the first expression unit is preferably an expression-inducible promoter.
3-3. Method for producing a female pupal dead silkworm strain The method for producing a female pupal dead silkworm strain of the present invention is not particularly limited because any method capable of producing a recombinant silkworm can be used. Examples of a method for producing a recombinant silkworm include a method of introducing a MascR gene expression vector into a silkworm. The specific method is the same as the method described in the section “2-3. Method for introducing host of MascR gene expression vector” in the second embodiment.
 MascR遺伝子発現ベクターが1つの遺伝子発現ユニットで構成される場合には、そのMascR遺伝子発現ベクターを、またMascR遺伝子発現ベクターが第1及び第2発現ユニットの2つの遺伝子発現ユニットで構成される場合には、第2発現ユニットを、カイコに導入することで雌蚕致死カイコ系統を得ることができる。
3-4.雌蚕致死カイコの作出方法
 本発明の雌蚕致死カイコ系統を用いて、オス個体群のみから構成される雌蚕致死カイコを作出するには、例えば、(1)雌蚕致死カイコ系統に発現誘導処理を施す方法、及び(2)MascR遺伝子発現ベクターの第1発現ユニットと第2発現ユニットをそれぞれ有する2つの遺伝子組換えカイコの系統を交配して第1発現ユニットと第2発現ユニットの両方を有するF1個体を得る方法が挙げられる。以下、それぞれの方法について説明をするが、これらの方法に限定はされない。
(1)雌蚕致死カイコ系統に発現誘導処理を施す方法
 この方法は、雌蚕致死カイコ系統が有するMascR遺伝子発現ベクターに包含されるユビキタスなプロモーターが発現誘導型プロモーターの場合に実施される。主として、雌蚕致死カイコ系統が1つの遺伝子発現ユニットで構成されるMascR遺伝子発現ベクターを有する場合、又はMascR遺伝子発現ベクターを構成する第1及び第2発現ユニットの2つの遺伝子発現ユニットが同一のカイコ個体又はカイコ系統の染色体上に存在する場合に用いられる。
When the MascR gene expression vector is composed of one gene expression unit, the MascR gene expression vector is composed, and when the MascR gene expression vector is composed of two gene expression units, the first and second expression units. Can introduce a fetus lethal silkworm strain by introducing the second expression unit into the silkworm.
3-4. Method for producing female pupal dead silkworm In order to produce female pupal dead silkworm composed only of male population using the female pupal dead silkworm strain of the present invention, for example, (1) expression induction in female pupal dead dead silkworm strain And (2) mating two transgenic silkworm strains each having the first expression unit and the second expression unit of the MascR gene expression vector, and combining both the first expression unit and the second expression unit. The method of obtaining F1 individual | organism | solid which has is mentioned. Hereinafter, although each method is demonstrated, it is not limited to these methods.
(1) Method of performing expression induction treatment on female pupal dead silkworm strain This method is carried out when the ubiquitous promoter included in the MascR gene expression vector possessed by the female pupal dead silkworm strain is an expression inducible promoter. Mainly, when the female dead lethal silkworm strain has a MascR gene expression vector composed of one gene expression unit, or the two gene expression units of the first and second expression units constituting the MascR gene expression vector are the same silkworm Used when present on the chromosome of an individual or silkworm strain.
 この雌蚕致死カイコ系統では、発現誘導未処理の状態ではMascR遺伝子の発現が抑制されており、雌蚕致死カイコとはならないため野生型のカイコと同様に系統を維持、管理することができる。雌蚕致死カイコが必要な場合には、この雌蚕致死カイコ系統に対して初期胚の段階で発現誘導処理を行えばよい。発現誘導処理の方法は、発現誘導型プロモーターの性質に応じて適宜選択すればよい。例えば、発現誘導型プロモーターがhsp70プロモーターであれば、初期胚を42℃で30分~1時間処理することで雌蚕致死カイコを作出することができる。
(2)2つの遺伝子組換えカイコの系統を交配させる方法
 この方法は、MascR遺伝子発現ベクターが第1及び第2発現ユニットの2つの遺伝子発現ユニットで構成され、かつ第1発現ユニットを有する遺伝子組換えカイコ系統と第2発現ユニットを有する雌蚕致死カイコ系統が存在する場合に実施される。2つの遺伝子組換えカイコ系統を交配させることによって、F1個体で第1及び第2発現ユニットを有する雌蚕致死カイコを作出することができる。
In this female pupal dead silkworm line, the expression of the MascR gene is suppressed in an untreated state of expression induction, and since it does not become a female pupal dead silkworm, it can be maintained and managed in the same manner as a wild type silkworm. When a female pupal dead silkworm is required, an expression inducing treatment may be performed at the early embryo stage for this female pupal dead silkworm strain. The expression induction treatment method may be appropriately selected according to the properties of the expression inducible promoter. For example, if the expression-inducible promoter is an hsp70 promoter, a female pupal dead silkworm can be produced by treating the early embryo at 42 ° C. for 30 minutes to 1 hour.
(2) Method of mating two transgenic silkworm strains This method is a gene set in which the MascR gene expression vector is composed of two gene expression units, the first and second expression units, and has the first expression unit. This is carried out when there is a female silkworm dead silkworm strain having a replacement silkworm strain and a second expression unit. By mating two transgenic silkworm strains, it is possible to produce female pupal dead silkworms having first and second expression units in F1 individuals.
 交配は、第1発現ユニットを有する遺伝子組換えカイコ系統と第2発現ユニットを有する雌蚕致死カイコ系統を常法に基づいて交配させればよい。2つの発現ユニットを有する遺伝子組換えカイコは、予め兄妹交配又は同系交配を行い、各発現ユニットに関してホモ接合体にしておくことが好ましい。交配後、第1及び第2発現ユニットを有するF1個体を、それぞれの発現ベクターに含まれる標識遺伝子がコードする標識タンパク質の活性に基づいて選抜すればよい。
4.雌蚕致死雄蚕不妊カイコ系統
4-1.概要
 本発明の第4の態様は、雌蚕致死雄蚕不妊カイコ系統である。本発明の雌蚕致死雄蚕不妊カイコ系統は、第3態様の雌蚕致死カイコ系統の一形態と解することもできる。本系統を用いることで、メス個体が致死となるだけでなく、生存するオス個体が不妊となったカイコ集団を得ることができる。
4-2.構成
 本態様の基本構成は、第3態様の構成と同じであることから、ここでは本態様に特徴的な構成について以下で説明する。
For mating, a genetically modified silkworm strain having the first expression unit and a female pupal dead silkworm strain having the second expression unit may be crossed based on a conventional method. A transgenic silkworm having two expression units is preferably preliminarily sibling or inbred and made homozygous for each expression unit. After mating, F1 individuals having the first and second expression units may be selected based on the activity of the labeled protein encoded by the labeled gene contained in each expression vector.
4). 4. Infertile female silkworm sterilized silkworm strain 4-1. Outline | summary The 4th aspect of this invention is a female pupal dead dead male silkworm infertile silkworm strain | stump | stock. The female pupal dead male silkworm infertile silkworm strain of the present invention can also be understood as one form of the female pupal dead silkworm strain of the third aspect. By using this strain, it is possible to obtain a silkworm population in which not only the female individual is lethal but also the surviving male individual is infertile.
4-2. Configuration Since the basic configuration of this aspect is the same as the configuration of the third aspect, a characteristic configuration of this aspect will be described below.
 本明細書で「雌蚕致死雄蚕不妊カイコ」とは、メス個体が発生段階で致死となり、同時に生存するオス個体が不妊となるカイコをいう。「雄蚕不妊」又は「オス(個体)の不妊」とは、オス個体の生殖能力が失われていることをいう。雌蚕致死雄蚕不妊カイコは、不妊のオス個体のみで構成される。 In this specification, “female dead dead male sterilized silkworm” refers to a silkworm in which a female individual becomes lethal at the developmental stage and a living male individual becomes infertile. “Male sterility” or “male (individual) infertility” means that the male fertility is lost. Infertile silkworms that are deadly male and female are composed only of infertile male individuals.
 雌蚕致死雄蚕不妊カイコは、後述するMascR遺伝子発現ベクターの第1及び第2発現ユニットを細胞内に有している。プロモーターの活性化により第2発現ユニットから発現されるMascRタンパク質によってメス個体を致死化すると共に、第1発現ユニットにコードされた転写調節因子GAL4タンパク質の作用によりオス個体を不妊化することができる。 The female mortal male sterilized silkworm has first and second expression units of the MascR gene expression vector described later in the cell. A female individual can be killed by the MascR protein expressed from the second expression unit by activating the promoter, and a male individual can be sterilized by the action of the transcriptional regulatory factor GAL4 protein encoded by the first expression unit.
 「雌蚕致死雄蚕不妊カイコ系統」とは、メス個体を致死化すると共にオス個体を不妊にする潜在性を有する継代可能な遺伝子組換えカイコ又はその後代をいう。 The “female-lethal dead male sterilized silkworm strain” refers to a genetically-transmissible silkworm or its progeny that can be passaged and has the potential to let female individuals become dead and males become infertile.
 本発明の雌蚕致死雄蚕不妊カイコ系統は、第2態様に記載のMascR遺伝子発現ベクターを有する。このMascR遺伝子発現ベクターは、第1及び第2発現ユニットからなる2つの遺伝子発現ユニットで構成される。 The female mortal male sterilized silkworm strain of the present invention has the MascR gene expression vector described in the second embodiment. This MascR gene expression vector is composed of two gene expression units composed of first and second expression units.
 第1発現ユニットの基本的構成は、第2態様に記載の第1発現ユニットの構成と同じでよい。ただし、本態様の第1発現ユニットは、ベクター内に包含する転写調節因子の遺伝子が酵母のガラクトース代謝活性化タンパク質であるGAL4タンパク質コードするGAL4遺伝子に限定されている。 The basic configuration of the first expression unit may be the same as the configuration of the first expression unit described in the second aspect. However, in the first expression unit of this embodiment, the gene of the transcriptional regulatory factor included in the vector is limited to the GAL4 gene encoded by the GAL4 protein, which is a galactose metabolic activation protein of yeast.
 また、第2発現ユニットも、基本的構成は第2態様に記載の第2発現ユニットの構成と同じでよい。ただし、第1発現ユニットに包含される転写調節因子の遺伝子がGAL4遺伝子であることから、第2発現ユニットに包含される転写調節因子の標的プロモーターは、GAL4の標的プロモーターでなければならない。GAL4の標的プロモーターとしては、例えば、UAS挙げられる。 The basic structure of the second expression unit may be the same as that of the second expression unit described in the second aspect. However, since the gene of the transcriptional regulatory factor included in the first expression unit is the GAL4 gene, the target promoter of the transcriptional regulatory factor included in the second expression unit must be the target promoter of GAL4. An example of a target promoter for GAL4 is UAS.
 雌蚕致死雄蚕不妊カイコ系統は、第1及び第2発現ユニットのいずれか一方を有する。第3態様と異なり、本態様では第2発現ユニットのみを有する遺伝子組換えカイコ系統のみならず、第1発現ユニットのみを有する遺伝子組換えカイコ系統も本発明の雌蚕致死雄蚕不妊カイコ系統に含まれる。 The female pupal lethal male sterilized silkworm strain has either one of the first and second expression units. Unlike the third embodiment, in this embodiment, not only the transgenic silkworm strain having only the second expression unit but also the transgenic silkworm strain having only the first expression unit is the female pupal lethal male pupal infertile silkworm strain of the present invention. included.
 雌蚕致死雄蚕不妊カイコ系統において、MascR遺伝子発現ベクターは、カイコ細胞内に一過的に存在してもよいし、また染色体中に導入された状態等で安定的かつ継続的に存在してもよい。通常は、安定的かつ継続的に存在することが好ましい。MascR遺伝子発現ベクターの2つの発現ベクターが染色体上に存在する場合には、各発現ベクターは異なる染色体上に存在することが好ましい。
4-3.雌蚕致死雄蚕不妊カイコ系統の作出方法
 本発明の雌蚕致死雄蚕不妊カイコ系統の作出方法は、第3態様の雌蚕致死カイコ系統の作出方法に準ずる。ただし、本態様の作出方法では、MascR遺伝子発現ベクターが第1及び第2発現ユニットの2つの遺伝子発現ユニットで構成される場合のみが該当する。
4-4.雌蚕致死雄蚕不妊カイコの作出方法
 本発明の雌蚕致死雄蚕不妊カイコ系統を用いて、不妊オス個体群のみから構成される雌蚕致死カイコを作出するには、第3態様の雌蚕致死カイコの作出方法における「2つの遺伝子組換えカイコの系統を交配させる方法」に準じて行えばよい。
In the female pupal dead male silkworm infertile silkworm strain, the MascR gene expression vector may be transiently present in the silkworm cell, or may be stably and continuously present in the state introduced into the chromosome. Also good. Usually, it is preferable to exist stably and continuously. When two expression vectors of the MascR gene expression vector are present on the chromosome, each expression vector is preferably present on a different chromosome.
4-3. Method for producing female slaughtered male sterilized silkworm strain The method for producing a female slaughtered male sterilized silkworm strain of the present invention is in accordance with the method for producing the female slaughtered male silkworm strain of the third aspect. However, in the production method of this embodiment, only the case where the MascR gene expression vector is composed of two gene expression units of the first and second expression units is applicable.
4-4. Method for producing female pupal dead dead male silkworm infertile silkworm Using the female female dead dead male silkworm infertile silkworm strain of the present invention, to produce female female dead dead silkworm composed only of infertile male population, the female silkworm of the third aspect The method may be carried out in accordance with the “method of mating two transgenic silkworm strains” in the method for producing lethal silkworms.
<実施例1: MascR遺伝子発現ベクターの構築>
(目的)
 本発明のMascR遺伝子発現ベクターを構築する。
(方法)
 本実施例では、第1発現ユニットと第2発現ユニットの2つの遺伝子発現ユニットからなるMascR遺伝子発現ベクターを構築した。第1発現ユニットとしては、ユビキタスなプロモーターであるアクチン3プロモーターと、転写調節因子の遺伝子であるGAL4遺伝子を有する既知の形質転換用遺伝子発現ベクターpBac[A3-GAL4: 3xP3-DsRed](Uchino et al., 2006, J. Insect Biotechnol. Sericology 75: 89-97)を用いたことから、ここでは、第2発現ユニットとしてpUAS-MascRベクターを構築した。また第2発現ユニットの対照用として野生型カイコMusc遺伝子を含むpUAS-Mascベクターを構築した。
<Example 1: Construction of MascR gene expression vector>
(the purpose)
The MascR gene expression vector of the present invention is constructed.
(Method)
In this example, a MascR gene expression vector composed of two gene expression units, a first expression unit and a second expression unit, was constructed. As the first expression unit, a known gene expression vector for transformation pBac [A3-GAL4: 3xP3-DsRed] having an actin 3 promoter which is a ubiquitous promoter and a GAL4 gene which is a gene of a transcriptional regulator (Uchino et al ., 2006, J. Insect Biotechnol. Sericology 75: 89-97), a pUAS-MascR vector was constructed here as the second expression unit. Moreover, the pUAS-Masc vector containing the wild-type silkworm Musc gene was constructed as a control for the second expression unit.
 まず、カイコp50T系統のオス個体から総RNAを抽出した。抽出は、Trizol(life technologies )を用いて行った。具体的な手順は、キットに添付のプロトコルに従った。得られた総RNAを鋳型としてRNA PCR Kit(TaKaRa Bio Inc.)を用いて逆転写反応を行いcDNAを合成した。具体的な手順は、キットに添付のプロトコルに従った。このcDNAを鋳型にカイコMasc遺伝子のコード領域を含むDNAをMasc_SF(配列番号11)及びMasc_SR(配列番号12)のプライマーペアを用いてPCRで増幅した。PCRは、PrimeSTAR GXL(TaKaRa Bio Inc.)を用いて行い、反応液組成は、PrimeSTAR GXLに添付されたプロトコルのスタンダードな方法に従った。PCRサイクルの条件は、98℃10秒、60℃15秒及び68℃2分を1サイクルとして、40サイクル行った。得られた増幅産物に10×A-attachment Mix(TOYOBO)を用いてA付加を行った上でpGemTeasy(プロメガ)にクローニングし、カイコMasc遺伝子のクローニングベクターを「Masc-pGemTeasy」を構築した。 First, total RNA was extracted from a male individual of the silkworm p50T strain. Extraction was performed using Trizol (life technologies). The specific procedure followed the protocol attached to the kit. Using the obtained total RNA as a template, a reverse transcription reaction was performed using RNA-PCR-Kit (TaKaRa Bio-Inc.) To synthesize cDNA. The specific procedure followed the protocol attached to the kit. Using this cDNA as a template, DNA containing the coding region of the silkworm Masc gene was amplified by PCR using a primer pair of Masc_SF (SEQ ID NO: 11) and Masc_SR (SEQ ID NO: 12). PCR was performed using Prime STAR® GXL (TaKaRa Bio Inc.), and the composition of the reaction solution was in accordance with the standard method of the protocol attached to Prime STAR® GXL. The PCR cycle conditions were 40 cycles with 98 ° C. for 10 seconds, 60 ° C. for 15 seconds and 68 ° C. for 2 minutes as one cycle. The amplification product thus obtained was subjected to A addition using 10 × A-attachment Mix (TOYOBO) and then cloned into pGemTeasy (Promega) to construct a silkworm Masc gene cloning vector “Masc-pGemTeasy”.
 次に、Masc-pGemTeasyを鋳型として、Masc_hind_FlagF(配列番号13)及びMasc_bamR(配列番号14)のプライマーペアを用いてPCRを行った。PCRの条件は、上記条件に準じた。得られた増幅産物は、N末端側にFLAGタグを融合したカイコMascタンパク質をコードしている。この増幅断片をpIZ/V5-His(life technologies)のHindIII/BamHI部位に挿入し、「Masc-pIZ」を構築した。 Next, PCR was performed using Masc-pGemTeasy as a template and a primer pair of Masc_hind_FlagF (SEQ ID NO: 13) and Masc_bamR (SEQ ID NO: 14). PCR conditions were in accordance with the above conditions. The obtained amplification product encodes a silkworm Masc protein in which a FLAG tag is fused on the N-terminal side. This amplified fragment was inserted into the HindIII / BamHI site of pIZ / V5-His (life technologies) to construct “Masc-pIZ”.
 一方、MascR遺伝子は、図1で示すようにFem piRNA認識配列中に5カ所の塩基置換を導入したものである。Masc-pIZを鋳型として、PrimeSTAR Mutagenesis Basal Kit (TaKaRa)とMasc_ resistant1(配列番号19)及びMasc_ resistant2(配列番号20)のプライマーペアを用いてPCRを行い、N末端側にFLAGタグを融合したカイコMascRタンパク質を含むプラスミドを構築し、「MascR-pIZ」とした。 On the other hand, the MascR gene has 5 base substitutions introduced into the FemFpiRNA recognition sequence as shown in FIG. PCR using PrimeSTAR Mutagenesis Basal Kit (TaKaRa) and Masc_ resistant1 (SEQ ID NO: 19) and Masc_ resistant2 (SEQ ID NO: 20) primer pairs using Masc-pIZ as a template, and a silkworm fused with a FLAG tag on the N-terminal side A plasmid containing MascR protein was constructed and designated as “MascR-pIZ”.
 続いて、Masc-pIZ及びMascR-pIZを鋳型として、in fusion-FLAG_F(配列番号15)及びin fusion-masc_R(配列番号16)のプライマーペアを用いて、それぞれPCRを行い、Masc ORF及びMascR ORFの増幅産物を得た。In-Fusion(登録商標) HD Cloning Kit(Clontech)を用いて、各増幅産物をカイコの形質転換用遺伝子発現ベクターであるpBacMCS[UAS-SV40, 3xP3-GFP TtoH]のユニークサイトBlnI部位に挿入した。具体的な挿入方法は、キットに添付の方法に従った。なお、pBacMCS[UAS-SV40, 3xP3-GFP TtoH]は、pBacMCS[UAS-SV40, 3XP3-EGFP] (Sakudoh et al., 2007, Proc Natl Acad Sci U S A 104: 8941-8946.)ベクターの3xP3-EGFPを含む断片を EcoRI による消化によってベクターから切り出した後、3xP3-EGFP断片の方向を転換して、同ベクターに再びライゲーションしたものである。
(結果)
 本発明のMascR遺伝子発現ベクター第2発現ユニットとしてpBacMCS[UAS-MascR-SV40,3xP3-EGFP](本明細書ではしばしば「pUAS-MascR」と表記する)と、その対照用第2発現ユニットとしてpBacMCS[UAS-Masc-SV40, 3xP3-EGFP](本明細書ではしばしば「pUAS-Masc」と表記する)を得た。pUAS-MascR及びpUAS-Mascの構成を図3に示す。
Subsequently, using Masc-pIZ and MascR-pIZ as templates, PCR was performed using primer pairs of in fusion-FLAG_F (SEQ ID NO: 15) and in fusion-masc_R (SEQ ID NO: 16), respectively, and Masc ORF and MascR ORF. Amplification product was obtained. Using In-Fusion (registered trademark) HD Cloning Kit (Clontech), each amplification product was inserted into the unique site BlnI site of pBacMCS [UAS-SV40, 3xP3-GFP TtoH], a gene expression vector for silkworm transformation. . The specific insertion method followed the method attached to the kit. PBacMCS [UAS-SV40, 3xP3-GFP TtoH] is a pBacMCS [UAS-SV40, 3XP3-EGFP] (Sakudoh et al., 2007, Proc Natl Acad Sci USA 104: 8941-8946.) Vector 3xP3-EGFP After the fragment containing the DNA was excised from the vector by digestion with EcoRI, the direction of the 3xP3-EGFP fragment was changed and ligated again to the vector.
(result)
PBacMCS [UAS-MascR-SV40,3xP3-EGFP] (often referred to herein as “pUAS-MascR”) as the second expression unit of the MascR gene expression vector of the present invention and pBacMCS as the second expression unit for the control [UAS-Masc-SV40, 3xP3-EGFP] (often referred to herein as “pUAS-Masc”) was obtained. The structures of pUAS-MascR and pUAS-Masc are shown in FIG.
 これらの第2発現ユニットにおける転写因子の標的プロモーターはUASであり、ターミネーターはSV40ターミネーターである。また、標識遺伝子は、胚、幼虫及び成虫の眼においてEGFPを発現する3xP3 EGFPである。さらに、UASの上流と標識遺伝子の下流に、トランスポゾンの逆位末端反復配列(ITRs)として、それぞれpiggyBacL及びpiggyBacRを含んでいる。
<実施例2:雌蚕致死カイコ系統の作出>
(目的)
 実施例1で構築したMascR遺伝子発現ベクターを用いて本発明の雌蚕致死カイコ系統を作出する。
(方法)
 実施例1で構築したMascR遺伝子発現ベクター第2発現ユニットpUAS-MascRとその対照用第2発現ユニットpUAS-Mascを、Qiagen Plasmid Midi Kit (Qiagen)を用いて精製した。具体的な生成方法は、キットに添付のプロトコルに従った。精製後のpUAS-MascRとpUAS-Mascを、それぞれトランスポゾン転移酵素をコードするpiggyBacヘルパープラスミドと共に、非休眠系統であるカイコw1, pnd系統の産卵後2~8時間の卵に顕微注入した(Tamura et al. 2000;前述)。注入後の卵は、加湿状態下、25℃で孵化するまでインキュベートした。孵化後、12時間明期と12時間暗期の光条件で25℃の飼育室にて、全齢を人工飼料(シルクメイト原種1-3齢S、日本農産工)で飼育した。人工飼料は2~3日毎に交換した(Uchino K. et al., 2006;前述 )。羽化後、兄妹交配を行い、得られたF1卵を孵化させて、3xP3-EGFPマーカーによる眼の蛍光の有無で選抜し、目的の遺伝子組換えカイコ系統を作出した。遺伝子組換えカイコ系統は、休眠系統であるw-cと交配させて系統を維持した。
(結果)
 pUAS-MascRが染色体に組込まれた雌蚕致死カイコ系統として「sumi13系統」(sumi13-1及びsumi13-3の2系統)と、UAS-Mascが染色体に組込まれた対照用系統として「sumi12系統」(sumi12-1及びsumi12-2の2系統)を得た。なお、雌蚕致死カイコ系統の2系統について、pUAS-MascRの染色体への挿入は、サザンブロッティングにより確認した(図示せず)。
<実施例3:雌蚕致死カイコにおける性比の検証>
(目的)
 本発明の雌蚕致死カイコ系統を用いて作出される雌蚕致死カイコがオス個体のみとなることを検証する。
(方法)
 実施例2で樹立したsumi13系統(UAS-MascR系統;雌蚕致死カイコ系統)とsumi12系統系統(UAS-Masc;対照用系統)のオス個体を、それぞれ193-2系統(BmA3-GAL4系統)(Uchino et al., 2006;前述)のメス個体と交配させてF1個体を得た。193-2系統は、カイコアクチン3プロモーターとGAL4遺伝子を連結した第1発現ユニットの構成を有する既知遺伝子発現ベクターを染色体に組込んだ遺伝子組換えカイコ系統である。
The target promoter of the transcription factor in these second expression units is UAS and the terminator is SV40 terminator. The marker gene is 3xP3 EGFP that expresses EGFP in embryonic, larval and adult eyes. Further, piggyBacL and piggyBacR are included as transposon inverted terminal repeats (ITRs) upstream of UAS and downstream of the marker gene, respectively.
<Example 2: Production of a silkworm strain killed by female pupae>
(the purpose)
Using the MascR gene expression vector constructed in Example 1, the female pupal dead silkworm strain of the present invention is produced.
(Method)
The MascR gene expression vector second expression unit pUAS-MascR constructed in Example 1 and its control second expression unit pUAS-Masc were purified using Qiagen Plasmid Midi Kit (Qiagen). The specific production method followed the protocol attached to the kit. The purified pUAS-MascR and pUAS-Masc were microinjected together with piggyBac helper plasmids, each encoding transposon transferase, into eggs 2-8 hours after laying in silkworm w1, pnd, which is a non-dormant strain (Tamura et al.) al. 2000; supra). Eggs after injection were incubated at 25 ° C. in a humidified state until hatched. After hatching, all ages were reared on artificial feed (silk mate species 1-3 years old S, Japanese Agricultural & Industrial Co., Ltd.) in a 25 ° C rearing room under light conditions of 12 hours light period and 12 hours dark period. Artificial feed was changed every 2-3 days (Uchino K. et al., 2006; supra). After emergence, brother-sister mating was performed, and the obtained F1 eggs were hatched and selected based on the presence or absence of eye fluorescence with a 3xP3-EGFP marker to produce the desired transgenic silkworm strain. The transgenic silkworm line was crossed with wc, a dormant line, to maintain the line.
(result)
“sumi13 strain” (two strains of sumi13-1 and sumi13-3) as a female dead lethal silkworm strain with pUAS-MascR integrated into the chromosome, and “sumi12 strain” as a control strain with UAS-Masc integrated into the chromosome (2 systems of sumi12-1 and sumi12-2) were obtained. In addition, the insertion of pUAS-MascR into the chromosome was confirmed by Southern blotting (not shown) for two strains of the female dead lethal silkworm strain.
<Example 3: Verification of sex ratio in female dead lethal silkworm>
(the purpose)
It is verified that a female pupal dead silkworm produced using the female pupal dead silkworm strain of the present invention is only a male individual.
(Method)
The male individuals of the sumi13 line (UAS-MascR line; female pupal dead silkworm line) and the sumi12 line (UAS-Masc; control line) established in Example 2 were respectively 193-2 lines (BmA3-GAL4 line) ( F1 individuals were obtained by mating with female individuals of Uchino et al., 2006; Line 193-2 is a transgenic silkworm line in which a known gene expression vector having the structure of the first expression unit in which the silkworm actin 3 promoter and the GAL4 gene are linked is incorporated into the chromosome.
 その後、得られたF1胚(卵)について、その性比を確認した。それぞれ一匹のメスから得られた胚の発生を進め、孵化した幼虫を眼の色素マーカーに基づいて選択し、各F1個体をそれぞれの遺伝子型に分類した。第2発現ユニット及びその対照ユニットを有するUAS系統(sumi13及びsumi12)は、選択マーカーとして3xP3-EGFPを有する。また、第1発現ユニットであるアクチンGAL4系統は選択マーカーとして3xP3-DsRedを有する。したがって、pUAS-MascR又はpUAS-Mascのみを有する個体では眼が緑色蛍光(G)を、BmA3-GAL4系統のみを有する個体では眼が赤色蛍光(R)を、そしてBmA3-GAL4とUAS-MascR、又はBmA3-GAL4とUAS-Mascを有する個体では、眼が緑色及び赤色蛍光(G+R)を呈する。また、いずれの発現ユニットも持たない個体では、眼に蛍光色が見られない(Negative)。分類した遺伝子型は、以上の4種類とした。各遺伝子型のF1個体を飼育し、孵化数、5齢幼虫ステージにおいて生存していたF1個体の雌雄鑑別を行い、性比を調べた。
(結果)
 表2に、各遺伝子型の胚数、孵化率及び5齢(終齢)幼虫の雌雄個体数を、図4に各系統における遺伝子型の性比を示す。
Thereafter, the sex ratio of the obtained F1 embryo (egg) was confirmed. Development of embryos obtained from one female each proceeded, hatched larvae were selected based on eye pigment markers, and each F1 individual was classified into its respective genotype. UAS lines (sumi13 and sumi12) with the second expression unit and its control unit have 3xP3-EGFP as a selectable marker. The actin GAL4 line which is the first expression unit has 3xP3-DsRed as a selection marker. Thus, in individuals with only pUAS-MascR or pUAS-Masc, the eye has green fluorescence (G), in individuals with only the BmA3-GAL4 line, the eye has red fluorescence (R), and BmA3-GAL4 and UAS-MascR, Or in individuals with BmA3-GAL4 and UAS-Masc, the eyes exhibit green and red fluorescence (G + R). In addition, in individuals that do not have any expression unit, no fluorescent color is seen in the eye (Negative). The classified genotypes were the above four types. F1 individuals of each genotype were bred and the number of hatched and F1 individuals who survived at the 5th instar larva stage were identified, and the sex ratio was examined.
(result)
Table 2 shows the number of embryos of each genotype, the hatching rate, and the number of male and female individuals of 5th instar (final) larvae, and FIG. 4 shows the genotype sex ratio in each line.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 表2から、いずれの遺伝子型の胚も孵化率は、ほとんどが80%を超えていた。しかし、sumi13系統(UAS-MascR系統)と193-2系統(BmA3-GAL4系統)を交配させて得られたF1個体のうち第1発現ユニットと第2発現ユニットを有するF1個体(G+R)では、5齢ステージまでに生存数がほぼ半減した。また、これら5齢ステージに生存していた個体はオスであった。一方、対照用のsumi12系統(UAS-Masc系統)と193-2系統(BmA3-GAL4系統)を交配させて得られたF1個体では、このような形質は認められなかった。また、第2発現ユニット又は対照用第2発現ユニットのみを有するF1個体(G)や第1発現ユニットのみを有するF1個体(R)でも5齢ステージまでの生存数の半減は認められず、性比もほぼ1:1であった(図4)。 From Table 2, most of the embryos of all genotypes exceeded 80%. However, among the F1 individuals obtained by crossing the sumi13 line (UAS-MascR line) and the 193-2 line (BmA3-GAL4 line), the F1 individual (G + R) having the first expression unit and the second expression unit. Then, the number of survivors was almost halved by the 5th stage. In addition, the individuals who survived at these 5-year-old stages were males. On the other hand, such traits were not observed in the F1 individuals obtained by crossing the control sumi12 line (UAS-Masc line) and the 193-2 line (BmA3-GAL4 line). In addition, even in F1 individuals (G) having only the second expression unit or the control second expression unit or F1 individuals (R) having only the first expression unit, the number of survivors up to the age of 5 years was not halved. The ratio was also approximately 1: 1 (FIG. 4).
 以上の結果から、第1発現ユニットと第2発現ユニットを有するF1個体(G+R)、すなわち、本発明の雌蚕致死カイコ系統を用いて作出された、MascR遺伝子を発現する雌蚕致死カイコでは、メスが出現せず、オスのみの集団となることが立証された。
<実施例4:雌蚕致死カイコにおけるメス致死性の検証>
(目的)
 実施例3で得られた第1発現ユニットと第2発現ユニットを有するF1個体(G+R)において、致死個体がメスであることを確認する。
(方法)
 実施例3の表2の結果からMascR遺伝子を発現する雌蚕致死カイコ(G+R)は、5齢ステージまでに約半数の個体が飼育中に死亡した。そこで、死亡した個体からゲノムを抽出後、性染色体を検出するPCRによって個体性別を判定した。
From the above results, F1 individuals (G + R) having a first expression unit and a second expression unit, that is, a female pupal lethal silkworm expressing the MascR gene produced using the female pupal lethal silkworm strain of the present invention. Then, it was proved that a female does not appear and it becomes a group of only a male.
<Example 4: Verification of female lethality in female pupae dead silkworm>
(the purpose)
In the F1 individual (G + R) having the first expression unit and the second expression unit obtained in Example 3, it is confirmed that the lethal individual is a female.
(Method)
From the results shown in Table 2 of Example 3, about half of the female pupal dead silkworms (G + R) expressing the MascR gene died during breeding by the age of 5 years. Therefore, after extracting the genome from the dead individual, individual sex was determined by PCR detecting sex chromosomes.
 sumi13-1×193-2(G+R)区の幼虫の死亡個体(17個体)、及びsumi13-3×193-2(G+R)区の幼虫の死亡個体(9個体)からゲノムDNAを抽出した。ゲノムDNAの抽出方法は、抽出方法は、Green & Sambrook(2012;前述)に記載の方法に従った。性別の判定は、W染色体上のRAPDマーカーをPCRにより検出する方法を用いた。PCRには、ゲノムDNAを鋳型にして、Musashi-A1(配列番号17)とMusashi-B1(配列番号18)をプライマーペアに用いた。PCRは、ExTaq(TaKaRa Bio Inc.)を用いて、反応液組成は、ExTaqに添付されたプロトコルのスタンダードな方法に従った。PCRサイクルの条件は、98℃10秒、55℃30秒及び72℃1分を1サイクルとして、40サイクル行った。反応後、増幅産物を1.5%アガロースゲルで電気泳動して、バンド数から性別を確認した。
(結果)
 図5Aに結果を示す。sumi13-1×193-2(G+R)区、sumi13-3×193-2(G+R)区ともに、死亡個体の大多数がメスであることが明らかとなった。また、これらの死亡個体では、2齢以降の生育が、正常に生育したオス個体と比較して著しく遅延していた(図示せず)。したがって、MascRタンパク質は、メス個体において幼虫期の生育遅延を引き起こし、メス致死を誘導することが示唆された。
Genomic DNA from larvae dead individuals (17 individuals) in sumi13-1 × 193-2 (G + R) group and larvae dead individuals (9 individuals) in sumi13-3 × 193-2 (G + R) group Extracted. The genomic DNA was extracted according to the method described in Green & Sambrook (2012; mentioned above). Gender was determined using a method of detecting the RAPD marker on the W chromosome by PCR. For PCR, genomic DNA was used as a template, and Musashi-A1 (SEQ ID NO: 17) and Musashi-B1 (SEQ ID NO: 18) were used as primer pairs. PCR was performed using ExTaq (TaKaRa Bio Inc.), and the composition of the reaction solution was in accordance with the standard method of the protocol attached to ExTaq. The PCR cycle conditions were 40 cycles, with 98 ° C for 10 seconds, 55 ° C for 30 seconds and 72 ° C for 1 minute as one cycle. After the reaction, the amplified product was electrophoresed on a 1.5% agarose gel, and the sex was confirmed from the number of bands.
(result)
The results are shown in FIG. 5A. In both the sumi13-1 × 193-2 (G + R) and sumi13-3 × 193-2 (G + R) wards, the majority of the dead individuals were female. Moreover, in these dead individuals, the growth after 2 years of age was significantly delayed compared to male individuals that grew normally (not shown). Therefore, it was suggested that MascR protein causes growth delay in the larva stage in female individuals and induces female lethality.
 以上より、MascRを発現する雌蚕致死カイコでは、メスが致死となる結果、オスのみが生存することが確認された。
<実施例5:雌蚕致死カイコが形成する繭の検証>
(目的)
 本発明の雌蚕致死カイコ系統から作出される雌蚕致死カイコが形成する繭の形態等について検証する。
(方法)
 実施例3のsumi13-1×193-2(G+R)区、及びsumi13-3×193-2(G+R)区で得られた雌蚕致死カイコの生存個体は、全てオスであった。これらの個体が性染色体レベルでオスであることを確認するために各個体の核型を調べた。sumi13-1×193-2(G+R)区から5齢幼虫11個体、sumi13-3×193-2(G+R)区から5齢幼虫3個体を選択して、各個体からゲノムDNAを抽出した後、核型を判定するためのPCRを行った。具体的な方法は、実施例4に記載の方法に準じた。
From the above, it was confirmed that in male pupal dead silkworms expressing MascR, only males survive as a result of female mortality.
<Example 5: Verification of cocoons formed by dead pupae silkworm>
(the purpose)
It verifies about the form etc. of the cocoon which the female pupal dead silkworm produced from the female pupal dead silkworm line of this invention forms.
(Method)
The surviving individuals of female pupal dead silkworms obtained in the sumi13-1 × 193-2 (G + R) group and the sumi13-3 × 193-2 (G + R) group of Example 3 were all male. . In order to confirm that these individuals were male at the sex chromosome level, the karyotype of each individual was examined. Select 11 5th instar larvae from sumi13-1 × 193-2 (G + R) group and 3 5th instar larvae from sumi13-3 × 193-2 (G + R) group. After extraction, PCR was performed to determine the karyotype. The specific method was in accordance with the method described in Example 4.
 また、sumi13-1×193-2(G+R)区、及びsumi13-3×193-2(G+R)区で得られた生存個体に繭を形成させて、その形態に異常が見られないか確認した。さらに、繭から蛹を取り出して、蛹の形態異常と性別についても確認した。蛹の性別は、尾端部の形態的な違いから鑑別した。
(結果)
 図5B及び図6に結果を示す。
In addition, the surviving individuals obtained in the sumi13-1 × 193-2 (G + R) and sumi13-3 × 193-2 (G + R) groups have wings formed, and abnormalities are observed in their morphology. I checked it. Furthermore, the cocoon was taken out of the cocoon and the morphological abnormalities and sex were confirmed. The gender of the moth was identified from the morphological difference at the tail end.
(result)
The results are shown in FIG. 5B and FIG.
 図5Bは、雌蚕致死カイコの5齢幼虫における性染色体の核型を示している。雌蚕致死カイコの生存個体は、全て性染色体型がZZ型のオスであることが確認された。 FIG. 5B shows the karyotype of the sex chromosome in the 5th instar larva of the female dead lethal silkworm. It was confirmed that the surviving individuals of the female pupae dead silkworm were males with sex chromosome type ZZ.
 図6は、雌蚕致死カイコを含む各系統のカイコに繭を形成させたときの繭の形態(A)とその繭内の蛹の形態及び性別(B)を示している。Aからも明らかなように、雌蚕致死カイコ(図中、sumi13-1(G+R)及びsumi13-1(G+R)で示す)が形成する繭には形態的な異常は認めず、雌蚕致死カイコからも正常な繭が得られることが判明した。またBから、その蛹の形態も正常であり、全てオスであることも確認された。
<実施例6:193-2系統におけるオス不妊性の検証>
(目的)
 実施例3で作出した雌蚕致死カイコ系統は、193-2系統が転写調節因子の遺伝子としてGAL4遺伝子を包含し、sumi13系統がGAL4の標的プロモーターであるUASとMascR遺伝子を包含することから雌蚕致死カイコ系統だけでなく、生存するオスが不妊となる雌蚕致死雄蚕不妊カイコ系統でもある。
FIG. 6 shows the form of a cocoon (A) and the form and sex (B) of the cocoon in the cocoon when the silkworm of each strain including a female pupal dead silkworm is formed. As is clear from A, no morphological abnormality was observed in the pupae formed by female pupal dead silkworms (indicated by sumi13-1 (G + R) and sumi13-1 (G + R) in the figure) It was found that normal silkworms can be obtained from dead female silkworms. B also confirmed that the wings were normal and all male.
<Example 6: Verification of male infertility in line 193-2>
(the purpose)
As for the female pupal lethal silkworm line produced in Example 3, the 193-2 line contains the GAL4 gene as a transcriptional regulator gene, and the sumi13 line contains the UAS and MascR genes that are the target promoters of GAL4. It is not only a lethal silkworm strain, but also a female dead lethal male infertile silkworm strain in which a surviving male becomes infertile.
 本発明の雌蚕致死雄蚕不妊カイコ系統の作出に使用した193-2系統が、オス不妊性となることを検証する。
(方法)
 193-2系統がオス不妊系統であることは、Uchinoら(Uchino et al., 2008, JIBS, Insect biochem. Mol. Biol., 38: 1165-1173)に記載されている。そこで、193-2系統のメスと白/C系統のオスを交配させた場合、及び白/C系統のメスと193-2系統のオスを交配させた場合、それぞれのメスの産卵数を確認した。
It is verified that the 193-2 line used for the production of the female mortal male sterilized silkworm line of the present invention becomes male infertile.
(Method)
It is described in Uchino et al. (Uchino et al., 2008, JIBS, Insect biochem. Mol. Biol., 38: 1165-1173) that the 193-2 line is a male infertile line. Therefore, when mating 193-2 females and white / C males, and when mating white / C females and 193-2 males, the number of eggs laid by each female was confirmed. .
 また、白/C系統のメスに193-2系統、w1-pnd系統、及び白/C系統のオスをそれぞれ交配させて、各メス個体の産卵数を測定した。産卵数は、複数の蛾区の平均値とした。
(結果)
 図7及び図8に結果を示す。
In addition, white / C females were mated with males of 193-2, w1-pnd, and white / C, respectively, and the number of eggs laid in each female was measured. The number of eggs laid was the average value of a plurality of Sakai Wards.
(result)
The results are shown in FIGS.
 図7は、193-2系統と白/C系統を相互交配させた時のメスの産卵状態を示している。Aは193-2系統のメスと白/C系統のオスを交配させた場合、Bは白/C系統のメスと193-2系統のオスを交配させた場合である。193-2系統のメスは正常に産卵し、次世代を得ることができたが、193-2系統のオスと交配した白/C系統のメスは、正常産卵数の1/4以下しか産卵できず、しかもそれらは全て孵化しなかった。 FIG. 7 shows the egg-laying state of the female when the 193-2 line and the white / C line are crossed with each other. A shows the case where 193-2 females and white / C males were crossed, and B shows the case where white / C females and 193-2 males were crossed. 193-2 females laid eggs normally and the next generation was obtained, but white / C females mated with 193-2 males could lay eggs less than 1/4 of the normal number of eggs laid. And none of them hatched.
 図8は、白/C系統のメスと様々な系統のオスを交配させたときの白/C系統メスにおける産卵数の違いを示す図である。1は未交尾メス、2は白/C系統メス×193-2系統オス、3は白/C系統メス×w1-pnd系統オス、及び4は白/C系統メス×白/C系統オスの結果である。同系統のメスを使用した場合であっても193-2系統オスを使用した場合には、未交尾メスの産卵数をも下回り、またその卵も全て孵化しなかった。 FIG. 8 is a diagram showing the difference in the number of eggs laid in white / C females when white / C females and various males are crossed. 1 is unmating female, 2 is white / C female x193-2 male, 3 is white / C female xw1-pnd male, and 4 is white / C female x white / C male It is. Even when females of the same strain were used, when 193-2 males were used, the number of eggs laid by unmated females was lower, and none of the eggs hatched.
 以上の結果から、193-2系統のオス、すなわちGAL4遺伝子を有するオスは不妊性であることが確認された。本発明の雌蚕致死雄蚕不妊カイコ系統から作出される雌蚕致死雄蚕不妊カイコも生存するオス個体は、第1発現ユニットに由来するGAL4遺伝子を有する。したがって、雌蚕致死雄蚕不妊カイコはオス不妊性であることが示唆された。 From the above results, it was confirmed that 193-2 strains of males, that is, males having the GAL4 gene, are infertile. A male individual who survives a female mortal male sterilized silkworm produced from the female mortal male sterilized silkworm strain of the present invention has a GAL4 gene derived from the first expression unit. Therefore, it was suggested that the female sterilized male sterilized silkworm is male infertile.
 なお、本明細書で引用した全ての刊行物、特許及び特許出願はそのまま引用により本明細書に組み入れられるものとする。 It should be noted that all publications, patents and patent applications cited in this specification are incorporated herein by reference as they are.

Claims (14)

  1.  Fem piRNA-Siwi複合体に対する切断耐性と野生型Masc遺伝子の活性を有する変異型Masc遺伝子であって、
     配列番号1で示される塩基配列からなるカイコMasc遺伝子において1391位~1419位のFem piRNA認識配列内、又は
     カイコMasc遺伝子のチョウ目昆虫のオルソログにおいて前記Fem piRNA認識配列に対応する塩基配列内
    に1又は2以上の、ナンセンス変異以外の塩基置換、フレームシフトを生じない欠失、及び/又はフレームシフトを生じない付加を有する前記変異型Masc遺伝子。
    A mutant Masc gene having cleavage resistance to the Fem piRNA-Siwi complex and the activity of the wild-type Masc gene,
    1 in the Fem piRNA recognition sequence at positions 1391 to 1419 in the silkworm Masc gene consisting of the base sequence shown in SEQ ID NO: 1, or in the base sequence corresponding to the Fem piRNA recognition sequence in the ortholog of the Lepidoptera insect of the silkworm Masc gene Alternatively, the mutant Masc gene having two or more base substitutions other than a nonsense mutation, a deletion that does not cause a frame shift, and / or an addition that does not cause a frame shift.
  2.  前記変異が
     カイコMasc遺伝子におけるFem piRNA認識配列内の1409位及び1410位を含む連続する15塩基からなる領域内、又は
     カイコMasc遺伝子のチョウ目昆虫のオルソログにおける対応する領域内
    に存在する、請求項1に記載の変異型Masc遺伝子。
    The mutation is present in a region consisting of 15 consecutive bases including positions 1409 and 1410 in the Fem piRNA recognition sequence in the silkworm Masc gene, or in a corresponding region in the ortholog of the Lepidoptera insect of the silkworm Masc gene. 2. The mutant Masc gene according to 1.
  3.  前記塩基置換がサイレント変異である、請求項1又は2に記載の変異型Masc遺伝子。 The mutant Masc gene according to claim 1 or 2, wherein the base substitution is a silent mutation.
  4.  ユビキタスな発現誘導型プロモーターの下流に機能的に連結した請求項1~3のいずれか一項に記載の変異型Masc遺伝子を発現可能な状態で含む変異型Masc遺伝子発現ベクター。 A mutant Masc gene expression vector comprising the mutant Masc gene according to any one of claims 1 to 3 operably linked downstream of a ubiquitous expression-inducible promoter.
  5.  前記ユビキタスな発現誘導型プロモーターが熱ショックタンパク質70プロモーターである、請求項4に記載の変異型Masc遺伝子発現ベクター。 The mutant Masc gene expression vector according to claim 4, wherein the ubiquitous expression-inducible promoter is a heat shock protein 70 promoter.
  6.  ユビキタスなプロモーター及び該プロモーターの下流に機能的に連結した転写調節因子をコードする遺伝子を含む第1発現ユニット、及び
     該転写調節因子の標的プロモーター及び該標的プロモーターの下流に機能的に連結した請求項1~3のいずれか一項に記載の変異型Masc遺伝子を含む第2発現ユニット
    から構成される変異型Masc遺伝子発現ベクター。
    A first expression unit comprising a gene encoding a ubiquitous promoter and a transcriptional regulatory factor operably linked downstream of the promoter, and a target promoter of the transcriptional regulatory factor and a functionally linked downstream of the target promoter A mutant Masc gene expression vector comprising a second expression unit comprising the mutant Masc gene according to any one of 1 to 3.
  7.  前記ユビキタスなプロモーターがアクチン3プロモーター、熱ショックタンパク質70プロモーター、又は伸長因子プロモーターである、請求項6に記載の変異型Masc遺伝子発現ベクター。 The mutant Masc gene expression vector according to claim 6, wherein the ubiquitous promoter is an actin 3 promoter, a heat shock protein 70 promoter, or an elongation factor promoter.
  8.  前記転写調節因子をコードする遺伝子がGAL4遺伝子であり、かつ該転写調節因子の標的プロモーターがUASプロモーターである、請求項6又は7に記載の変異型Masc遺伝子発現ベクター。 The mutant Masc gene expression vector according to claim 6 or 7, wherein the gene encoding the transcriptional regulatory factor is a GAL4 gene and the target promoter of the transcriptional regulatory factor is a UAS promoter.
  9.  請求項4又は5に記載の変異型Masc遺伝子発現ベクターを含む雌蚕致死カイコ系統。 A female pupal dead silkworm strain comprising the mutant Masc gene expression vector according to claim 4 or 5.
  10.  請求項6に記載の第2発現ユニットのみを含む雌蚕致死カイコ系統。 A female dead lethal silkworm strain containing only the second expression unit according to claim 6.
  11.  請求項8に記載の第2発現ユニットのみを含む雌蚕致死雄蚕不妊カイコ系統。 A female pupal dead male sterilized silkworm strain containing only the second expression unit according to claim 8.
  12.  請求項9に記載の雌蚕致死カイコ系統において、発生初期の胚に発現誘導処理を施す工程を含む雌蚕致死カイコの作出方法。 A method for producing a female pupal dead silkworm, comprising the step of subjecting an embryo in the early development stage to an expression induction treatment in the female pupal dead silkworm strain according to claim 9.
  13.  請求項6又は7に記載の第1発現ユニットを有する遺伝子組換えカイコ系統と請求項10に記載の雌蚕致死カイコ系統とを交配させる工程、及び
     前記第1及び第2発現ユニットを有する雌蚕致死カイコを選択する工程
    を含む雌蚕致死カイコの作出方法。
    The step of crossing the transgenic silkworm strain having the first expression unit according to claim 6 or 7 with the female silkworm lethal silkworm strain according to claim 10, and the female pupa having the first and second expression units. A method for producing a female dead dead silkworm, including a step of selecting a dead dead silkworm.
  14.  請求項8に記載の第1発現ユニットを有する雌蚕致死雄蚕不妊カイコ系統と請求項11に記載の雌蚕致死雄蚕不妊カイコ系統とを交配させる工程、及び
     前記第1及び第2発現ユニットを有する雌蚕致死雄蚕不妊カイコを選択する工程
    を含む雌蚕致死雄蚕不妊カイコの作出方法。
    The step of mating the female pup dead male sterilized silkworm strain having the first expression unit according to claim 8 and the female pup dead male sterilized silkworm strain according to claim 11, and the first and second expression units. A method for producing a female slaughtered male sterilized silkworm, comprising a step of selecting a female slaughtered male sterilized silkworm.
PCT/JP2015/081397 2014-11-14 2015-11-06 Female silkworm lethal strain of bombyx mori WO2016076240A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014232218A JP6497605B2 (en) 2014-11-14 2014-11-14 Female pupal dead silkworm strain
JP2014-232218 2014-11-14

Publications (1)

Publication Number Publication Date
WO2016076240A1 true WO2016076240A1 (en) 2016-05-19

Family

ID=55954327

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/081397 WO2016076240A1 (en) 2014-11-14 2015-11-06 Female silkworm lethal strain of bombyx mori

Country Status (2)

Country Link
JP (1) JP6497605B2 (en)
WO (1) WO2016076240A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117613A (en) * 2018-02-05 2019-08-13 中国科学院上海生命科学研究院 A kind of method preparing male sterile lepidopterous insects and its nucleic acid constructs
CN112175967A (en) * 2020-10-10 2021-01-05 安徽农业大学 PEN1 gene for enhancing plant resistance to lepidoptera pests and application thereof
CN113692225A (en) * 2019-03-05 2021-11-23 以色列农业和农村发展部农业研究组织(范卡尼中心) Genome-edited birds
CN114113569A (en) * 2021-11-25 2022-03-01 江苏科技大学 Method for establishing BmNPV resistant strain silkworm screening standard based on metabonomics technology
CN114317613A (en) * 2020-09-30 2022-04-12 浙江省农业科学院 Method for constructing female sterile line of lepidoptera insects by utilizing genome editing technology
CN114885906A (en) * 2022-04-28 2022-08-12 广西壮族自治区蚕业技术推广站 Method for rapidly fusing and purifying BmNPV resistance character and silkworm yellow cocoon character
CN114921469A (en) * 2022-04-12 2022-08-19 广西壮族自治区蚕业技术推广站 Application of bombyx mori olfactory receptor gene BmOR56

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DATABASE GenBank 30 May 2014 (2014-05-30), KAWAMOTO M. ET AL.: "Definition: Bombyx mori Masc mRNA for zinc finger protein, complete cds, strain: p50T", Database accession no. AB840788 *
HIROKI SAKAI ET AL.: "Kaiko ni Okeru Fem no Kino Kaiseki", DAI 37 KAI THE MOLECULAR BIOLOGY SOCIETY OF JAPAN NENKAI KOEN YOSHISHU, 7 November 2014 (2014-11-07), pages 1P-0641 *
IMAMURA M. ET AL.: "Targeted gene expression using the GAL4/UAS system in the silkworm Bombyx mori", GENETICS, vol. 165, no. 3, 2003, pages 1329 - 1340, ISSN: 0016-6731 *
KIUCHI T. ET AL.: "A single female-specific piRNA is the primary determiner of sex in the silkworm", NATURE, vol. 509, 2014, pages 633 - 636, ISSN: 0028-0836 *
SUSUMU KATSUMA ET AL.: "Kaiko Osu-ka Tanpakushitsu Masc no Kino Kaiseki", DAI 37 KAI THE MOLECULAR BIOLOGY SOCIETY OF JAPAN NENKAI KOEN YOSHISHU, 7 November 2014 (2014-11-07), pages 3P-0023 *
TAKAHIRO SHIOTSUKI ET AL.: "Induction of precocious metamorphosis by a transgenic technique for mouse", JSCE NEWS, vol. 2005, no. 119, 2005, pages 8 - 12 *
TAKASHI KIUCHI ET AL.: "A single female-specific piRNA is the primary determiner of sex in the silkworm", LIFE SCIENCE SHINCHAKU RONBUN REVIEW, 3 June 2014 (2014-06-03), Retrieved from the Internet <URL:http://first.lifesciencedb.jp/archives/8827> [retrieved on 20160104] *
TAKASHI KIUCHI ET AL.: "Kaiko no Sei wa Tatta Hitotsu no Chiisana RNA ga Kettei suru -80 Nenrai no Nazo o Tsuini Kaimei! Kaiko no Sei Kettei Mechanism", GRADUATE SCHOOL OF AGRICULTURAL AND LIFE SCIENCES, 15 May 2014 (2014-05-15), Faculty of Agriculture, The University of Tokyo, Retrieved from the Internet <URL:http://www.a.u-tokyo.ac.jp/topics/2014/20140515-l.html> [retrieved on 20160104] *
UCHINO K. ET AL.: "Evaluating promoter sequences for trapping an enhancer activity in the silkworm Bombyx mori", JOURNAL OF INSECT BIOTECHNOLOGY AND SERICOLOGY, vol. 75, no. 2, 2006, pages 85 - 97, ISSN: 1346-8073 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117613A (en) * 2018-02-05 2019-08-13 中国科学院上海生命科学研究院 A kind of method preparing male sterile lepidopterous insects and its nucleic acid constructs
CN110117613B (en) * 2018-02-05 2022-10-11 中国科学院分子植物科学卓越创新中心 Method for preparing male sterile lepidoptera insect and nucleic acid construct thereof
CN113692225A (en) * 2019-03-05 2021-11-23 以色列农业和农村发展部农业研究组织(范卡尼中心) Genome-edited birds
CN114317613A (en) * 2020-09-30 2022-04-12 浙江省农业科学院 Method for constructing female sterile line of lepidoptera insects by utilizing genome editing technology
CN114317613B (en) * 2020-09-30 2023-12-22 浙江省农业科学院 Method for constructing lepidopteran insect female sterile line by utilizing genome editing technology
CN112175967A (en) * 2020-10-10 2021-01-05 安徽农业大学 PEN1 gene for enhancing plant resistance to lepidoptera pests and application thereof
CN114113569A (en) * 2021-11-25 2022-03-01 江苏科技大学 Method for establishing BmNPV resistant strain silkworm screening standard based on metabonomics technology
CN114113569B (en) * 2021-11-25 2023-10-27 江苏科技大学 Method for establishing BmNPV resistance strain silkworm screening standard based on metabonomics technology
CN114921469A (en) * 2022-04-12 2022-08-19 广西壮族自治区蚕业技术推广站 Application of bombyx mori olfactory receptor gene BmOR56
CN114921469B (en) * 2022-04-12 2024-02-27 广西壮族自治区蚕业技术推广站 Application of silkworm olfactory receptor gene BmOR56
CN114885906A (en) * 2022-04-28 2022-08-12 广西壮族自治区蚕业技术推广站 Method for rapidly fusing and purifying BmNPV resistance character and silkworm yellow cocoon character

Also Published As

Publication number Publication date
JP6497605B2 (en) 2019-04-10
JP2016093148A (en) 2016-05-26

Similar Documents

Publication Publication Date Title
JP6497605B2 (en) Female pupal dead silkworm strain
Criscione et al. GUY1 confers complete female lethality and is a strong candidate for a male-determining factor in Anopheles stephensi
EP2823047B1 (en) Biocontrol
Heinrich et al. Germ‐line transformation of the Australian sheep blowfly Lucilia cuprina
JP6326703B2 (en) Exogenous gene expression enhancer
CN109844112B (en) Gene recombination straw rain worm silk
CN112188834B (en) Self-limiting noctuid
Du et al. Identification and functional characterization of doublesex gene in the testis of Spodoptera litura
Duan et al. Cre-mediated targeted gene activation in the middle silk glands of transgenic silkworms (Bombyx mori)
JP6436908B2 (en) Exogenous gene expression vector, transformant discrimination marker and transformant
JP6300302B2 (en) Silkworm sericin 1 mutant strain
Takasu et al. Fibroin heavy chain gene replacement with a highly ordered synthetic repeat sequence in Bombyx mori
JP4431739B2 (en) Use of DNA encoding the silkworm kynurenine oxidase gene
JP6541173B2 (en) Cell death induction vector and site-specific cell death induction silkworm strain having the same
JP6948064B2 (en) Mitochondrial dysfunction genetically modified silk thread insect
JP5794620B2 (en) Arylalkylamine-N-acetyltransferase gene and use thereof
WO2023190453A1 (en) Genome-modified silkworm producing chimeric silk yarns
KR102114194B1 (en) Transgenic silkworms producing silk expressed KillerRed protein
JP2023119400A (en) Method for making transgenic silkworm using dormant egg
JP2023084919A (en) Method for producing sterile lepidopteran insects and sterilizing agent for lepidopteran insects
CN117958220A (en) Self-limiting noctuid
Petrella HOW TO PRODUCE MALE-ONLY PROGENY IN PEST INSECTS FOR SIT: A BIOTECH APPROACH.
Class et al. Inventors: Luke Alphey (Abingdon, GB)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15858772

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15858772

Country of ref document: EP

Kind code of ref document: A1